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Abstract 
 
The Himalayan mountain range contains the highest peaks on Earth and has 
provided a diversity of environments for humans, some of which have required 
substantial genetic adaptation. I have used a combination of SNP-chip data, genome 
sequences and functional studies to explore the demographic history, genetic 
structure and signatures of adaptation in Himalayan populations. Eight hundred and 
eighty three individuals from 49 different autochthonous groups from Nepal, Bhutan, 
North India, and the Tibetan Plateau in China were genotyped for ~600,000 genome-
wide SNPs. High-coverage whole-genome sequences of 87 individuals from a subset 
of these populations plus three additional ones were also generated. Himalayan 
populations share a common genetic component derived from a single ancestral 
population, followed by the development of local fine structure correlating with 
language and geographical distribution. I find higher genetic diversification within the 
Himalayan populations than in the surrounding regions which correlates with the 
distribution of Indo-European and Tibeto-Burman speakers, suggesting that both 
language and geography have influenced the genetic structure of these populations. I 
refined Himalayan population demographic history, using both autosomal and 
uniparental sequences. Himalayan populations display different proportions of gene 
flow with neighbouring populations and diverse effective population sizes and split 
times. The Y-chromosome lineages identified are common in South and East Asia and 
Tibet, but mostly form distinct clusters in the Himalayas. High altitude adaptation 
seems to have originated in a single ancestral population and then spread widely in 
the Himalayan region in the last 5,000 years. Genetic signatures of adaptation to high 
altitude are observed in the Endothelial PAS Domain Protein 1 gene (EPAS1) and 
several other known and novel candidates. EPAS1 has previously been reported to be 
under selection and involved in adaptation to living at high altitudes and was 
suggested to result from introgression of DNA from an extinct hominin species 
(Denisovans) into Tibetans. However, functional studies of EPAS1 variants have not 
been systematically carried out and it is still unknown which variant(s) are 
responsible for high altitude adaptation and their mechanism of action. I used both in 
silico and in vitro studies to explore these topics and validate EPAS1 candidate 
regulatory variants. The introgressed haplotype extends for over 300 kb spanning six 
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genes (EPAS1, TMEM247, ATP6V1E2, RHOQ, CRIPT, PIGF). I optimised a protocol to 
induce hypoxia in cell lines with and without the Denisovan introgressed haplotype. 
Preliminary results show that in cell lines without the introgressed haplotype, EPAS1 
expression increases under hypoxic conditions, whereas in the cell lines with the 
introgressed haplotype the expression of EPAS1 remains constant.  The most likely 
functional candidate variants fall in a ~32.7kb region within EPAS1. High altitude 
adaptation thus seems to be driven by EPAS1 as well as coordinated by other genes 
involved in the hypoxic response.   
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1. Introduction 
1.1 Human origins, ancient migrations and 
mixing 
 
The origin of the genus Homo in Africa was proposed for the first time by 
Charles Darwin in “The Descent of Man and Selection in Relation to Sex” (1871) (1). 
Founded on embryological and Thomas Huxley’s comparative anatomical studies that 
illustrated how modern humans and apes share a common ancestor (2), Darwin came 
to the conclusion that the last shared ancestor of humans and apes probably lived in 
Africa. The discovery of relevant fossils and, more recently, the advent of genetic 
studies, confirmed Darwin and Huxley’s suggestions. The earliest known human 
species, Homo habilis, lived around 2.5 million years ago in Africa, and the closely 
related species Homo erectus and Homo ergaster appeared after 1.9 million years ago.  
Homo erectus was the first species with a body size and shape resembling modern 
humans and was also the first to expand outside Africa. Between 700,000–300,000 
years ago, at least four main human lineages were present in different part of the 
world: Homo erectus in Asia, Homo neanderthalensis in Eurasia, Homo sapiens in Africa 
and the Denisovans in Asia, a group closely related to Neanderthals (3, 4). 
Anatomically modern humans (AMH) seem to have evolved in Africa in the last 300 
thousand years (ka) where the earliest AMH fossils known thus far have been found 
at Jebel Irhoud in Morocco dating to ~310 thousand years ago (5), and at the 
Ethiopian sites of Omo Kibish dating to ~195 ka (6), and Herto dating to ~160 ka (7).  
Nowadays, although there is general acceptance of the African origin of modern 
humans, where specifically within this continent modern humans originated, and how 
and when the expansion of our ancestors from Africa to the rest of the world occurred, 
are still debatable. The traditional location for modern human origins has been 
Eastern Africa, where the human fossils of Omo Kibish and Herto were discovered, 
which were for many years the oldest known AMH remains. Genetic studies 
supporting this hypothesis reported that non-African populations carry part of the 
genetic diversity present in Eastern African individuals (8, 9). Nevertheless, this 
hypothesis has been challenged in recent years by new archaeological and genetic 
discoveries.  The recent report of human fossils dating back to ~300 thousand years 
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ago in Morocco raise the possibility of a Northern African origin. Genetic evidence 
from the Y chromosome reported the deepest-rooting Y chromosome clade (called 
A00) in West Africa (10, 11). On the other hand, the genetic analysis of sub-Saharan 
African hunter-gatherer communities suggested the possibility of a Southern African 
origin. The analysis of population differentiation and linkage disequilibrium (LD) 
patterns suggested that these populations are the most genetically differentiated in 
the world and thus in agreement with a South African modern human origin (12). New 
genetic and archaeological evidences could confirm one of these hypotheses or even 
suggest a more complex origin of our species from multiple regions (13).  
Another topic of debate is the route of the modern human dispersal out of Africa 
(OoA). Currently there are two main hypotheses, both with dispersal from Eastern 
Africa, but via a northern or southern route (14, 15). The northern path passes across 
northern Egypt into the Sinai Peninsula through a land corridor. Modern human 
remains found at Skhul (16) and Qafzeh (17) in Israel dating between 120 and 90 ka 
support this route of dispersal into the Middle East. More recently, a maxilla with 
associated dentition was discovered at Misliya Cave in Israel and dated to around 177-
194 ka, suggesting that modern humans might have left Africa even earlier than 
previously thought through a northern route (18, 19).  Conversely, the southern route 
implies crossing the Bab al Mandab Strait between the current countries of Eritrea 
and Yemen, and a rapid dispersal to South-East Asia and Oceania. This path involves 
crossing of a body of water, although during glacial periods it was less wide than the 
current state and easier to cross (14, 15, 20). Nevertheless, this coastal route is 
supported by some genetic evidence, although it lacks of clear archaeological 
evidence (21-23).  
The timing of the OoA expansion and the involvement of single or multiple 
waves of dispersal are also topics with little consensus.  Currently, there are two main 
hypotheses. In the first scenario, modern humans left Africa in a single major dispersal 
around 60-50 ka, and earlier dispersals in the Levant (Middle East) represented by 
individuals such as Skhul, Qafzeh and Misliya Cave did not contribute to present-day 
populations. The second hypothesis includes multiple waves of dispersal starting 
around 100-130 ka. The discovery of human remains and artefacts across Asia and 
Australia dated before 60 ka raises the possibility that the earlier dispersal into the 
Middle East (Skhul, Qafzeh, Misliya Cave) extended to East and South-East Asia (24-
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28). Genetic studies have generally favoured a single dispersal (23), but some have 
reported evidence for a small contribution (<2%) from an earlier migration (29). 
Modern humans during their dispersals into different parts of the world subsequently 
encountered and intermixed with at least other two human species, the Neanderthals 
and the Denisovans. The Denisovans were a population closely related to 
Neanderthals that split from the latter after the separation of both from the modern 
human lineage around 400–700 ka (4, 30, 31).  Neanderthals contributed genetic 
material to all non-African individuals, with slightly more in East Asians than West 
Asians/Europeans. One hypothesis proposes two events of introgression: a first event 
in the Levant close in time to the modern human out-of-Africa migration around 
50,000–60,000 years ago (32), followed by a second smaller introgression that only 
contributed genetically to Asians (33). An alternative hypothesis suggests dilution of 
the Neanderthal contribution in Europeans by mixing with a population lacking 
Neanderthal introgression. Denisovans contributed genetic material to more 
geographically-specific groups of modern humans including populations from South-
East Asia (including Himalayans), and dwellers of Papua New Guinea and Aboriginal 
Australians (34, 35). A recent study outlined the possibility of two pulses of Denisovan 
introgression, one including both South-East Asian and Oceanian individuals, and a 
second one only into the former group (36).  
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1.2 Genetic variation and positive selection in 
human populations 
 
1.2.1 Human genetic variation 
 
The eukaryotic cell is composed of cytoplasm, and a nucleus enclosed within 
membranes that contains the nuclear DNA. The cytoplasm has organelles, such as the 
mitochondria, that are essential for the functioning of the cell. These organelles are 
responsible for cellular metabolism and energy production, and contain a circular 
molecule of DNA that is maternally inherited and independent from the DNA present 
in the nucleus. In each cell, there are many mitochondria. The human nuclear genome 
is organised into 23 chromosome pairs, of which 22 are autosomes and the last pair 
are sex chromosomes. Females carry two copies of the X chromosome, whereas males 
have one copy of the X and one of the Y chromosome. The human genome contains 
around 20,000 genes that code for proteins and together make up 1–2% of the 
genome. In the remaining ~99% of the DNA, many genomic regions play important 
roles in regulating gene function (37-39).  
Genetic variation is the term used to describe differences in the DNA sequence 
between individuals. These genetic differences are mostly neutral but can result in 
differences in phenotype. Genetic variation can arise in both the germline (sperm and 
egg cells) and in somatic tissues, but only the variation occurring in the germline can 
be transmitted from one generation to the next and thus affect population dynamics. 
Two major sources of genetic variation are recombination and mutation. 
 Recombination is the process by which the genetic material inherited from 
both parents mixes when homologous chromosomes align and exchange genetic 
material, crossing over, during prophase I of meiosis. The crossing over shuffles 
paternal and maternal DNA in the offspring. Recombination between the X and Y 
chromosomes, except as described below, disrupts sex determination resulting in 
males with the absence of essential genes on the Y chromosome and females with 
possibly damaging genes. Hence, 95% of the human Y chromosome does not 
recombine and just two pseudoautosomal regions at the extremities of these 
chromosomes recombine. The rest of the Y chromosome is passed patrilineally from 
one generation to the other intact except for mutations (40). Likewise, mtDNA does 
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not recombine and passes matrilineally from one generation to the other intact, 
unless a mutation occurs (41).   
Mutations are changes to the DNA sequence and occur at different scales from 
entire chromosomal aberrations, such as translocation of chromosomal segments or 
changes in chromosome numbers, to single nucleotides. They can involve the 
insertion, deletion or duplication of up to millions of base-pairs (Mb) (structural 
variant, SV,  or copy-number variant, CNV), or the insertion or deletions of a few bases 
(INDEL). Insertion of transposable elements and change in number of tandem repeats 
of DNA motifs are also mutational events. The smallest mutations are single base 
substitutions resulting in single nucleotide polymorphisms, SNPs. Most new 
mutations are neutral, and do not affect the fitness of an organism. However, some of 
them can be beneficial or deleterious (42). CNVs are widespread in human 
populations and, although most do not have any phenotypic effect, others can be 
advantageous or deleterious (43, 44). For example, the duplication of the salivary 
amylase gene has undergone positive selection in populations with high-starch diets, 
whereas the alpha-thalassemia deletion in the alpha-globin gene cluster is considered 
protective against malaria (45, 46). On the other hand, CNVs have been associated 
with the increase risk of developing diseases such as cancer and a series of Mendelian 
diseases and complex traits (43, 47). Likewise, small INDELs can be deleterious 
especially when they occur within an open reading frame (ORF) because they can lead 
to a different protein sequence or to shifting the reading frame and premature 
termination. INDELs have been associated with diseases such as cystic fibrosis, acute 
myeloid leukaemia and other types of cancer (48). On the other hand, INDELs can 
bring beneficial effects such as the insertion-deletion variant (c.34delCinsTCCT) in 
HTRA1 that has been reported as protective against age-related macular degeneration 
in the Chinese population (49). Another example is the 4 bp deletion located in the 
second intron of EPAS1 that has been associated with high altitude adaptation in 
Tibetans (50).  
SNPs are the most abundant and most studied type of genetic variation within 
human populations. One of the main causes for base substitution is incorrect base 
incorporation during DNA replication. New (de novo) mutations arise when incorrect 
base incorporation during DNA replication is not corrected by DNA repair enzymes 
and the new base gets fixed in the DNA. However, replication is a high-fidelity process 
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and errors occur at very low frequency (10-9-10-11 per nucleotide per replication). 
Nevertheless, the substitution rate is not uniform across the genome. The CpG islands 
are genomic regions rich in dinucleotides where a cytosine is followed by a guanine 
in the 5' → 3' direction, and are mutational hotspots. Most CpG dinucleotides (~75%) 
are targets of DNA methylation with the formation of 5-methylcytosine by the 
addition of a methyl (-CH3) group to the 5-carbon of the cytosine ring by a 
methyltransferase enzyme. On the other strand, the complementary bases form a CpG 
site as well, thus methylation also affects the C base on this strand. When 5-
methycytosine is deaminated, it yields a uracil and subsequent mispairing with the 
guanosine on the other strand. These can lead to two scenarios: the U-G mispair can 
be fixed by replacing G with an A producing (after DNA replication) a T-A pair, or by 
changing the U to a C re-forming a C-G pair. (42, 51). Similarly to CNVs and INDELs, 
SNPs in different parts of the genome can have different functional impacts. 
Substitutions that do not alter any amino acid are called synonymous, and are 
frequently assumed to be selectively neutral. Mutations that lead to an amino acid 
change are called nonsynonymous or missense substitutions and can have different 
effects on function according to their position in the protein (42). Loss-of-function 
(LoF) mutations are predicted to reduce or completely abolished protein coding-
genes function. On the other hand, gain-of-function (GoF) mutations can confer an 
abnormal activity on a protein (52, 53). 
Overall, the term ‘variant’ is used to refer to any genetic difference between 
two DNA sequences, and different versions of the same variant are called ‘alleles’. 
Conventionally, the reference allele denotes the base that is found in the reference 
genome assembly (https://www.ncbi.nlm.nih.gov/grc). Conversely, the alternative 
allele indicates any variant that differs from the reference. It is important to note that 
the reference allele is not necessarily the more frequent allele (major allele) or the 
alternative the less frequent (minor allele) in a population. Moreover, the reference 
allele does not necessarily represent the ancestral state of an allele. The ancestral 
allele is defined as the ancestral state of a variant, and the derived allele has arisen 
subsequently by mutation. In practice, the ancestral allele for humans is inferred from   
the alignment of different primates from Ensembl compara and thus takes into 
account the alleles of several different apes (54).  
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Alleles that are physically close on the same chromosome tend to be inherited 
together more often than expected by chance. These blocks of alleles form relatively 
stable haplotypes. LD is a measure of how often two alleles are inherited together, and 
the coefficient (D) of LD is defined as the difference between the observed frequency 
of a pair of alleles at two loci (pAB) and the product of the frequencies of those two 
alleles expected for random association (pApB)(55): 
DAB = pAB − pApB 
Each pair of alleles is characterised by their own coefficient of disequilibrium. 
The extent of LD across the genome is variable within different human populations 
and LD maps are population specific (56, 57). African individuals generally show 
lower levels of LD compared to populations outside Africa, probably due to the larger 
size of human populations in Africa over time and greater time depth, compared with 
the relatively small number of modern humans that exited Africa during their 
expansion into the rest of the world (58).  
In population genetics, the variation in allele frequencies within populations is 
a valuable metric to understand population dynamics over time. According to the 
Hardy-Weinberg equilibrium theory, in the absence of any evolutionary force, the 
allele and genotype frequencies in an infinitely large and panmictic population will 
remain constant through time (59, 60). Factors that can change the allele frequency 
in a population and violate the Hardy-Weinberg equilibrium include mutations, 
genetic drift, non-random mating, gene flow and natural selection, for example. 
Mutations introduce new alleles into a population and, therefore, change the allele 
frequency spectrum. The frequency of the original allele will decrease because 
mutation changes it into a different allele (42). Genetic drift is the change in the 
frequency of an existing allele due to stochastic sampling of individuals in creating the 
next generation. The effect of genetic drift over time relates to the population size, 
with less genetic drift in large populations and vice versa (42, 61): in a small 
population, an allele can rapidly get either lost (allele frequency =0) or fixed (allele 
frequency =1), whereas in a big population alleles tend to vary less and stay near their 
starting frequencies. To summarise the effect of genetic drift in a population, the 
concept of effective population size (Ne) is often used. Ne differs from the census size 
(N) of a population and in genetics represents the number of individuals on an 
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idealised population that undergoes the same amount of genetic drift as the 
respective natural population. The effective population size is usually smaller than 
the census size of a population (42, 62-64). Ne is most commonly measured with 
respect to coalescence time. In an idealised diploid population with no selection, the 
pairwise nucleotide diversity is equal to 4µNe, where µ is the mutation rate. Hence, 
the effective population size can be calculated by dividing the nucleotide diversity by 
the mutation rate (65).  Similarly, gene flow is another cause of departure from Hardy-
Weinberg equilibrium. It consists of the movement of alleles from one population to 
another through interbreeding. This may be coupled with physical migration of 
individuals from one population to the other. The higher the gene flow, the lower the 
genetic difference between two populations. Inversely, isolation can increase the 
genetic differentiation between two populations (42). Lastly, natural selection is 
another mechanism leading to changes in allele frequencies over time. Natural 
selection occurs when individuals with a certain genotype have an advantage over 
other individuals with a different genotype in their ability to pass their alleles to their 
offspring. Positive selection increases the frequency of beneficial alleles in a 
population and the probability that these variants get fixed within the population, 
while negative selection decreases the frequency of deleterious alleles (42). However, 
both will skew local variation spectrum towards an excess of rare alleles. 
Advances in SNP genotyping and high throughput sequencing technologies 
over the last ten years have allowed the genotyping and sequencing of large numbers 
of samples in a cost-effective way, leading to the availability of large modern human 
population datasets. Datasets such as the 1000 Genomes Project (66), the Human 
Genome Diversity Project (HGDP) (67), the Simons Diversity Project (SGDP) (23) and 
the Estonian Biocentre Human Genome Diversity Panel (EGDP) (29) contain 
individuals from worldwide populations. They have allowed the description of 
worldwide patterns of human genetic variation and are a valuable resource for 
comparison when new populations are sequenced. In the last decade, the advent of 
new protocols for the extraction of ancient DNA (42, 68, 69) have resulted in an 
increasing number of ancient human DNA sequences and a better understanding of 
worldwide prehistorical and historical migrations, and how they have influenced the 
genetic variation we see today (70-72). Different approaches have been developed to 
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summarise genetic variation, in particular to measure genetic distances and genetic 
relationships between individuals. Widely used methods to estimate and display 
genetic distances are principal component analysis (PCA), STRUCTURE-like plots 
(particularly ADMIXTURE) (73, 74) and the Fixation index (FST). PCA is an 
unsupervised statistical approach used to reduce dimensionality in large datasets 
while minimising the information loss. In genetics, it clusters individuals based on 
their ancestry creating new uncorrelated variables that sequentially maximize 
variance. It is widely used in population genetics to identify population structure, 
individual outliers and potential genotyping errors (75, 76). STRUCTURE and 
ADMIXTURE are model-based clustering approaches also used to summarise 
population structure. However, in contrast to PCA, they require the specification of 
the number of ancestral components to use for assigning the ancestry of the 
individuals in the dataset.  FST is an allele frequency based measure of genetic 
differentiation between populations and, thus, informative about genetic distance 
between them. Phylogenetic tree and network methods are used to compare genetic 
relationships between individuals and populations. They can be based on allele 
frequency differences such as TreeMix (77) or genetic linkage information 
(haplotypes) such as ChromoPainter and fineSTRUCTURE (78). The latter methods 
use phased haplotypes to assess genetic similarity between individuals. Moreover, 
methods such as PCAdmix (79), RFmix (80) and HAPMIX (81) use haplotype 
information to infer local ancestry in admixed populations using reference panels 
related to the admixture sources. More recently, new approaches to study genetic 
affinity within modern human populations, and between them and ancient 
individuals, such as f3 and f4 statistics and D statistics, have been commonly used 
(82). These methods assay genetic affinity by computing tests of allele frequency 
correlations within individuals. They normally test if the allele frequencies in the 
populations analysed are consistent with a simple tree topology or if admixture 
events happened between them. Finally, coalescent methods such as PSMC or MSMC 
are used to reconstruct population demographic histories (42, 83, 84) and, because 
they require information from both variant and non-variant sites, can be only 
performed on whole-genome sequencing data. These methods infer the history of 
effective population size over time using the distribution of coalescence times within 
a genome.  When multiple genomes from different populations are used, it is possible 
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to infer the divergence time between two populations comparing the relative rates of 
within and between-population coalescences.  
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1.2.2 Natural selection 
 
Positive selection, as described in the previous section, is the mechanism 
through which beneficial alleles rise in frequency in populations over time. A trait 
undergoes positive selection if it is advantageous for the individual to survive and 
reproduce, and if it is heritable so that it can pass on to the next generation. The 
availability of whole-genome data for many different modern human populations has 
allowed the study of genome-wide patterns of positive selection in humans adapted 
to live in different environments around the world (42, 85). More recently, the 
increased number of genome sequences from archaic and ancient humans and other 
species has permitted a better understanding of the time depth of many adaptive 
signals in modern populations. At the molecular level, when alleles under positive 
selection become more frequent in a population, they leave specific signatures of 
genetic variation in the DNA sequences of the population. These patterns can be 
identified by comparison with the overall background distribution of human genetic 
variation that, according to the neutral theory, has evolved mainly under neutrality. 
Under this assumption, most of the population changes in genetic variation over time 
are due to genetic drift (86, 87). One of the biggest challenges is being able to tell if a 
change in genetic variation is due to selection or to demographic history confounder 
effects, such as substructure, bottlenecks (period of reduced sample size) or 
expansion.   
The most studied selective sweeps, hard or classic sweeps, happen when a new 
advantageous allele rapidly increases in frequency and carries with it the haplotype 
on which it occurred, reducing levels of variation in the neighbouring area (88). This 
effect is reduced with the increase of genetic distance from the allele under selection 
due to recombination. A soft sweep occurs when a neutral variant segregating in the 
population becomes beneficial, due to an environmental change for example. This is 
also called a sweep from standing variation (variants that are polymorphic in a 
population), and the advantageous allele already present in the population rises in 
frequency. A second case is a soft sweep from recurrent mutation that occurs when 
the sweep includes multiple distinct beneficial alleles appearing at the same locus 
increasing their frequencies. A partial sweep arises when a beneficial allele raises 
from low frequency to intermediate, but is still polymorphic (89-91). Hard sweeps are 
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relatively straightforward to detect and have been extensively studied. On the other 
hand, soft sweeps are more complicated to detect and distinguish from neutrality 
(42). Polygenic adaptation represents an alternative mode where the adaptive change 
involves small frequency changes in possibly hundreds or thousands of alleles in 
different genes (91, 92). Many human traits and diseases are highly polygenic, such 
as height, skin pigmentation, body mass index and  type 2 diabetes (93). Balancing 
selection is another kind of selective process where multiple alleles are actively 
maintained in the gene pool of a population by selection favouring heterozygotes or 
the rare allele (whichever it is). The most famous example of heterozygote advantage 
is the sickle-cell anaemia phenotype at the β-haemoglobin locus. Individuals 
heterozygous for the sickle-cell (S) allele show resistance to malaria (94). Finally, 
background selection is a process by which weakly deleterious mutations are purged 
from the population. This can cause reduction in genetic diversity, particularly around 
functionally-important regions (91).  
Over the decades, many methods for detecting positive selection and selective 
sweeps have been proposed. Most of them use information about ancestral and 
derived alleles, instead of reference and alternative. These methods can be classified 
into three main categories 1) SFS-based; 2) LD-based and 3) Population allele 
frequency based. The site frequency spectrum (SFS) is the distribution of the allele 
frequencies at many loci, such as SNPs or INDELs, in a sample or population (95, 96). 
SFS-based methods rely on the departure of the allele frequency spectrum in the 
region of a selective sweep from the neutral expectation.  In particular, an increase of 
high- and low-frequency derived variants is expected in the vicinity of the beneficial 
allele under a classic sweep model. Examples of these methods are Tajima’s D and Fay 
and Wu’s H (42, 97). LD-based approaches rely on the extent of linkage disequilibrium 
in the selected region. Selection on one allele can rapidly increase the frequency of the 
surrounding haplotype and, thus, LD can remain high at each side of the advantageous 
allele (42, 97). These methods are generally called extended haplotype tests, and 
examples are the extended haplotype homozygosity (EHH) test, the cross-population 
extended haplotype homozygosity (XP-EHH) test and the integrated haplotype score 
(iHS) (42). The last category of methods relies on measures of inter-population 
differentiation. They assume that selection has acted on one population, but not on 
the other. If two populations have an extreme difference in the allele frequency of a 
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variant compared with the allele frequencies of other variants, it is possible that 
selection is the cause of such a difference. Methods that measure differences in 
derived allele frequencies between populations, such as ΔDAF, single locus fixation 
index (FST) and population branch statistics (PBS), are widely used to detect signals 
of positive selection in human populations (42, 98, 99), and are applicable to both 
classic and soft sweeps. DeltaDAF (ΔDAF) is the measure of the allele frequency 
differences between a pair of populations (42). PBS is the measure of distance 
between three populations using FST and it estimates if there is an allele with extreme 
frequency difference compared to two other populations (99).  Exploiting all these 
approaches, strong candidates of positive selection have been found in modern 
humans including SNPs in the Ectodysplasin A receptor (EDAR) gene, associated with 
hair, tooth and skin development in Asians, the solute carrier family 24 member 5 
(SLC24A5) and the solute carrier family 45 member 2 (SLC45A2), both involved in 
light skin pigmentation in Europeans (100). Variants in proximity to the lactase gene 
(LCT) have been linked to the ability to digest lactose as an adult in Europe and 
Western Asia. Moreover, several candidates for selection seem to be involved in 
malaria resistance, including the Duffy antigen protein (DARC) and Glucose-6-
phosphate dehydrogenase (G6PD), and mutations in the α- and β-globin genes that 
can lead to thalassemias or sickle cell anemia (42, 46, 101, 102). Finally, another signal 
of adaptation to extreme environments is the high altitude adaptation in Ethiopians, 
Andeans and Himalayans (103). In particular, Himalayans show permanent 
adaptation to high altitude, and variants lying in the Endothelial PAS Domain Protein 
1 (EPAS1) gene show the strongest signature of selection (99). Interestingly, it has 
been discovered that this gene has a highly unusual haplotype structure in Tibetans 
compared to other modern human populations, probably due to introgression of DNA 
from Denisovans into the ancestors of Tibetans (104). 
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1.3 The Himalayan region: an overview 
 
The Greater Himalayan Region is a geographical area containing the world’s 
highest mountain peaks and a diversity of environments that have required 
substantial genetic adaptations by the humans who live there. This mountain barrier 
has also shaped the genetic, cultural and ethnolinguistic mosaic of South and East 
Asia. At present, the area falls into the countries of Nepal, Bhutan, India, Pakistan and 
the Tibetan Plateau in China. Opinions are divided about whether the Himalayas were 
used as a corridor that facilitated human migrations from the Tibetan plateau to South 
Asia in ancient times, or alternatively remained uninhabited due to their inhospitality 
until more recent times (105-108). Archaeological data suggest that the central 
Tibetan Plateau was populated during the Neolithic period (109), and there is 
evidence of earlier human occupation in the north-eastern Qinghai region (110). 
 
The Himalayan region is also one of the most complex linguistic areas in the 
world, containing two main language families, Indo-European and Sino-Tibetan, with 
Sino-Tibetan divided into the Tibeto-Burman (TB) and Chinese subfamilies.  Tibeto-
Burman speakers represent the majority of the Himalayan populations whereas the 
Indo-European speakers are restricted to the south of the mountain range. In all, the 
region contains six linguistic phyla with multiple languages within each phylum, and 
at least two language isolates (Burushaski and Kusunda) (111, 112).   However, the 
region has not been fully represented in earlier genetic studies. Previous analyses 
have mainly focused on populations residing to the north or south of this area, or on 
small numbers of populations (105, 113-116). In fact, most of the studies have focused 
on high altitude Tibetans and Sherpa, and a few other Nepalese populations, leaving 
unpresented most the genetic variation in the region (50, 99, 116, 117). Key aims of 
these initial studies were to understand the population separation between Han 
Chinese and Tibetans, and to understand the genetic relationship between Tibetans 
and Sherpa. There is little agreement on the split time between Han Chinese and 
Tibetans, with estimates ranging from around 2,700 years ago, via an intermediate 
time around 7,000-9,000 years ago to a deep split time around 15,000-16,000 years 
ago (50, 118, 119). Another topic with little consensus is the divergence time between 
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Tibetans and the Nepalese Sherpa, and indeed whether or not they are genetically 
distinct groups.     
Some studies support the hypothesis of a very recent split (~ 1,500 years ago) 
and propose that Sherpa are a recently derived Tibetan sub-lineage. Other studies 
report a deeper split time between 3,200–11,300 years ago, and that Tibetans and 
Sherpa are genetically separate groups. Another open question is the origin of the 
different Himalayan populations and if they share a common genetic component. 
Studies on modern and, more recently, ancient individuals from the Himalayan region 
have shown that Himalayan populations have a possible East Asian origin with 
subsequent gene flow from South Asia (105, 120-122). However, the genetic 
relationships between highlanders and lowlanders in the Himalayan region, and the 
genetic background and the amount of gene flow in these populations, needs further 
investigation.  
 
The first systematic genetic survey of Himalayan populations, which used 
autosomal microsatellite markers (STRs) (111), showed that there is higher genetic 
diversification among the Himalayans compared with the populations from the 
surrounding regions, and observed genetic differentiation between Indo-European 
and Tibeto-Burman speakers, suggesting that both language and geography have 
influenced the genetic structure of these populations. 
 
Himalayan populations reside in a broad range of altitudes and environments. 
At one extreme, the Terai region at the foothills of Himalayas is a tropical forest with 
endemic mosquito-borne diseases, in particular malaria (123), dengue fever (124) 
and parasitic infections (125). In the early 1990s it was reported that a population of 
this region, the Tharu, carried an alpha-thalassaemia deletion that was almost fixed 
and probably adaptive against malaria, but this possibility has not been extensively 
explored from the genetic point of view (46). In contrast, other Himalayan 
populations reside at high altitudes, and have developed extraordinary adaptations 
to this environment. Genomic scans in the Himalayas have previously identified 
genomic regions associated with high altitude adaptation. In particular, a Denisovan-
derived EPAS1 haplotype, whose frequency is strongly correlated with altitude in the 
Himalayan populations (99, 104, 126, 127) has been identified, but the functional 
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variants within the locus and the molecular mechanisms of high altitude adaptation 
in Himalayans remain largely unknown.  
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1.4 High altitude adaptation and the hypoxia 
molecular pathway 
 
1.4.1 Adaptation at high altitude 
  
High altitude adaptation is an evolutionary mechanism that allows a species to 
survive permanently at high altitudes (>2500 meters above sea level). This adaptation 
involves long-term physiological responses to hypoxia that are often associated with 
heritable genetic modifications. Hypobaric hypoxia is caused by the decrease of 
barometric pressure with progressively increasing altitude, and therefore with fewer 
oxygen molecules in the air compared to sea level. This means that each human breath 
contains less oxygen than at low altitude. Hypobaric hypoxia is a source of severe 
stress as a constant supply of oxygen is required for mitochondrial metabolism (the 
mitochondrial respiratory chain). The oxygen transport system in the mitochondria 
probably evolved under normoxic conditions at sea level (103).  
Modern human populations residing in the Himalayas in Asia, in the Andes in South 
America, and in Ethiopia in Africa, have all evolved an ability to live in hypoxic 
environments. These populations have adapted so that they maintain appropriate 
oxygen levels in the tissues that permit survival, growth, reproduction and 
development. Individuals living at low altitudes can suffer from acute mountain 
sickness (AMS), a serious condition arising from exposure to extreme hypoxia, that 
can progress to high altitude pulmonary edema (HAPE) or high altitude cerebral 
edema (HACE) (128, 129). Indigenous high altitude populations do not suffer from 
AMS because they have undergone drastic physiological and genetic changes. From 
the physiological point of view, the main changes are at the levels of haemoglobin 
concentration and oxygen saturation (the percentage of haemoglobin binding sites 
occupied by oxygen) in the bloodstream that together control the arterial oxygen 
content. Andean dwellers show a higher haemoglobin concentration compared to 
lowlanders, mirroring in some ways the response of lowland individuals moving to 
high altitudes (acclimatisation). When Andeans move to low altitudes, their 
haemoglobin concentration decreases to normal levels. Nevertheless, Andeans have 
an increased arterial oxygen content compared to lowlanders that provides more 
efficient transportation of oxygen throughout the body and lower oxygen saturation 
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(103, 130). Similarly to Andeans, the Ethiopian highlanders have elevated 
haemoglobin levels and increased arterial oxygen. Although few studies have been 
conducted on Ethiopian highlanders, these individuals are adapted to live at high 
altitude and do not show any signs of illness (131-133).  Finally, Tibetans do not show 
increased haemoglobin concentration. Instead, they show lowered oxygen saturation 
and arterial oxygen content. They also exhibit enlarged lung volumes, higher training 
capacity and better oxygenation at birth (134, 135).  
Together with these physiological adjustments, high altitude populations also 
show genetic signatures of convergent evolution to living at high altitudes (Figure 
1.1). Numerous genome-wide scans for positive selection have been performed in 
these populations and several genes highlighted. In Andeans, the hypoxic inducible 
factor (HIF) genes EGLN1, PRKAA1, NOS2, TGFA, CXCR4 and VEGFB, as well as the non-
HIF genes ELTD1 and PRKG1 have implicated the nitric oxide pathway as a target of 
positive selection (133, 136).  Genomic scans of Ethiopian highlanders have reported 
genes shared with Andeans and Himalayans, plus novel candidates.  Examples of these 
are BHLHE41, ARNT2, THRB, CXCL17, PAFAH1B3 and a gene-rich region on 
chromosome 19 containing genes implicated in vascular physiology (137). Additional 
genes have been associated with angiogenesis (VAV3), and calcium uptake (CBARA1) 
(137). Himalayans are the most studied populations for high altitude adaptation.  The 
first genome-wide positive selection scans identified several genes in the HIF 
pathway, including EGLN1 and EPAS1. In particular, their EPAS1 haplotype has been 
suggested to be the result of introgression of DNA from an extinct hominin species 
(Denisovans), as mentioned in the previous section (104). The widespread 
distribution of this haplotype was confirmed by genotyping the EPAS1 locus in the 
large dataset of Himalayan populations used in this thesis. High altitude populations 
show the highest proportion of these variants and they may have spread through the 
region by gene flow (127). More recently, additional candidates of selection have been 
proposed in the Himalayans including HMOX2 (a modifier of haemoglobin 
metabolism), PTGIS, VDR and KCTD12 (50, 138). 
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Figure 1. 1 Candidate genes for high altitude adaptation in Andeans, Ethiopians and Tibetans.  The three 
geographic regions where these populations reside are highlighted in red.  A list of selection candidates 
for each population is contained in the boxes (50, 133, 136, 137). The shared candidates are shown in 
bold.  
 
Many candidate genes have thus been proposed and doubtless many more will 
be found associated with high altitude adaptation. From previous studies and the new 
results presented in this thesis, it seems that no single variant or gene is responsible 
for high altitude adaptation. To understand the roles of these genes, it is now 
important to move in the direction of linking genotype to phenotype by identifying 
the causal variants responsible for high altitude adaptation, as has been done for the 
functional validation of EGLN1 variants in Tibetans (126). 
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1.4.2 Hypoxia molecular pathway 
 
Hypoxia inducible factor (HIF) is the master transcriptional regulator that 
detects and coordinates cellular responses to hypoxia in most mammalian cells. It is 
a heterodimer that consists of one of three α subunits (HIF-1α, HIF-2α (EPAS1), or 
HIF-3α) and a common β subunit (HIF-β, also known as ARNT). The HIF family belong 
to the basic–helix–loop–helix-PAS (bHLH-PAS) superfamily and both α and β subunits 
contain a Per Arnt Sim (PAS) and N-terminal helix–loop–helix (HLH) domain. 
Furthermore, the α subunits contain a transcriptional activation and a C-terminal 
oxygen-dependent degradation domain. The HIF-𝛼 subunits are specifically induced 
by hypoxia whereas the HIF-𝛽 subunit is constitutively expressed. HIF activity is 
tightly regulated by oxygen concentration through site-specific prolyl hydroxylation 
of the different α subunits. Under normoxia, one of the members of the prolyl 
hydroxylase protein family, PHD1 (EGLN2), PHD2 (EGLN1), or PHD3 (EGLN3) 
hydroxylates the HIF-α subunit in its oxygen-dependent degradation domain. The 
PHDs are members of the 2-oxoglutarate-dependent dioxygenase family. The primary 
site of hydroxylation in HIF-1α is on Pro564, Pro531 in HIF-2α and Pro490 in HIF-3α. 
The hydroxylated α subunit  then becomes a  target for the von Hippel-Lindau (VHL) 
protein, a component of an E3 ubiquitin ligase complex that triggers the degradation 
of HIF-α by the ubiquitin–proteasome pathway (Figure 1.2). During hypoxia, the 
oxygen-dependent hydroxylation of HIF-α is prevented, leading to the stabilization of 
HIF-α and its dimerization with HIF-β (132, 139). It is important to note that the 
activity of PDH enzymes is also regulated by the concentration of reactive oxygen 
species (ROS), Krebs cycle intermediates, and ascorbate and iron concentrations 
(140). Moreover, HIF activity is mostly modulated by hydroxylation, but other post-
translational modifications, such as phosphorylation and acetylation, can also 
regulate its activity.  An additional regulation level of HIF-α is provided by the factor 
inhibitor HIF (FIH), another member of the 2-oxoglutarate-dependent dioxygenases 
family. FIH targets an asparagine residue in the HIF activation domain and 
hydroxylates it, specifically Asn803 in HIF-1α, and Asn851 in HIF-2α. In normoxic 
conditions, this hydroxylation blocks the interaction with the transcriptional 
coactivator CBP/p300. In contrast, under hypoxic condition, the reduction of this 
modification allows the functional interaction of HIF-α with CBP/p300 and thus 
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activates a transcriptional cascade. Therefore, hydroxylation plays a key role in 
regulating HIF activity by both conferring protein stability and transcriptional 
activation. Once HIF-α is stabilized, it forms a heterodimer with HIF-β via their HLH 
and PAS domains and then regulates the expression of hundreds of genes involved in 
cellular and systemic responses to hypoxia, by binding to specific sequence motifs on 
the target genes termed the hypoxia responsive elements (HRE) (132, 139, 141).  
 
Figure 1. 2 The molecular hypoxic pathway. In normoxia, PHD2 prolyl hydroxylates HIF-α subunits, 
targeting them for degradation via VHL-dependent ubiquitination. In hypoxia, the hydroxylation is 
blocked, allowing HIF-α stabilization, dimerization with HIF-β, and binding to target genes through the 
hypoxia response element (HRE). 
 
HIF-1α and HIF-2α can regulate both common and distinct genes and cellular 
responses. Both can regulate the activity of the Vascular Endothelial Growth Factor A 
(VEGFA) that codes for a protein essential for angiogenesis. In genetically engineered 
mice with deletion of one or two copies of the gene, it has also been shown that 
haploinsufficiency of either HIF-1α or HIF-2α can prevent or delay hypoxia-induced 
pulmonary hypertension (132, 142). HIF-1α is the key regulator of glycolytic enzyme 
genes, mitochondrial biogenesis and oxidative phosphorylation. It is also important 
in the regulation of hematopoietic stem cell activity. In contrast, HIF-2α tightly 
regulates the erythropoietin (EPO) gene in kidney cells. EPO is responsible for 
erythropoiesis (red blood cell production). Evidence in both mice and humans 
40 
 
 
 
showed that HIF-2α LoF leads to anaemia, whereas GoF leads to erythrocytosis 
(increased number of circulating red blood cells). Furthermore, it has been shown 
that HIF-1α and HIF-2α can also display antagonistic effects: the former triggers cell 
cycle arrest whereas the latter stimulates its progression. In murine endothelial cells, 
HIF-1α induces nitric oxide (NO) production through the activation of the NO 
synthase gene (NOS2), whereas HIF-2α inhibits NO production, inducing the activity 
of the arginase gene (ARG) (132). Little is known about HIF3-α, but it seems to act 
both as an activator and repressor of transcription (132).  
Like the HIF factors, the PHDs can have common and individual functions. PHD2 is the 
most studied and, possibly, the most important. Mouse knockout of PHD2 leads to 
embryonic lethality, whereas PHD1 and PHD3 knockouts are viable and fertile (143). 
Moreover, PHD2 plays an important role in the regulation of erythropoiesis through 
the regulation of HIF-2α and the transcription of EPO (126, 132). Studies of PHD1 and 
PHD3 have been limited compared to PHD2, but it seems that PHD3 is a HIF target and 
down-regulates HIF activity through a negative feedback loop (144).  
Himalayan populations consistently show strong signals of positive selection at the 
EGLN1 (PHD2) and EPAS1 (HIF-2α) genes. A key question is how the genetic changes 
in the two antagonists lead to the final phenotype of adaptation. Many different 
scenarios can be proposed from the different regulation of these two factors in 
highlanders versus lowlanders. In lowlanders, levels of HIF-1α and HIF-2α are kept 
low through hydroxylation and degradation. At high altitude, PHD2 activity is reduced 
and the activity of HIF-1α and HIF-2α triggered. In highlanders, it is possible that the 
PHD2 allele is either a LoF with attenuated hydroxylase activity, or a GoF with 
enhanced activity. Likewise, HIF-2α can show increased activity (GoF) or reduced 
activity (LoF). This indicate the possibility of four different models of adaptation in 
Himalayans (132): 
1. PHD2 activity is reduced (LoF) and, thus, HIF-2α activity in enhanced (GoF). 
However, this model seems unlikely as it would predict high haemoglobin 
levels, which are not observed in Tibetans and Sherpa (145). 
2. GoF for both PHD2 and HIF-2α: This combination would be possible if the 
PHD2 allele was stronger than the HIF-2α one. 
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3.  GoF for PHD2 and LoF for HIF-2α: This would lead to reduced activity of HIF-
α factors. In particular, it would reduce EPO with a consequently diminished 
response to hypoxia. 
4. LoF for both PHD2 and HIF-2α: The LoF of PHD2 would imply that the HIF-2α 
allele is a very strong LoF allele that could lead to the inhibition of HIF-2α and 
simultaneous activation of HIF-1α. 
 
Finally, oxygen deprivation leads to the production of reactive oxygen species 
(ROS) in the mitochondria. ROS are a variety of free radicals, chemical species with 
one unpaired electron, and molecules derived from molecular oxygen. Most of them 
derive from their precursor, the superoxide. The latter are formed when the redox 
centres in the mitochondrial electron transport chain leak electrons to oxygen (139).  
ROS lead to the stabilisation of HIF-α isoforms during hypoxia, and activation of the 
downstream pathway.  There is increasing evidence that mitochondria are one of the 
most important oxygen sensors, and hence they have a central role in the hypoxic 
response. Under hypoxic conditions, mutations in the mitochondrial respiratory chain 
or complex 1 inhibitors block the stabilisation of HIF-α (139). Hence, the hypoxic 
response involves tight regulation steps both at the cytoplasmic and nuclear levels of 
the cell. Functional studies in Himalayan individuals are necessary to understand 
which putative model of adaptation they went through and which genes are involved 
in this mechanism.  
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1.5 Aims and objectives 
 
The aim of this thesis was to provide a fine-scale description of the human 
genetic variation in the Himalayas. In particular, my goal was to describe populations 
that had not previously been genetically characterised, exploring their population 
structure and demographic history. My intent was to understand when Himalayans 
communities separated from each other, and from the neighbouring populations in 
South and East Asia, and the genetic relationships between them. Furthermore, my 
objective was to understand how geographical isolation, genetic drift and selection 
have affected the genetic landscape of Himalayan populations. Similarly, I wanted to 
explore if there was correlation between genes and languages in this region, and if 
both of them participated in shaping the variability we see today in the Himalayas.  
Finally, because Himalayan populations live in a broad range of environments and 
altitudes, my intention was to look for signals of positive selection at both low and 
high altitudes. Moreover, due to the great number of high altitude populations in the 
dataset, I wanted to explore the genetic relationships between them and look for 
known and possibly new candidates of high altitude adaptation. Finally, because of 
the unknown molecular mechanism of action, I wished to explore candidate 
functional variants in EPAS1 both in silico and in vitro. Using cell lines heterozygous 
for the Denisovan introgressed and non-introgressed haplotypes from the same 
genetic background, I wanted to understand if differential expression in EPAS1 was 
detectable between them. My hypothesis was a scenario in which there was LoF for 
HIF-2α leading to reduced activity of the HIF-α factor, and subsequent suppression of 
EPO expression in introgressed cell lines. Hence, to address these scientific questions, 
I used a combination of SNP-genotype data, whole-genome sequences, functional 
work and expression data. 
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1.6 Outline of the thesis 
 
This thesis presents the results of the largest genome-wide population-genetic 
analysis of humans residing in the Himalayan region thus far reported, and a 
preliminary biological and functional analysis of positive selection of the EPAS1 gene 
in high altitude Himalayan populations. The first results chapter (Chapter 2) describes 
the characterisation of the populations, their structure, and genome-wide signatures 
of high altitude adaptation using SNP-chip genotype data. The second results chapter 
(Chapter 3) uses a subset of samples with high coverage whole-genome sequencing 
data to refine demographic history using autosomal and uniparentally inherited 
sequences (mtDNA and Y chromosomes) with both common and rare variants. The 
third results chapter (Chapter 4) describes the experimental exploration of EPAS1 
molecular function under laboratory-induced hypoxia, simulating high altitude, and 
the analyses of its expression profile using quantitative PCR and RNA-sequencing. The 
general introduction at the beginning is expanded in the individual chapters, giving 
more detailed information about chapter-specific topics, and general discussion 
points are covered in the final chapter (Chapter 5). 
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2. Population genetic analyses of 
Himalayan samples using SNP-genotype 
data 
2.1 Introduction 
 
The genetic characterisation of human populations requires a large number of 
samples and genetic markers. In the past, analyses of population history and the 
genetic relationships between populations were mostly performed using the 
uniparentally inherited mtDNA and Y chromosome and single autosomal locus 
markers, such as the human leukocyte antigen (HLA) (146). More recently, 
technological advances such as next-generation sequencing methods have allowed us 
to perform genome-wide analyses in a reasonably short time period and in a cost-
effective way, improving drastically researchers’ possibility to describe human 
populations and detect alleles associated with a specific disease. In particular, single 
nucleotide polymorphisms (SNP) genotyping arrays have become one of the most 
used methods for assessing human genetic variation. High-throughput SNP-
genotyping is a technique that allows us to assay SNPs across the genome of an 
individual on a large scale. There is a plethora of commercially available SNP-chips 
designed for different purposes and for diverse species with the aim of testing 
hundreds of thousands of SNPs on a single chip. Human SNP-chips from Illumina and 
Affimetrix are used most frequently and, even though there are differences between 
the two platforms, they both can assess hundreds of thousands to millions of markers. 
Both rely on DNA base pair complementarity where A binds to T and C binds to G 
(147). Short nucleotide probes are designed to bind specific DNA target sequences 
and directly tag SNPs. Genomic DNA is amplified by PCR, fragmented, labelled with a 
fluorescent marker and bound to the chip. After the hybridisation of the DNA to the 
probes, all the non-specific and unbound DNA is washed away. The occurrence of the 
target allele in the DNA sample is assessed by evaluating the fluorescent signal at each 
probe. Genome-wide genotyping has the advantage of being an affordable and reliable 
platform for describing genetic variation across the entire genome of many 
individuals and for identifying genomic regions linked to a specific phenotype or 
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disease susceptibility. Although whole-genome sequencing provides a finer base-by-
base resolution of the genome, it is still too expensive to perform for the big cohorts 
commonly used in genome-wide association studies (GWAS).   
SNP-chips have been widely used in population genetics to characterise 
human populations, describing their genetic structure, and to identify loci undergoing 
positive selection (148). SNP-chip data produced by different studies are easy to 
combine together and many bioinformatic tools have been developed to handle such 
data. Nevertheless, genome-wide genotyping has some drawbacks. One of them is the 
ascertainment bias. This is the systematic bias of statistical results as a result of the 
choice of SNPs included in the chip. These have to be polymorphic in at least one 
population and, since European populations are the most studied, many of the 
commercially available SNP-chips are constructed using markers known to be 
polymorphic in Europeans. This bias can have important effects on the analysis 
results. Firstly, the allele frequency distribution can be skewed towards intermediate 
frequency alleles and the heterozygosity in Europeans can be over-estimated 
compared with non-Europeans individuals. In addition, the SNP distribution across 
the genome is not uniform with certain regions of the genome being enriched for SNPs 
whereas others are depleted. SNP ascertainment bias can affect linkage 
disequilibrium (LD) inferences such as the ability to tag specific genomic regions by 
SNPs, which relies on the strength of LD. Therefore, it is important to take into account 
the ascertainment bias when performing population genetics analyses and 
demographic inferences. In particular, it is critical to acknowledge this bias when 
performing demographic history analyses or positive selection scans that use allele 
frequency distributions and heterozygosity estimates (148-150). Nevertheless, 
despite these caveats, many of the computational methods developed to analyse 
genome-wide genotype data are relatively robust to ascertainment bias and the 
design of some of the SNP-chips captures variation across multiple worldwide 
populations. For example, the Affymetrix Human Origins array has been developed 
specifically for investigating human migrations, history and natural selection (82). It 
contains SNPs from eleven modern human populations from the Human Genome 
Diversity Cell Line Panel (HGDP-CEPH), Neanderthals, Denisovans and chimpanzees 
(82, 151). Markers were chosen to avoid confounding biases and to allow robust 
statistical analyses in population genetics. Similarly, the Illumina 
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HumanOmniExpress arrays have been designed selecting genomic variants from the 
HapMap project to represent the best amount of common SNP variation (MAF > 5%) 
in individuals with European, Asian and African ancestry (152). Overall, SNP 
ascertainment bias is an important concern when performing analyses, but it should 
not only be interpreted as problematic and SNP-chips are an invaluable and 
inexpensive platform for population genetics and GWAS. 
Finally, genome–wide SNP genotyping has also been chosen as one of the 
approaches for capturing genetic variability from human ancient genomes. To enrich 
for the small amount of human DNA versus the abundant microbial sequences in most 
post-mortem human bone remains, researchers at the Max Plank Institute in Leipzig 
designed a method to fish human DNA out of ancient samples. This targeted 
sequencing approach involved the use of fifty-two-bases long DNA sequences 
designed to capture over a million variable positions across the human genome (153). 
This approach proved to be very cost-effective and sensitive for capturing genetic 
variation, although for a limited number of genomic positions. To have a complete 
overview of genetic variability a better approach is to perform whole-genome 
sequencing of the ancient remains, but this is expensive and time-consuming and 
usually results in very low coverage of the sample, due to the low endogenous ancient 
DNA content. 
In this chapter, I will describe the analyses performed using genome-wide 
SNP-genotype data from the biggest modern Himalayan population dataset analysed 
thus far. It comprises individuals from 49 diverse populations from Nepal, Bhutan, 
Tibet and North India, representing the two major language families, Tibeto-Burman 
and Indo-European. The main aim of this project was to genetically characterise 
human populations that had not been extensively studied before and give a better 
picture of the genetic variation in the Himalayan region. Another focus was on 
understanding the genetic relationships within the Himalayan populations and, due 
to the linguistic richness in the Himalayan region, to examine whether there was a 
correlation between genes and languages. I also explored the genetic relationship of 
the Himalayan individuals with other worldwide populations, in particular South and 
East Asians, and investigated possible admixture events with those populations. I also 
investigated the genetic affinity of modern Himalayans with ancient Eurasian 
individuals. Finally, due the harsh environment in which many Himalayan 
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populations live, I screened for variants underlying positive selection in association 
with high altitude adaptation. The text and figures of this chapter have been mostly 
taken from Arciero et al, 2018 (154). 
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2.2 Materials and Methods 
 
2.2.1 Samples and dataset 
 
Eight hundred and eighty-three individuals belonging to 49 Himalayan 
populations were genotyped and analysed after obtaining informed consent. The 
dataset included 26 populations from Nepal, 16 from Bhutan, two from North India 
sampled in Bhutan, and five from Tibet in China (Figure 2.1; Table 2.1). The samples 
represent the two major linguistic families in the area: Indo-European and Tibeto-
Burman (also known as Trans-Himalayan). Specifically, 44 populations comprise 
Tibeto-Burman speakers from Tibet, Bhutan, North India or Nepal, and five comprise 
Indo-European speakers from Nepal (Chetri, Damai, Majhi, Sarki and Sonar). The 
Bhutanese, North Indian and Nepalese samples were collected as part of the 
‘Language and Genes of the Greater Himalayan Region’ project, a genetic survey of 
Tibeto-Burman and Indo-European speakers from these Himalayan countries, and 
have been described previously (111). Tibetan samples were selected from 
participating members of an epidemiological study in the Tibet Autonomous Region, 
China, in 2007, that was approved by the institutional ethics review board of BGI-
Shenzhen. Samples were collected from healthy unrelated Tibetans from five villages 
based on their medical records and a comprehensive medical examination during 
sampling. Peripheral venous blood or saliva was collected for DNA extraction and 
genotyping. All participants had a self-reported family history of at least three 
generations living at the sampling site. The samples were genotyped using three 
Illumina SNP-chips: 1) HumanOmniExpress-12 v1.0 BeadChip (741k SNPs) at the 
Wellcome Sanger Institute; 2) HumanOmni1-Quad BeadChip (~1M SNPs) at the 
Leiden University Medical Center; and 3) HumanOmniExpress-24 BeadChip (~713k 
SNPs) at BGI-Shenzhen. Genotype calling and QC on all samples were performed using 
the Sanger Institute’s variant calling pipelines, and SNP positions were mapped to the 
human reference assembly GRCh37. Genotypes from the three arrays were merged 
using PLINK 1.92 (155), resulting in a dataset of  600,838 SNPs. 
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Code Population Sample size Language family Latitude (⁰) Longitude (⁰) Altitude (m) 
Bhutan             
KAT Brokkat 16 Tibeto-Burman 27.73 90.43 3750 
BRP Brokpa 14 Tibeto-Burman 27.40 91.72 1608 
BUM Bumthang 19 Tibeto-Burman 27.67 90.55 3250 
CHL Chali 19 Tibeto-Burman 27.38 91.02 3201 
DAK Dakpa 2 Tibeto-Burman 27.47 91.52 2169 
DZA Dzala 14 Tibeto-Burman 27.90 91.15 2705 
GNG Gongduk 17 Tibeto-Burman 27.08 90.93 1437 
KHG Khengpa 18 Tibeto-Burman 27.13 90.68 808 
KUR Kurtöp 19 Tibeto-Burman 27.82 90.82 3850 
LHK Lakha 18 Tibeto-Burman 27.68 90.15 2985 
LAY Layap 12 Tibeto-Burman 28.07 89.68 4115 
MNG Mangde 18 Tibeto-Burman 27.42 90.22 2980 
MON Black Mountain 
Mönpa 
20 Tibeto-Burman 27.22 90.22 2027 
NGA 'Ngalop 18 Tibeto-Burman 27.53 89.48 2880 
NUP Nup 18 Tibeto-Burman 27.58 90.33 2385 
TSH Tshangla 19 Tibeto-Burman 27.18 91.32 2240 
India             
BOD Bodo 18 Tibeto-Burman 26.67 90.33 99 
TOT Toto 46 Tibeto-Burman 26.67 89.00 86 
Nepal             
BHI Bahing 1 Tibeto-Burman 27.23 86.33 1561 
BTW Bantawa 2 Tibeto-Burman 26.53 87.06 1500 
BAR Barâm 20 Tibeto-Burman 28.07 84.67 1080 
CHM Chamling 7 Tibeto-Burman 28.24 83.22 1550 
CHN Chantyal 20 Tibeto-Burman 28.40 83.37 1932 
CHP Chepang 18 Tibeto-Burman 27.58 84.70 241 
CHE Chetri 19 Indo_european 29.17 81.20 987 
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DAM Damai 8 Indo_european 27.33 83.03 987 
DHI Dhimal 20 Tibeto-Burman 26.50 87.70 86 
DUM Dumi 2 Tibeto-Burman 27.19 86.51 1650 
GUR Gurung 17 Tibeto-Burman 28.30 84.12 2182 
KUL Kulung 2 Tibeto-Burman 27.35 86.56 1400 
LIM Limbu 19 Tibeto-Burman 27.19 87.83 1094 
MGR Magar 17 Tibeto-Burman 28.08 83.83 844 
MAJ Majhi 17 Indo_european 27.83 83.67 969 
NAC Nachiring 1 Tibeto-Burman 27.23 86.51 2350 
NWR Newar 17 Tibeto-Burman 27.62 85.40 1665 
PUM Puma 1 Tibeto-Burman 26.54 86.56 1400 
SAM Sampang 3 Tibeto-Burman 27.15 87.08 1300 
SAR Sarki 6 Indo_european 27.37 83.07 987 
SHE Sherpa 10 Tibeto-Burman 27.73 86.58 4550 
SON Sonar 2 Indo_european 27.39 83.09 987 
SUN Sunwar 4 Tibeto-Burman 27.34 86.16 1750 
TMG Tamang 19 Tibeto-Burman 27.88 85.42 1900 
THK Thakali 16 Tibeto-Burman 28.82 83.75 3035 
WAM Wambule 13 Tibeto-Burman 27.07 86.36 1350 
Tibet             
LHA Lhasa 36 Tibeto-Burman 29.65 91.23 3700 
NAG Nagqu 31 Tibeto-Burman 32.00 91.13 4500 
NYI Nyingchi 20 Tibeto-Burman 28.42 94.43 2900 
SHA Shannan 26 Tibeto-Burman 29.03 91.69 3600 
TIN Tingri 19 Tibeto-Burman 29.47 87.03 4500 
 
Table 2. 1 List of populations analysed in this study. The table is subset into regions and reports the three letter population codes, the full population name, the 
population sample sizes, language family, geographical coordinates (latitude, longitude) and altitude (m). 
52 
 
 
 
2.2.2 Methods used for the analyses 
 
2.2.2.1 Data quality control and datasets 
 
The assessment of SNP-chip data quality plays an essential role for the precision 
and accuracy of downstream analyses. I used tools implemented in PLINK 1.92 and 
EIGENSOFT 6.0 for performing quality control (QC) of my dataset (156, 157). Firstly, I set 
the genotyping success rate and sample missingness thresholds to 99% and 10%, 
respectively, to exclude variants and individuals with an excess of missing genotypes. 
Sex-linked and mitochondrial SNPs as well as autosomal ones with Hardy-Weinberg 
Equilibrium p-value <0.0000001 were removed. SNPs departing to this extent from 
Hardy-Weinberg equilibrium are likely to be genotype and variant call errors (158). 
Another important assumption for population genetic studies is that the samples be 
unrelated, as including duplicated samples or first-second degree relatives can skew the 
allele frequency distribution and not be a good representation of the entire population. I 
used estimates of identity by state (IBS) for identifying pairs of samples that looked 
genetically more similar than would be expected by chance in a random sample. IBS was 
calculated for each pair of individuals as the number of shared alleles at the autosomal 
genotyped SNPs. From the genome-wide IBS values it is possible to infer estimates of 
identity by descent (IBD), the degree of recent shared ancestry for each pair of samples.  
IBD values of 1 indicate duplicated or monozygotic twin individuals, IBD values of 0.5, 
0.25 and 0.125 are for first, second and third-degree relatives, respectively.  I filtered out 
individuals with an IBD score > 0.35 (PI_HAT > 0.35): I chose this cut-off as it was good 
for removing related individuals that could affect the analyses without removing a big 
proportion of the samples.  
 
I also removed outliers (individuals that show allele frequency that differ from the 
distributions of the remaining individuals of the same population) using EIGENSOFT 6.0 
(157, 159). These filters resulted in a final dataset of 738 individuals and 583,011 SNPs. 
For comparison with worldwide populations, the final Himalayan dataset was merged 
with published datasets (Table 2.2) (67, 160, 161) resulting in 1,962 individuals and 
268,861 SNPs. Two additionally pruned datasets were generated from these by filtering 
out SNPs in high LD (r2 > 0.5) to reduce the occurrence of highly correlated pairs of SNPs 
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that could skew allele frequency distributions. The pruned Himalayan dataset consisted 
of 256,506 SNPs, and the pruned worldwide dataset included 190,287 SNPs. For 
comparison with ancient samples, I generated two further datasets: 1) I  merged my 
dataset with the Human Origins data, a dataset comprising both modern and ancient 
individuals including archaic genomes from Denisovans and Neanderthals, and a 
chimpanzee (82), resulting in 82,647 SNPs in common; and 2) we merged our Himalayan 
and worldwide datasets with published ancient Himalayan genomes from the Annapurna 
Conservation Area in Nepal (121). From the published ancient BAMs a single sequence 
with a minimum quality of ≥20 to represent each SNP in our Himalayan dataset was 
randomly sampled (162), trimming 5 bp from both ends of reads to reduce the effect of 
ancient DNA deamination. The calling from the Himalayan ancient samples was 
performed by Dr Marc Haber. This resulted in 582,810 SNPs in the Himalayan dataset 
being covered by at least one of the ancient samples (Table 2.2). 
 
Dataset Number of individuals Number of SNPs 
Modern Himalaya 738 583,011 
Modern Himalaya LD pruned 738 256,506 
World (Himalaya + Li et al., 2008 + South 
Asians: Metspalu et al., 2011, Chaubey et al., 
2010) 
1,962 268,861 
World LD pruned (Himalaya + + Li et al., 2008  
+ South Asians: Metspalu et al., 2011, Chaubey 
et al., 2010) 
1,962 190,287 
Himalaya + The 1000 Genomes Project 
Consortium., 2015 
3,274 579,640 
Modern Himalaya + Ancient Himalaya (Jeong 
et al., 2016) 
743 582,810 
Himalaya + Human Origins (Patterson et al., 
2012) 
2,809 82,647 
 
Table 2. 2 Datasets used for the analyses. The table reports the number of individuals and number of 
genomic variants contained in each dataset. 
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2.2.2.2 Population characterization and demography 
 
The genetic structure of the Himalayan populations was examined using several 
statistical approaches. Firstly, I performed principal component analysis (PCA) using 
EIGENSOFT 6.0 (157, 159) on the LD-pruned datasets. For the worldwide dataset, the 
eigenvectors were calculated using the global diversity and the Himalayan individuals 
were projected onto the plot. I ran ADMIXTURE v1.2(74) on the pruned datasets for 
cluster analysis and the cross validation (CV) error for identifying the best K value, which 
represents the best number of ancestral populations to describe the dataset. ADMIXTURE 
is a programme designed to estimate individual ancestries from dense SNP genotype 
dataset using a maximum likelihood approach. Estimation of long-term effective 
population size (Ne) for each Himalayan population and population divergence time was 
performed by Dr Massimo Mezzavilla using the NeON R package (163), which calculates 
the harmonic mean of the population size at each generation and the time of divergence 
between populations in generations. More specifically, using LD information (r2) and 
recombination distance (c) the effective population size is estimated using the nonlinear 
regression model: yi =1/(α+βci)+ei, with yi = (r2 1/n) (r2 adjusted for chromosome sample 
size) for SNP pair i at recombination distance ci (in Morgans) .The change in population 
size over time is then estimated, as LD between loci with a recombination rate of c that 
reflects the ancestral effective population size 1/(2c) generations ago (164). The model 
is based on the assumption of linear growth or decline. However, some populations might 
depart from the assumed model characteristics and LD patterns in these will be affected, 
so the relationship t = 1/(2c) should be viewed only as an approximate, but useful 
indication of timeframes (165). Furthermore, the time of divergence estimates are based 
on the assumption of a ‘‘clean’’ population split, and migration will create a stronger 
correlation of LD (larger values of r2), thereby biasing the estimate of divergence time 
downwards. Nevertheless, this method is still useful to assess isolation and difference in 
Ne between populations (166, 167). Only populations with sample size ≥10 were used, as 
the harmonic mean is sensitive to sample size. For all analyses we assumed a generation 
time of 29 years (168).  
 
Runs of homozygosity (ROHs) are long stretches of the genome where identical 
haplotypes are inherited from each parent that in turn they inherited from a recent 
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common ancestor. This produces a region of homozygous variants and the length of the 
run is indicative of when the inbreeding event happened. I identified ROHs using PLINK 
1.92 (155) with specific thresholds to maximize the detection of autozygous segments in 
the Himalayan populations (169) and other worldwide populations: a pruned dataset 
(LD, r2 > 0.5) with only common variants (MAF >0.05) was used. The minimum number 
of SNPs to call an ROH was set to 100, the heterozygote allowance was set to zero, the 
missing SNP allowance was set to 5 (5% of the SNP threshold), and the window threshold 
to call an ROH was set to 0.05. I also calculated the coefficient of inbreeding (F) with 
PLINK 1.92 to test for positive correlation between the total length of ROHs and F in each 
individual (155).  
 
A worldwide dataset using a maximum of 10 individuals from every population 
was used in the ChromoPainter and fineSTRUCTURE-2.0.6 (78) analyses to study the 
genetic relationship between Himalayan populations. ChromoPainter is a tool for 
inferring the ancestry of each individual by reconstructing their haplotype segments from 
other individuals in the dataset. FineSTRUCTURE uses the co-ancestry matrix inferred 
from ChromoPainter to construct a model-based Bayesian population-relationship tree 
and was run with 10,000,000 burn-in steps and 10,000,000 iterations. The software 
requires phased data as input. The haplotypes were phased with SHAPEIT (66) using the 
1000 Genomes Project Phase 3 dataset (66) as a reference panel. I also performed a PCA 
using the co-ancestry matrix generated by fineSTRUCTURE. To assess the robustness of 
the results from the above dataset, I additionally ran fineSTRUCTURE on a dataset with 
fewer samples (the Himalayans and 1000 Genomes Project Phase 3 populations), but 
more markers (579,640 SNPs) using the same parameters. 
 
The Himalaya dataset comprises sixteen extreme high altitude populations 
(altitude of 2500 meters or more above sea level) (135), residing at different 
geographical locations across the Himalayas. To understand whether there is a 
correlation between genetic similarity among high altitude populations and their 
geographical location, I used D-statistics, a tool for detecting genetic similarity and 
mixture events within individuals of pairs of populations. I used YRI (Yoruba in Ibadan, 
Nigeria) as an outgroup and calculated D-statistics (qpDstat function in ADMIXTOOLS v3 
package (82)) using the following phylogeny: D(Yoruba, Han; high altitude Himalayan 1, 
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high altitude Himalayan 2) where high altitude Himalayan 1 and high altitude Himalayan 
2 are pairs of Sherpa, Tibetan or Bhutanese populations (82) (120). I computed D-
statistics with the above phylogeny using the worldwide dataset for comparison 
(supplementary tables S1 and S3). Then, I tested the correlation between values of D-
statistics with pairwise differences in longitude and latitude for each pair of populations 
using the Mantel test implemented in the “Ade4” R package (mantel.rtest function) (170). 
Population admixture was studied using ALDER v1.03 (171), three-population 
statistics (f3) (82, 172) and TreeMix 1.12 (77). The ALDER software computes a LD-based 
test for admixture that can estimate the time of the admixture event, whereas three-
population f3 statistics and TreeMix are allele frequency based methods. Only 
populations with at least six individuals were included in these tests. ALDER was used 
with the default parameters and the threshold of LD in the reference groups was inferred 
by the program. A test was considered positive when both the 2-ref weighted LD curve 
was significant and the decay rates between the 2-ref and 1-ref curves were consistent. 
For f3-statistics analyses I considered a jack-knife block of 500 SNPs. I also estimated the 
shared genetic drift between modern populations and ancient samples using outgroup 
f3-statistics (ancient genome, X, Yoruba) (82) with the Yoruba as an outgroup. I used 
different ancient genomes in this investigation:  
1. Eurasian hunter-gatherer (MA1, 24,000-year-old Upper Palaeolithic Siberian) 
genetically related to Native American lineages and to modern Europeans  (173). 
2. Bronze Age Yamnaya population (3500-2700-year-old) from the Pontic-Caspian 
steppe that expanded into Eurasia impacting the genetic landscape during the 
Bronze Age. The Yamnaya population expansion parallels the expansion of Indo-
European languages, making the Yamnaya a good candidate for the putative 
spread of Indo-European languages across Eurasia (174). 
3.  Neolithic European farmer from the Linear Pottery culture (LBK_EN, 5,500-
4,800-year-old) (175). 
4. Mesolithic hunter-gatherer (La Braña, 7,000-year-old) (176) that shares genetic 
ancestry with MA1 and some modern-day northern European populations.  
5. Eurasian hunter-gatherer (Ust’-Ishim, 45,000-year-old Upper Palaeolithic 
Siberian) deriving from an ancestral population that lived before or concomitantly 
to the separation of western and eastern Eurasians and has slightly more genetic 
affinity to East Asian populations than to Western Eurasians (153);  
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6. Five ancient  Himalayan genomes 3,150-1,250-years-old (C1, M63, S10, S35 and 
S41) from the Annapurna Conservation Area, Nepal (121).  
I also used the archaic Denisovan and Neanderthal genomes and the chimpanzee to study 
genetic affinity of Himalayan samples to these archaic individuals: I calculated principal 
components using Denisovan, Neanderthal and chimpanzee, and projected modern 
samples onto them (35). I also computed D-statistics using (Yoruba, X; Denisovan, 
Chimpanzee) where X were different modern human populations from the worldwide 
dataset. 
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2.2.2.3 Positive selection  
 
Signals of positive selection were evaluated in four ways to try and reduce, as 
much as possible, the spurious signals of selection due to the extensive population 
structure and relatedness of the Himalayan samples. First, I considered the Spearman’s 
correlation between derived allele frequency and the residence altitude of each 
population (127), adjusting the p-value for multiple tests by applying the Bonferroni 
correction (requiring <0.05/number of tests). Spearman's correlation is a non-
parametric test that measures the strength of correlation between two variables where 
the value rho = 1.0 is perfect positive correlation and the value rho = -1 is a perfect 
negative correlation. It does not, however, take into account the population structure. 
Second, I calculated a genome-wide association between allele frequency and altitude 
using a mixed model approach implemented in the Efficient Mixed-Model Association 
eXpedited program (EMMAX) (177). EMMAX detects variants where the observed allele 
frequency is significantly divergent from the expected frequency, and accounts for 
population stratification and sample relatedness through a variance component 
approach. A kinship matrix was constructed to account for population structure and 
implemented in a linear mixed model. Variants with p-value <5x10-8 were considered 
significantly associated with altitude. Although these methods detect associations 
between allele frequency and altitude, they are not able to distinguish between high- and 
low altitude selection signals. For this reason I also calculated the Fixation Index (FST) 
(178) for each SNP position between Himalayan, European (CEU; Utah Residents (CEPH) 
with Northern and Western European Ancestry) and East Asian (CHB; Han Chinese in 
Beijing, China) from the 1000 Genomes Project Phase 3 populations, and searched for 
unusual values using the Population Branch Statistic (PBS) (99). To reduce noise due to 
population structure within the Himalayan populations and differences in sample sizes, I 
ran PBS assuming that the CHB is the most closely related population to Tibetans and 
looked specifically for signals of high altitude adaptation (99). For this analysis, I only 
used the populations from Bhutan and Tibet that clustered together in the 
fineSTRUCTURE analysis compared with CEU and CHB. Variants above the 99.99th 
percentile of the empirical distribution were considered statistically significant (179, 
180). The top hits from each method were assessed and the overlap collated. LD 
estimations for the regions containing the top candidates were calculated and plotted 
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using Haploview (181). I also used Fisher’s method (182) for combining p-values of the 
three statistics used for detecting positive selection. Firstly, I calculated a rank p-value of 
the PBS values (values were ranked in decreasing order from the most significant value 
and divided by the total number of SNPs used in the analysis); I then combined the p-
values of the three statistics genome-wide and adjusted the p-value for multiple tests by 
applying the Bonferroni correction (requiring < 0.01/number of tests). Finally, to further 
validate the selection signals, I calculated genome-wide associations between allele 
frequency and altitude using BayEnv v2 (183, 184), a Bayesian framework specifically 
designed to detect correlation between allele frequencies and environmental factors 
taking population structure into account. I generated the input files for BayEnv2 v2 from 
a LD (r2 > 0.5) pruned SNP file using PGDSpider (185) and I standardised altitude (the 
environmental variable) according to the BayEnv2 v2 manual. BayEnv v2 was run with 
the default parameters and the Bayes Factors interpreted according to previous 
recommendations (186): only candidate variants falling into the category “Decisive” 
(Bayes Factors (BF) > 100, log10(BF) > 2) were considered significant. Where possible, 
allele frequencies in the five Himalayan ancient genomes for our top candidates of 
selection were also calculated.  
 
I generated a protein homology model for SLC52A3 using Phyre2 software (187) 
and mapped the missense variant found in SLC52A3 onto the protein structure using 
PyMOL (The PyMOL Molecular Graphics System, Version 1.8 Schrödinger, LLC). I 
predicted protein-protein interaction networks using the STRING software (v. 10.5) 
(188) for our top selection candidates. Finally, I used the Ensembl Variant Effect Predictor 
(VEP) (189) to predict the consequences of variants of interest on gene expression and 
protein sequence. I retrieved the Combined Annotation Dependent Depletion v.1.2 
(CADD) scores (190) of our top candidates and also overlapped the results with the 
Genotype-Tissue Expression (GTEx) database (191). 
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2.3 Results 
 
2.3.1 Himalayan samples show distinct patterns of 
population structure 
 
I first investigated the population history and demography of the Himalayan 
region (Figure 2.1, Table 2.1) by determining the genetic relationships among the 
Himalayan populations, and comparing them with other worldwide populations from 
published datasets such as the Human Genome Diversity Project (HGDP), 1000 Genomes 
Project and other South Asian specific datasets (Table 2.2).  
 
 
 
Figure 2. 1 Population samples analysed in this project. A. Map of South and East Asia, highlighting the four 
regions examined, and the colour assigned to each. B. Samples from the Tibetan Plateau. C. Samples from 
Nepal. D. Samples from Bhutan and India. The circle areas are proportional to the sample sizes. The three 
letter population codes in B-D are defined in Table 2.1. 
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Principal Components Analysis (PCA) shows that the Himalayan populations form 
a cline, lying between the South and East Asian samples. Populations from Nepal are close 
to Indians, whereas those from Bhutan and Tibet are closer to East Asians (Figure 2.2A, 
B). This pattern of genetic affinity to South and East Asian populations is also supported 
by an ADMIXTURE analysis at K=10 of worldwide populations (Figure 2.2C), where the 
genetic component from South Asia (orange) is observed particularly in the Nepalese, 
and the East Asian (gold) component in the Nepalese, as well as the Bhutanese and 
Tibetans. However, except for the Toto, all other Himalayan populations are mainly 
characterised by their own ancestral component (blue). I also found some detectable 
European and Middle Eastern ancestral components (off-white and green) in some 
Nepalese. 
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Figure 2. 2 PCA and ADMIXTURE analysis using the world dataset. A. PCA of the world dataset. Each dot represents a sample, coded by region as indicated. The 
Himalayan region samples lie between other East Asian and South Asian samples. B. The plot displays a zoom of Himalayan populations in their worldwide context. 
Nepalese samples lie close to Indians, whereas Bhutanese and Tibetans are close to East Asian populations. C. ADMIXTURE results for K=10. Himalayan populations 
display their own ancestral component (blue) that is also visible in some of the Pakistani and East Asian populations. Himalayan populations are also characterised 
by the presence of South Asian (orange) and East Asian (gold) components. 
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On a finer scale, the first component of a PCA using only the Himalayan 
populations shows strong geographical clustering with the Toto population forming an 
outlier, while the second principal component identifies substructure within the 
Himalayan populations (Figure 2.3A). Individuals from Nepal lie in several dispersed 
clusters, whereas those from Bhutan and Tibet group together. Interestingly, the 
Nepalese Sherpa cluster with the Tibetans and some Bhutanese populations from high 
altitude. A distinct cluster is formed by Dhimal and Bodo individuals from Nepal and 
North India, respectively (Figure 2.3A)
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Figure 2. 3 PCA and ADMIXTURE analysis using the Himalayan dataset. A. PCA of the Himalayan populations alone. Each dot represents a sample, coded by country 
or region as indicated. Most samples lie on an arc between Bhutanese and Nepalese samples; Toto (India) are seen as extreme outlier in the bottom left corner, while 
Dhimal (Nepal) and Bodo (India) also form outliers. B. Zoom of PCA using the Himalayan dataset only. The plot displays Bhutanese and Tibetans clustering together. 
Sherpa from Nepal cluster with other high altitude populations from Bhutan and Tibet. C. ADMIXTURE (K values of 2 to 6, as indicated) analysis of the Himalayan 
samples. Note that most increases in the value of K result in single population being distinguished. 
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The ADMIXTURE analysis using only the Himalayan populations shows patterns 
consistent with the PCA, with different proportions of ancestral components between 
Nepal, Bhutan, North India and Tibet (Figure 2.3C). Each increase in the value of K 
between 2 and 5 usually leads to a single population being distinguished, suggesting 
extensive genetic isolation and drift. Toto, an outlier in the PCA, is also characterised by 
an independent ancestral component even at a K value of 2 (Figure 2.3C). By contrast, the 
five Tibetan populations do not show any substructure in this analysis. The lowest CV 
error was at a K value of 6, where we observe a single widespread ancestral component 
(grey) which is shared among all the high altitude populations and is significantly 
positively correlated with altitude (rho = 0.79; p=2.2 x 10-18) (Fig 2.4).  
 
 
 
 
Figure 2. 4 Positive correlation between the high altitude-specific genetic component and altitude. The plot 
shows the correlation between the percentage of the grey component from the ADMIXTURE analysis (K=6) 
in each Himalayan population (Figure 2.3C) and the altitude at which the population resides. 
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Figure 2. 5 Long-term effective population size (Ne) and divergence times of Himalayan populations. A. 
Long-term effective population size (Ne) of Himalayan populations. The plot displays the harmonic mean 
of the Ne for each population. Only populations with sample size ≥ 10 were used for this analysis. Within 
the Himalayan populations, Chetri have the highest Ne, whereas Toto have the lowest. B. UPGMA tree based 
on estimated time of divergence of the Himalayan populations. The populations analysed are shown on the 
x-axis and the time of divergence (Kya) on the y-axis. Most of the Himalayan populations show a split time 
with Indian populations around 25,000-20,000 years ago and with East Asians around 15,000-10,000 years 
ago. Chetri, Damai and Sarki are outliers to other Himalayan populations as they show divergence times 
similar to Indians. Tibetan populations display a split time among them of around 1,000 years ago. 
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Long-term Ne values can be estimated using SNP genotyping data, but these have 
limitations and can only be used as a proxy for the variability of their effective population 
sizes and thus the overall genetic diversity. Nevertheless they permit some informative 
comparisons. The Chetri have the highest long-term Ne, whereas Toto have the lowest 
(Figure 2.5A), suggesting that the low genetic variation in Toto could be due to genetic 
drift or endogamy (192).  All Tibetan populations display similar population sizes (Figure 
2.5A) (165). The sequence of splits suggests that the Himalayans separated first from 
Indian populations (with possible exceptions of Chetri, Damai and Sarki), then from East 
Asians and finally among themselves. Interestingly, all of the high altitude populations in 
this dataset display a similar differentiation time from other Himalayans, and place this 
at around 6,000-5,000 years ago (Fig 2.5B). Despite the limitations of this approach, this 
estimate is in line with several previous genetic and linguistic estimates (50, 118), but 
differs from others that estimated older (∼15,000–9,000 years ago) or more recent split 
times (~2,700 years ago) respectively (99, 108, 110, 119). The various Tibetan 
populations display very recent split times from each other, which is consistent with the 
lack of substructure within these populations. 
 
I also explored whether or not Himalayan populations show extended runs of 
homozygosity (ROHs), which may arise from endogamy. Overall, Himalayan populations 
are characterized by a high number of autozygous segments of different lengths across 
the genome (119). Nepalese and Bhutanese populations show the most numerous ROHs, 
and these are also the longest, up to ~80 and ~90 Mb in length, respectively. Toto from 
India are characterized by the highest number of individual ROHs up to ~50 Mb in length. 
On the other hand, Tibetan populations show the lowest number and length of ROHs (Fig 
2.6A). The total length of ROHs per sample correlates positively with the coefficient of 
inbreeding (F) (Fig 2.6B). Bhutanese, Indian and Nepalese populations show the highest 
coefficient of inbreeding values and have total lengths of ROHs around 300-400 Mb. 
Tibetans show a very low coefficient of inbreeding associated with low numbers of ROHs. 
Overall, the number and length of ROHs in Himalayan populations are in line with those 
in other worldwide populations: in such a comparison, Toto show the highest numbers, 
followed by American and Middle Eastern populations, while Bhutanese populations 
show a total length and number of ROHs similar to populations from South Asia.   
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Figure 2. 6 Runs of homozygosity (ROHs) in the Himalayan populations. A. Distribution of runs of 
homozygosity (ROHs) in the Himalayan populations. The x-axis shows the populations analysed and the y-
axis represents the median length of ROHs in each population. Nepalese and Bhutanese populations show 
the highest number and longest ROHs, whereas Tibetan populations show the lowest number and length 
of ROHs. B. Positive correlation between total length of ROHs per sample and coefficient of inbreeding (F). 
The total length (Mb) of ROHs per sample is shown on the x-axis, and the coefficient of inbreeding (F) on 
the y-axis. Note the different scale in each section. Bhutanese, Indian and Nepalese populations display the 
highest coefficient of inbreeding values and the highest total length of ROHs.  Tibetan populations show the 
lowest coefficient of inbreeding and the lowest number of ROHs. 
 
I also used the phased Himalayan and worldwide population data to reconstruct 
phylogenetic relationships between the samples and to identify population structure 
through a Bayesian clustering algorithm implemented in fineSTRUCTURE. The inferred 
phylogenetic tree shows two main branches splitting Nepalese from Bhutanese plus 
Tibetans (Figure 2.7A). All the Himalayan high altitude populations, including the 
Tibetans, cluster together, with the exception of the Thakali population from Nepal, which 
clusters with its Nepalese neighbours. Within genetic clusters of the Nepalese and 
Bhutanese it is possible to recognize substructure based on population and linguistic 
features. This tree topology was replicated when fineSTRUCTURE was applied to a 
dataset comprising only Himalayan and 1000 Genomes Project Phase 3 populations, 
which allowed a higher number of SNPs to be used. PCA was also calculated from the co-
ancestry matrix generated by fineSTRUCTURE confirming that the Himalayan 
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populations are distributed along a cline with the Sherpa, Bhutanese and Tibetans 
clustering together.  
The Himalayan region is one of the richest areas from the linguistic point of view 
with many different language families and linguistic isolates spoken. To test if there was 
correlation between genetic and linguistic variability in the Himalayas, I compared the 
genetic tree with the linguistic affiliation of each Himalayan population (Figure 2.7B). I 
observe, particularly in Bhutan, that there is agreement between genetic and linguistic 
sub-divisions. Speakers of Kiranti languages from Nepal form a separate cluster, and their 
languages constitute a distinct linguistic subgroup within the Tibeto-Burman language 
family. Dhimal from Nepal and Bodo from North India form a separate branch, supporting 
the PCA result, but not the traditionally-accepted language affiliation, and also 
correspond well with a new linguistic hypothesis which groups Dhimal and the Bodo-
Koch languages together within a “Brahmaputran” subgroup (193). 
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Figure 2. 7 Genetic structure of the Himalayan populations from haplotype analysis using fineSTRUCTURE, 
and comparison with language. A. Populations are clustered according to haplotype sharing; the branching 
pattern represents this hierarchy, but the branch lengths have no meaning. Note the geographical 
clustering of populations, particularly the Bhutanese. B. Language family annotation of the genetic clusters 
revealing correspondences between genetics and language. Population codes are defined in table 
2.1.Indicated on the tree are branch confidence values. Branches without values have a confidence of 1.   
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Finally, I computed D-statistics (Yoruba, Han; high altitude Himalayan 1, high 
altitude Himalayan 2) for pairs of Sherpa, Tibetan and Bhutanese populations using our 
worldwide dataset to test for the presence of correlation between genetic similarity and 
geographical location of the high altitude populations. Jeong et al 2017 found an east-
west longitudinal cline within Tibetan samples with individuals from more eastern 
locations having higher genetic affinity with lowland East Asians (120). I tested a similar 
hypothesis using the high altitude populations available to me. D-statistics values were 
close to zero for most of the pairs (0.0001≤|D-statistic|≤0.0061), with just 36 out of 210 
tests statistically significant at a Z score ≥4 (values 0.072≤|Z|≤7.656), showing that some 
high altitude Himalayan populations have increased genetic affinity with the low altitude 
East Asians (Fig 2.8A). However, unlike the Tibetan samples in Jeong et al 2017, our 
Himalayan populations do not follow a longitudinal cline (or a latitudinal one) related to 
their genetic affinity to low altitude East Asians (Mantel test r=0.15 and p-value = 0.18 
for longitude, r=0.11 and p-value=0.18 for correlation with latitude). This difference may 
reflect the smaller range of longitude of our samples (Fig 2.8B). 
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Figure 2. 8 Statistical analysis of genetic sharing between pairs of modern high altitude Himalayan 
populations and Han individuals. A. The plot shows the results for the D-statistic test (x-axis) in the form 
D(Yoruba, Han; high altitude Himalaya1, high altitude Himalaya Himalaya2). Left: value of the D-statistic; 
right: associated Z-score for statistical significance. Values of D-statistics departing from zero and with Z-
score in the extreme tail of the distribution (vertical dashed line in the plot) are indicative of more genetic 
sharing of one of the Himalayan populations with Han. B. Correlation plot of genetic and spatial distance 
between pairs of modern high altitude Himalayan populations. The plot shows the results for D-statistic 
test in the form of D(Yoruba, Han; high altitude Himalaya1, high altitude Himalaya2) (y-axis) compared 
with the difference in longitude (A) or latitude (B) for pairs of Himalayan populations (x-axis). The 
correlation coefficient (r) and the p-value are the results of the Mantel test between genetic distance (D-
statistics values) and spatial distance (longitude and latitude). 
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2.3.2 Complex demographic history in the Himalayas 
 
The Himalayan region separates South Asia from East Asia and is ideal to study 
admixture between highlanders residing in the Himalayas and their neighbouring 
lowland populations. To test this, I studied gene flow and admixture between Himalayan 
and nearby populations through three approaches: f3-statistics, ALDER and TreeMix. All 
the tests provide evidence of admixture between Himalayan and other populations 
(Figure 2.9, 2.10). Overall, Himalayan populations are characterized by gene flow within 
the region and with neighbouring populations from South and East Asia. The f3-statistics 
and ALDER show significant admixture events between the Nepalese, North Indians, 
Tibetans from China, South Asians, Middle Eastern and European populations (Figure 
2.9). ALDER also detected extra, although limited, admixture events between the 
Bhutanese and populations from South and East Asia around 800 and 900 years ago. 
Furthermore, Chetri, Majhi, Newar, Dhimal, Bodo and Lhasa show gene flow from Europe 
and the Middle East that might be attributed to the presence of these western 
components as part of the Ancestral North Indian component in South Asians (71, 160, 
172, 194). Chetri, Bodo, Majhi and Dhimal show a signature of admixture dated to 
between 1000 and 200 years ago. Newar and Lhasa display older signatures of gene flow 
dated between 1000 and 2000 years ago (Figure 2.9).  
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Figure 2. 9 Admixture history of five Himalayan populations. The five populations, each named on the left, 
could be modelled as a mixture between different source populations from two regions. One of these is 
shown on the vertical axis, while the second is indicated by the colour of the horizontal bar. The position of 
this bar represents the inferred time of admixture, and the length in time of these admixture events, 
according to the scale on the horizontal axis. Thus, the Chetri, for example, can be modelled as a mixture of 
a large number of Asian and European pairs of populations, occurring around 200-400 years ago. 
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 TreeMix analysis shows long branches for the Toto, Mönpa and Chepang 
populations in agreement with the genetic drift patterns (Figure 2.10). This is supported 
by the lack of detectable admixture events for these populations with f3-statistics and 
only a few significant results for Toto with ALDER, showing an admixture event around 
600-800 years ago with Chinese and Indian populations. Migration edges involving 
populations from South and East Asia are detectable (Figure 2.10). 
 
The genetic affinity between the Himalayan populations and five ancient Eurasian 
genomes was examined using the f3-outgroup statistics. Himalayans show greater 
affinity to Eurasian hunter-gatherers (MA-1, a 24,000-year-old Upper Palaeolithic 
Siberian), and the related Bronze Age Yamnaya, than to European farmers (5,500-4,800 
years ago; Figure 2.11A, C and D) or European hunter-gatherers (La Braña, 7,000 years 
ago; Figure 2.11B), like other South and East Asian populations. I also explored the 
affinity of Himalayan populations by comparing them with the 45,000-year-old Upper 
Palaeolithic hunter-gatherer (Ust’-Ishim) and each of MA-1, La Braña, or Yamnaya. 
Himalayan individuals cluster together with other East Asian populations and show equal 
distance from Ust’-Ishim and the other ancient genomes, probably because Ust’-Ishim 
belongs to a much earlier period of time.  
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Figure 2. 10 TreeMix results from the worldwide dataset. The tree displays phylogenetic relationships and 
migration edges between the Himalayan populations and other worldwide populations. The x-axis 
represents the amount of genetic drift and migration edges are represented by arrows. The tree shows long 
branches for Toto, Mönpa and Chepang in agreement with their strong genetic drift patterns.  Migration 
edges involving populations from South Asia, East Asia and Nepal are detectable. Dhimal and Bodo are 
characterised by migration events from South Asia (India and Pakistan). 
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Figure 2. 11 Relative genetic similarity of the Himalayan region and other populations to four ancient DNA 
samples. A.-D. Each plot shows a comparison between two ancient samples, and equal similarity is 
represented by the grey line. Each dot represents a present-day population. Thus, section A shows that the 
Himalayan region populations are more similar to the Upper Palaeolithic Siberian hunter-gatherer than to 
the Neolithic European farmer. 
 
I also investigated genetic affinity between modern Himalayan populations and 
five ancient Himalayans (3,150-1,250 years old) from Nepal. The ancient individuals 
cluster together with modern Himalayan populations in a worldwide PCA (Figure 2.12), 
and the f3-outgroup statistics show modern high altitude populations have the closest 
affinity with these ancient Himalayans, suggesting that these ancient individuals could 
represent a proxy for the first populations residing in the region.  
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Figure 2. 12 Principal component analysis of the world dataset with ancient Himalayans projected onto the 
plot. Ancient Himalayan samples (purple) cluster together with modern Himalayan populations. 
 
Finally, I explored the genetic affinity of Himalayan samples with the archaic 
genomes of Denisovans and Neanderthals (35), and found that they show a similar 
sharing pattern with Denisovans and Neanderthals as the other South and East Asian 
populations (Figure 2.13). Individuals belonging to four Nepalese (Dumi, Sunwar, Sherpa, 
Sarki, Nachiring), one Cambodian, and three Chinese populations show the highest 
Denisovan sharing (after populations from Australia and Papua New Guinea), but these 
values are not significantly greater than other South and East Asian populations. 
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Figure 2. 13 Principal component analysis of modern human populations, Denisova and Neanderthal. The 
plot shows the projection of modern human samples onto principal components calculated using Denisova, 
Neanderthal and Chimpanzee. Himalayan populations show a similar pattern of genetic sharing with 
Denisova to the other South-East Asian populations. 
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2.3.3 Signatures of adaptation in the Himalayan 
region 
 
Due to the harsh environment in which many individuals reside, I searched for 
variants under positive selection within Himalayan populations living at high altitudes, 
using four approaches: 1) Genome-wide Spearman’s correlation between derived allele 
frequency and altitude; 2) EMMAX, a genome-wide statistical test for association between 
SNP frequency and altitude that accounts for population substructure (195); 3) the 
Population Branch Statistic (PBS) which identifies SNPs with unusually high FST values 
between high- and low altitude samples, compared with an outgroup population (99); 
and 4) BayEnv v2, a Bayesian framework for specifically testing association between 
allele frequency and environmental variables, such as altitude (183, 184).  
 
Genome-wide Spearman’s correlations pinpointed 75 derived alleles with 
frequencies that correlated significantly with altitude (Spearman’s rho >0.72) (Figure 
2.14A). The EMMAX analysis showed that 99.98% of the variance was explained by the 
kinship matrix, and identified 56 variants where the observed allele frequency 
nevertheless diverged significantly from the expected frequency (Figure 2.14C). The PBS 
analysis highlighted 117 variants under possible selection for the derived allele, including 
ones in regions such as EPAS1 and Disrupted in Schizophrenia 1 (DISC1) previously 
identified by Tibetan exome sequencing (99) (Figure 2.14E).  
 
Twelve candidate variants lying in three different genomic regions overlap 
between these first three approaches (Figure 2.14G). Ten of them lie on chromosome 2 
in a ~330-kb genomic region that includes EPAS1, of which two are of potential functional 
significance. These are rs1868092, downstream of EPAS1 in a promoter-flanking region 
which has previously been associated with high altitude adaptation and shown to be a 
single-tissue eQTL in whole blood (196, 197), and  rs982414, an intronic variant ~231 kb 
downstream of EPAS1, which has been associated with hemoglobin concentration in 
Tibetans (103). Furthermore,  rs12986653, a variant in ATPase H+ Transporting V1 
Subunit E2 (ATP6V1E2) which falls in a CTCF binding site, shows single-tissue eQTLs 
associated with the ATP6V1E2, CXXC repeat containing interactor of PDZ3 domain 
(CRIPT) and Transmembrane protein 247 (TMEM247) genes (198) and has a high CADD 
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score of 20.6. The second region overlapping between the three methods is on 
chromosome 1 and includes the eleventh candidate SNP, rs6679627, an intronic variant 
in the Tripartite Motif Containing 67 (TRIM67) near Egl-9 family hypoxia inducible factor 
1 (EGLN1), which has previously been associated with high altitude adaptation in 
Tibetans (126, 199). The third overlapping region is on chromosome 5 and includes a 
SNP, rs4702062, which shows a strong EMMAX signal together with strong positive 
correlation with high altitude for the ancestral allele (between 80% and 97% in high 
altitude populations, compared with a maximum frequency ≤64% in 1000 Genomes 
Project populations) and has a CADD score of 12.9 (Figure 2.14F). This variant is also in 
high linkage disequilibrium LD (r2 = 0.87) with another nearby variant, rs844335, that 
was picked up by PBS because of its high derived allele frequency, between 80% and 97% 
in high altitude populations, compared with a maximum frequency ≤61% in 1000 
Genomes Project populations. rs4702062 lies in an intergenic region upstream of the 
ANKH inorganic pyrophosphate transport regulator (ANKH) gene on chromosome 5, 
while rs844335 lies within an open chromatin region nearby, and is also in LD (r2 = 0.73) 
with a third variant, rs1550825, that lies in a transcription factor binding site. The ANKH 
gene codes for a transporter that regulates the passage of inorganic phosphate through 
the cell and contains two hypoxia-responsive elements (HREs) in proximity to its 
promoter region, and thus its expression is regulated by hypoxic factors (HIFs) (200). 
 
Combining the p-values from the first three methods provides a concise way to 
merge their findings, although not a measure of the type-1 error rate because the tests 
are not completely independent. This approach identified 398 variants with Bonferroni-
adjusted p-value <0.01 (Figure 2.14G). The fourth method, BayEnv v2, could not be 
included in this combined p-value analysis as it used an LD-pruned subset of the SNPs. 
The strongest signals of selection from this last analysis, with multiple significant SNPs in 
each, included the three regions surrounding EPAS1, EGLN1 and ANKH discussed above, 
and also a region near the major histocompatibility complex. The EPAS1, EGLN1 and HLA-
DQB1 regions were also reported as associated with high altitude adaptation in a previous 
genome-wide association study between Tibetans and Han Chinese using a linear mixed 
model approach comparable to EMMAX (201). Multiple significant SNPs lying in these 
regions present single-tissue eQTLs and high CADD scores. An additional six regions with 
two or more significant SNPs stood out in the combined p-value analysis, surrounding the 
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RP11-384F7.2, Zinc finger protein 532 (ZNF532), Collagen type IV alpha 4 chain (COL4A4), 
Solute carrier family 52 member 3 (SLC52A3), Megakaryoblastic leukemia (translocation) 
1 (MKL1) and Growth factor receptor bound protein 2 (GRB2) genes (Figure 2.14G). The 
results from BayEnv v2 were then used for further validation of the candidate genes 
highlighted above. It pinpointed 503 variants falling into the category “Decisive” (Bayes 
Factor (BF) >100, log10 (BF) >2). Eight of the top ten candidate regions discussed above 
overlapped with the “Decisive” ones: EGLN1, EPAS1, COL4A4, RP11-384F7.2, ANKH, HLA-
DQB1/HLA-DPB1, ZNF532 and SLC52A3 while the MKL1 and GBR2 regions overlapped 
strong (10<BF<100, 1<log10(BF)<2) and substantial (3.2< BF<10, 0.5 < log10(BF)<1) 
candidates, respectively (Table 2.3). 
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Candidate gene Cluster of 
selected SNPs: 
GRCh37 
coordinates 
Number 
of SNPs 
in 
cluster 
Top SNP: 
Combined 
p-value 
Top SNP: 
 
Top SNP 
frequency 
high altitude 
populations 
Top SNP 
frequency 
East Asian 
populatio
ns 
Allele 
under 
selecti
on** 
eQTLs Comments 
EPAS1 2:46468276-
46852033 
26 1.83E-27 rs4953359 68% 14% D 9 Known high altitude selection signal 
EGLN1 1:231204794-
231897303 
21 3.45E-14 rs6655954 58%* 27%* A 10 Known high altitude selection signal 
HLA-DQB1/ 
HLA-DPB1 
6:32582075-
33175824 
15 1.66E-11 
 
rs10484569 77% 39% D 6 Known high altitude selection signal 
ANKH 5:14908578-
149285033 
5 2.63E-11 rs4702062 84%* 64%* A - Novel 
RP11-384F7.2 
AC068633.1 
3:117427214-
118549344 
5 6.68E-09 rs1081896 79%* 64%* A 2 Novel 
ZNF532 18:56562356-
56648324 
3 8.37E-09 rs3826597 18% 8% D - Novel 
COL4A4 2:227770592-
227922321 
8 1.19E-07 rs3769641 46% 19% D 1 Novel 
 
SLC52A3 20:744415-
745963 
2 1.22E-06 rs3746804 63% 25% D 1 Novel 
MKL1 22:40827319-
40905072 
3 3.97E-06 rs17001997 
 
47% 24% D 3 Novel 
GRB2 17:73326965-
73374945 
4 3.66E-05 rs4789182 
 
94% 83% D 4 Novel 
NOTE. * Frequency of ancestral allele ** A = Ancestral, D = Derived. Bold candidate genes: Decisive (log10Bayes Factor >2) candidates from BayEnv v2 
 
Table 2. 3 Genomic regions showing the strongest signals of positive selection in the Himalayan populations
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Figure 2. 14 Signals of positive selection (adaptation) in the Himalayan populations. A, C, E, G. Manhattan 
plots showing a measure of confidence in selection (vertical axis) plotted against genomic coordinate 
 
 
88 
 
 
 
(horizontal axis). Each dot represents a SNP. A. Spearman’s correlation between derived allele frequency 
and altitude. C. EMMAX. E. Population Branch Statistics. G. Fisher’s combined p-value from these three tests. 
B, D, F, H. Plots of allele frequency against altitude for four selection candidates. Each dot represents a 
Himalayan region population. 
 
We highlight further features of these candidate regions. The SLC52A3 region 
includes a missense variant (Pro267Leu, rs3746804) with derived allele frequency >70% 
in most high altitude populations compared with a maximum frequency ≤35% in the 
1000 Genomes Project populations, and a synonymous variant (rs3746807) with overall 
high derived allele frequency in Himalayan populations (42-100%) compared with a 
maximum frequency ≤24% in 1000 Genomes Project populations (Figure 2.14, Table 2.3). 
rs3746804 shows single-tissue eQTLs for SLC52A3 in lung and skin, and has a CADD score 
of 13.3. The COL4A4 region comprises eight SNPs: the top one, rs3769641, lies in a 
splicing regulatory region within COL4A4, and its derived allele frequency is positively 
correlated with altitude (Spearman’s rho= 0.70). This region also contains a missense 
variant (rs3752895) that shows single-tissue eQTLs in brain tissue for the Rhomboid 
domain containing 1 (RHBDD1) gene and a synonymous variant (rs2228557). These two 
variants show high CADD scores of 17.2 and 16.7, respectively. The GRB2 region on 
chromosome 17 shows four intronic SNPs and has previously been associated with 
hypoxia-induced oxidative stress level at the intestinal mucosal barrier in Tibetans 
compared with Han Chinese (202) (Figure 2.14G). Two of the four variants in GRB2, 
rs4542691 and rs4789182, show single-tissue eQTLs. The MKL1 region on chromosome 
22 carries three intronic SNPs, and has previously been associated with the regulation of 
the cellular response to chronic hypoxia in the vasculature of rats. All three variants in 
MKL1, rs2294352, rs6001931 and rs17001997, show single-tissue eQTLs in muscle-
skeletal tissue (Table 2.3) (203).  
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Figure 2. 15 SLC52A3 protein homology model. The plot shows the homology model generated for the 
SLC52A3 protein and its cellular transmembrane location. The missense variant, rs3746804, is indicated 
in red (Pro267Leu). 
 
We also examined the allele frequencies of the top SNPs in our ten candidate 
regions in the five ancient Himalayan genomes, and compared them with the allele 
frequencies in present-day Himalayans. Six variants in the EPAS1 region and eleven in the 
EGLN1 region show high derived allele frequencies in ancient Himalayans (≥ 0.60). The 
missense variant rs3746804 in the SLC52A3 locus also shows a high derived allele 
frequency of 0.67 in the ancient Himalayans. Variants in COL4A4, ANKH, RP11-
384F7.2/AC068633.1 and HLA-DBP1/DBP2 show derived allele frequencies in the ancient 
Himalayans of 0.56 -1.00, while two variants, rs4542691 and rs4789182, in the GRB2 
locus show a derived allele frequency of 100% in the ancient samples.  Finally, rs3826597 
in ZNF532 region show a derived allele frequency of 0.95 in the ancient Himalayans.  
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None of the top selection candidate regions, apart from EPAS1 (50, 104), show signatures 
of adaptive introgression from archaic Denisovans or Neanderthals according to 
published introgression maps (204). 
 
We also generated a protein homology model for SLC52A3, and investigated the 
position of the missense variant, rs3746804. The SLC52A3 structure resembles that of a 
glucose transporter and rs3746804 is predicted to lie in an exposed intracellular region 
which could act as an interaction surface for the intracellular environment (205) (Fig 
2.15). We finally generated protein-protein interaction networks for our top ten protein 
candidates. EPAS1, EGLN1, COL4A4 and GRB2 were predicted to be part of the same 
network.  Prostaglandin I2 synthase (PTGIS) and Vitamin D receptor (VDR), suggested 
previously by Hu et al. to be under selection for high altitude adaptation, are also 
predicted to be in the same protein-protein interaction network (50). 
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2.4 Discussion  
 
This study represents the most comprehensive survey thus far of genetic variation 
in the Himalayan region, aiming to elucidate the genetic ancestry of these populations, 
including their demographic histories, and the genetic adaptations they have undergone 
in order to survive in the varied and challenging environments present in the region.   
 
2.4.1 Population structure and demography 
 
In the broadest sense, all the Himalayan populations share ancestry with their 
geographical neighbours in South and East Asia, reflecting the common pattern of the 
distribution of human genetic diversity dominated by geography (Figure 2.2). Within this 
framework, I nevertheless detect an ancestral component that is abundant in most 
Himalayans, but rare elsewhere (Figure 2.2C), pointing to shared ancestry for these 
populations, a conclusion reinforced by their similar patterns of shared genetic drift with 
non-Himalayan ancient samples (Figure 2.12). At finer resolution, I see evidence for both 
substructure reflecting geography within the Himalayan region, and extreme drift 
leading to single populations forming outliers in the PCA (Figure 2.3A,B) or specific 
components in ADMIXTURE analysis (Figure 2.3C). The most striking example is 
provided by the Toto from North India, an isolated tribal group with the lowest genetic 
diversity among all the Himalayan populations examined here, indicated by the smallest 
long-term Ne (Figure 2.5A), and a reported census size of 321 in 1951 (206), although 
their numbers have subsequently increased. Despite this extreme substructure, shared 
common ancestry among the high altitude populations (Figure 2.3C and Figure 2.7) can 
be detected, and the Nepalese in general are distinguished from the Bhutanese and 
Tibetans (Figure 2.3C) and they also cluster separately (Figure 2.7). In a worldwide 
context, they share an ancestral component with South Asians (Figure 2.2C). On the other 
hand, the Tibetans do not show detectable population substructure, probably due to a 
much more recent split in comparison with the other populations (Figures 2.32 C and 
2.5). The genetic similarity between the high altitude populations, including Tibetans, 
Sherpa and Bhutanese, is also supported by their clustering together on the phylogenetic 
tree, the PCA generated from the co-ancestry matrix generated by fineSTRUCTURE 
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(Figure 2.7A), the lack of statistical significance for most of the D-statistics tests (Yoruba, 
Han; high altitude Himalayan 1, high altitude Himalayan 2), and the absence of correlation 
between the increased genetic affinity to lowland East Asians and the spatial location of 
the Himalayan populations (Figure 2.8). Together, these results suggest the presence of a 
single ancestral population carrying advantageous variants for high altitude adaptation 
that separated from lowland East Asians, and then spread and diverged into different 
populations across the Himalayan region. Genetic drift and admixture with other 
Himalayan, South and East Asian populations can explain the widespread distribution of 
the selected EPAS1 haplotype at lower frequencies in populations at lower altitudes 
(127), and the altitude clines in the other selection candidates (Figure 2.14). Our findings 
suggest a recent split (only a proxy for population differentiation given the limitations of 
the method applied) between Tibetans, Sherpa and, possibly, other high altitude 
populations, rather than the Tibetans being a mixture of Sherpa and Han Chinese (113, 
117). Whole-genome sequences from multiple high altitude populations will provide 
better estimates of such divergence times and a more detailed demographic history of the 
region. 
 
Himalayan populations show signatures of recent admixture events, mainly with 
South and East Asian populations as well as within the Himalayan region itself. Newar 
and Lhasa show the oldest signature of admixture, dated to between 2,000 and 1,000 
years ago. Majhi and Dhimal display signatures of admixture within the last 1,000 years. 
Chetri and Bodo show the most recent admixture events, between 500 and 200 years ago 
(Figure 2.9). The comparison between the genetic tree and the linguistic association of 
each Himalayan population highlights the agreement between genetic and linguistic sub-
divisions, in particular in the Bhutanese and Tibetan populations. Nepalese populations 
show more variability, with genetic sub-clusters of populations belonging to different 
linguistic affiliations (Figure 2.7B). Modern high altitude Himalayans show genetic 
affinity with ancient genomes from the same region (Figure 2.12), providing additional 
support for the idea of an ancient high altitude population that spread across the 
Himalayan region and subsequently diverged into several of the present-day populations. 
Furthermore, Himalayan populations show a similar pattern of allele sharing with 
Denisovans as other South-East Asian populations (Figure 2.13). Overall, geographical 
isolation, genetic drift, admixture with neighbouring populations and linguistic 
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subdivision played important roles in shaping the genetic variability we see in the 
Himalayan region today.  
 
2.4.2 High altitude adaptation 
 
The harsh environment at high altitude due to increased ultraviolet radiation, 
hypobaria and hypoxemia is inescapable, so it is expected to have triggered physiological 
and genetic adaptations including modifications in the cellular responses of the humans 
who settled there. Genomic scans for positive selection in Tibetans have previously 
implicated several genes as candidates for high altitude adaptation, especially an 
extended EPAS1 haplotype (99, 119, 207-209) that arose by introgression from 
Denisovans (104), and is widespread in the region (127). Positive selection scans can 
easily be confounded by population structure, and although simple correlations of SNP 
frequency with altitude replicated several of the candidates reported in previous studies 
(Figure 2.14), including those near EPAS1, DISC1 and ATP6V1E2 which are highly 
differentiated between lowland Han and Tibetans (99, 119), additional analyses better 
suited to sub-structured populations only confirmed a subset of these. The signal on 
chromosome 2 is particularly strong and includes a ~330-kb region encompassing 
EPAS1, ATP6V1E2 and PIGF/CRIPT (Figure 2.14). An expected signal of selection from 
EGLN1 was observed via nearby variants in TRIM67 and TSNAX-DISC1 (Figure 2.14) (210, 
211). A novel signal of selection was found in the region upstream of ANKH on 
chromosome 5 (Figure 2.14). This region shows extended LD, but the variant driving the 
selection could not be identified by our analysis. Nevertheless, ANKH is itself a strong 
candidate because it is involved in the regulation of the transportation of inorganic 
phosphate and its expression is regulated by HIF-2α (EPAS1) and HIF-1α (200, 212). 
ANKH is essential for maintaining cellular function and bone mineralization, and its 
concentration plays a central role in several metabolic pathways (213).  
 
In order to maximize the power to identify the additional selection candidates, I 
calculated combined p-values for three different statistics applied to our dataset, and 
then further validated these candidate genomic regions using a fourth statistic, BayEnv2.  
(Figure 2.15). Some of these additional variants may play important roles in the hypoxic 
environment, contributing to physiological responses to hypoxia. COL4A4 encodes one of 
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the subunits of collagen type IV, which is an essential component of basement 
membranes, and plays an important role in angiogenesis. Hypoxia exposure triggers 
vasoconstriction which requires structural remodelling of arterial vessels, especially in 
lung, and collagen metabolism is required for this process (214) (215). GRB2 is involved 
in the regulation of reactive oxygen species (ROS) production in hypoxic environments 
and it has been shown that, in Tibetans, downregulation of its expression reduces ROS 
damage and improves glucose and fat metabolism in intestinal tissues (202). MKL1 
encodes a myocardin-related transcription factor and is involved in smooth muscle cell 
differentiation (216). Down-regulation of MKL1 reduces the pulmonary arterial pressure 
in response to chronic hypoxia and regulates vascular remodelling in rats (203). SLC52A3 
encodes a transporter of riboflavin, a vitamin that modulates fatty acid and amino acid 
metabolism and reduces cellular oxidative stress (217). Riboflavin supplementation of 
the diets of mice improves their energetic metabolism under acute hypoxia. Thus, 
increased riboflavin could be effective in counteracting the alteration of human 
metabolism in hypoxic conditions (218). SLC52A3 is a transmembrane protein and the 
homology-based protein model we generated resembles the structure of a glucose 
transporter; our top candidate variant, rs3746804 (Pro267Leu), lies in the intracellular 
environment in a possible interaction region of the protein surface (Figure 2.15). This 
selection signal seems to be specific for Himalayan populations and could be related to 
the diet and environment, where efficient intake of riboflavin at high altitude would be 
advantageous (219). Two out of three additional candidates for high altitude adaptation 
(PTGIS and VDR) suggested by Hu et al. are predicted to be in the same protein-protein 
interaction pathway as some of our candidates, COL4A4 and GRB2, and linked with other 
genes (EPAS1, EGLN1, HIF-1α, VHL) involved in the hypoxic (50).  ANKH has also been 
reported as a candidate for high altitude adaptation in Tibetan pigs (220, 221).  
 
Thus, of the top ten selected candidate regions (seven novel) highlighted by our 
work, four are members of the most relevant protein-protein interaction network and 
three others have known functions relevant to high altitude adaptation: findings that are 
very unlikely due to chance. Furthermore, despite the strong ascertainment bias of the 
SNPs included on SNP-chips, variants lying in our top ten candidate regions are 
associated with single-tissue eQTLs and present high CADD scores, suggesting their 
possible importance in gene regulation and expression.  The presence of high derived 
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allele frequencies of variants in EGLN1, EPAS1, SLC52A3 and GRB2 loci in ancient 
Himalayans also supports our hypothesis that these candidates may be under selection 
and important for high altitude adaptation. According to available introgression maps 
(204), none of the top selected candidate regions, apart from the well-known EPAS1 
intronic region (50, 104), show signatures of adaptive introgression from Denisovans or 
Neanderthals. In all cases, high-coverage whole-genome sequences and comparisons 
with other species that have adapted to similar environments should help to identify or 
confirm the key causal variants and suggest strategies for functional follow-up. 
 
In conclusion, the current analyses have established the broad features of 
Himalayan genetic variation: a South or East Asian substrate influenced by local 
differentiation and mixing in ways that are now understood in outline, including extreme 
genetic drift in several populations. This work has provided a comprehensive dataset 
from the region for the community to use in future studies. In addition, there is evidence 
for early strong genetic adaptation to high altitude living followed by spread of the 
adapted population. Future functional investigations will allow these phenomena to be 
understood in more detail. 
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3. Fine-scale demographic history of 
Himalayan populations using whole-
genome sequencing data 
3.1 Introduction 
 
In the previous chapter, I presented the benefits of, and insights from, SNP-
genotype data for the study of Himalayan population structure and their relationship 
with worldwide populations and ancient genomes. However, SNP genotype arrays have 
limitations compared with whole genome sequencing, which can discover SNPs in an 
unbiased way, as well as discovering other types of variants, such as CNVs, SVs and 
INDELs. Sequence data can also directly identify causal variants rather than tag ones 
affecting gene regulation and expression and those responsible for specific phenotypes, 
including diseases and positively selected traits.  
To extend the study based on SNP genotypes in the previous chapter, this chapter 
is focused on analyses performed using a dataset of eighty-seven high coverage genomes 
(30x coverage) generated with the Illumina HiSeq X Ten platform at the Wellcome Sanger 
Institute. The aim is to refine the demographic history and explore the possibility of 
identifying functional variants for known as well as new signals of positive selection in 
the Himalayan populations. First, the different types of genetic variation, including SNPs, 
INDELs and CNVs for autosomal and uniparentally regions of the genome are 
characterized. Then, refined population structure and recent admixture with 
neighbouring populations are analysed, using both common and rare variants. A more 
complete picture of population demographic history can be generated using SMC++, 
MSMC and other methods which require whole genome sequencing data. Next, 
Neanderthal and Denisovan archaic introgression in the Himalayan individuals is 
explored using the Introgression-detection method (222).  Finally, narrowing down the 
signals of positive selection to possible causal driver SNPs is explored, both for the 
genomic regions identified in the previous chapter, and for new variants positively 
selected in high altitude populations. 
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3.2 Materials and Methods 
 
3.2.1 Samples and datasets 
 
Eighty-seven male samples were sequenced from 16 Himalayan populations, 
including four from each of eight populations in Nepal, six in Bhutan, one in North India 
and 27 from Tibetans in China. Thirteen of these populations were included in the SNP-
genotype data described in the previous chapter, plus three new populations we 
retrieved samples for that are Ghale and Tharu from Nepal or Lhokpu from Bhutan. Seven 
of these populations live at high altitude of 2500 meters or more above sea level (135). 
One population, Tharu, lives in the malaria-endemic Terai tropical forest in the foothills 
of the Himalayas. It has been reported that Tharu individuals have a lower prevalence of 
malaria than other ethnic groups in the same region, and this could possibly be explained 
by the particularly high frequency of α thalassemia in the Tharu population (46, 223).   
 
 
 
Figure 3. 1 Population samples included in this project. A. Map of South and East Asia, highlighting the four 
regions where the populations live, with a different colour assigned to each. B. Samples from the Tibetan 
Plateau. C. Samples from Nepal. D. Samples from Bhutan and India. The circle areas are proportional to the 
sample sizes. The three letter labels for each population are the same as in the previous chapter; the new 
populations, Ghale and Tharu from Nepal, and Lhokpu from Bhutan are labelled GHL, THR and LHP. 
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3.2.2 Variant calling and filtering 
 
3.2.2.1 SNPs and INDELs 
 
3.2.2.1.1 Autosomes 
 
The raw sequence reads were mapped to the human reference assembly GRCh38 
(GRCh38_full_analysis_set_plus_decoy_hla.fa) using BWA mem (224), and base quality 
score recalibration, indel realignment and duplicate removal were performed using the 
Genome Analysis Toolkit (GATK) by Dr. Shane McCarthy. One Genomic VCF (GVCF) per 
sample was generated using GATK HaplotypeCaller (225) and then merged into a joint 
file using the GATK GenotypeGVCFs tool, containing accurate genotype information, 
genotype likelihoods and annotations for the whole Himalaya dataset. Finally, a set of 
standard hard filtering parameters for SNPs and INDELs, according to the GATK best 
practices guidelines, was applied to the joint call set (226, 227).  Specifically, the following 
filtering parameters were used for SNPs (Fig. 3.2): 
1. FisherStrand (FS): This is the Phred-scaled p-value estimated using Fisher’s Exact Test to 
identify strand bias in the reads, and values > 60.0 are discarded as they indicate false 
positive calls. 
2. RMSMappingQuality (MQ): This is the root mean square of the mapping quality of the 
reads across all samples and its value should be < 40.0. 
3. MappingQualityRankSumTest (MQRankSum): This is applied to heterozygous calls and it 
represents the u-based z-approximation of the Mann-Whitney Rank Sum Test for 
mapping quality (reads with reference bases vs. those with the alternate allele). This value 
should be < 12.5. 
4. QualByDepth (QD): This is the variant confidence divided by the unfiltered depth of non-
reference samples and the values have to be < 2.0. 
5. ReadPosRankSumTest (ReadPosRankSum): This is applied to heterozygous calls and it is 
the u-based z-approximation of the Mann-Whitney Rank Sum Test for the distance from 
the end of the read for reads with alternate allele. The presence of an alternate allele near 
the ends of reads is indicative of an error. Values < -8.0 were discarded.  
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Figure 3. 2 The distribution of SNP parameters after filtering the Himalayan dataset. A. FS, B. MQ, C. 
MQRankSum, D. QD, E. ReadPosRankSum.  
 
101 
 
 
 
Only three of the above parameters were applied for INDEL filtering (Fig. 3.3): 
1. FisherStrand (FS) > 200.0 
2. QualByDepth (QD) < 2.0 
3. ReadPosRankSumTest (ReadPosRankSum) < -20.0 
 
 
Figure 3. 3 The distribution of INDEL parameters after filtering the Himalayan dataset. A. FS, B. MQ, C. QD, 
D. ReadPosRankSum. 
 
An additional filter was applied to the SNP dataset: depth (DP) of one third of, or 
three times greater than the average coverage and genotype quality (GQ) < 30 were also 
applied using bcftools 1.6 (228). All population-genetic analyses use only sites in the 
strict masked region of the genome from the 1000 Genomes Project (177, 229): around 
78% of the reference sequence. This step has been performed using the GATK 
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VariantFiltration and SelectVariants tools (226, 227). In total, the call set contains 
9,909,760 biallelic SNPs, 28,319 multiallelic SNPs and 1,043,093 INDELs.  Finally, for 
downstream analysis, multiallelic variants, all the sites with missingness greater than 
0.2% or Hardy-Weinberg equilibrium violations (hwe > 0.00001) were removed using 
vcftools 0.1.14 (230), bcftools 1.6 and PLINK 1.92 (155). This resulted in a dataset of 
9,901,395 SNPs and 1,021,861 INDELs. Out of these, 9,636,923 SNPs and 991,411 INDELs 
were autosomal.  The functional impacts of SNPs and INDELs were predicted using the 
Ensembl Variant Effect Predictor (VEP) (54, 189).  
 
3.2.2.1.2 Autosomal SNP LiftOver and filtering  
 
LiftOver is the process of converting genomic coordinates and annotations 
between assemblies and it is necessary to map all datasets to the same reference build. 
The GRCh37 assembly was released in 2009, whereas GRCh38 was released at the end of 
2013 and the latter assembly has major updates compared to GRCh37 with substantial 
improvements and better representation of the human genome. However, many of the 
population genetic and genome-wide association studies still use the GRCh37 assembly, 
and all archaic sequences (Neanderthals and Denisovans (4, 231)) and other ancient 
genomes published so far have been mapped onto GRCh37. Some efforts have been made 
to encourage researchers to use GRCh38 by releasing a LiftOver version of the 1000 
Genomes Project phase 3 VCFs and the re-mapped BAMs of the same dataset, for example 
(229). 
 
The call sets based on GRCh38 were used where possible for this project, but a 
LiftOver to GRCh37 dataset was also prepared using Picard 2.6.0 LiftoverVcf tool 
(http://broadinstitute.github.io/picard/) with default parameters for some analyses. 
Some technical issues were discovered during the merging process and later analyses: 
around 0.2% (~18,900 SNPs out of ~10 million) of genomic locations shared between 
the 1000 Genomes Project and the Himalayan dataset showed reference mismatches 
between GRCh37 and GRCh38, some of which are due to strand flips and others represent 
genuine difference between the references. For example, the reference for certain 
positions has been fixed from GRCh37 to GRCh38. These positions were called 
homozygous for the alternative allele (ALT/ALT) for all the 1000 Genomes Project 
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individuals in GRCh37, although the ALT allele is the ancestral allelic state. This has been 
swapped in GRCh38, hence all 1000 Genome Project samples are now called homozygous 
reference (REF/REF) for these positions. Most of the LiftOver tools available convert 
genomic coordinates within assemblies, however they are not aware of changes in the 
actual reference sequence. This can lead to large technical biases in the data as it can 
create artificial genetic variability. Thus, having taken care of all of these technical issues, 
I filtered the LiftOver call set by removing all these problematic position before 
proceeding with the downstream analyses. 
 
3.2.2.1.3 Y chromosome 
 
The call set for the Y chromosome was restricted to the commonly used ~10.3Mb 
region accessible by NGS (232). First, all of the samples were confirmed to be males by 
analysing the average read depth across the accessible regions on both X and Y 
chromosomes using GATK DepthOfCoverage, and found to be similar (Table 3.1).  
 
 In order to improve consistency across the different datasets and reduce the 
number of technical artefacts, three different sets of joint calls from BAM files of 
Himalayan samples and two reference datasets, the 1000 Genomes Project Phase 3 
(1000GP) (66, 232) and the Simons Genome Diversity Project (SGDP) (23) were 
generated. First, all of the reads from the Y chromosome in the Himalayan BAMs in 
GRCh38 were extracted using SAMtools 1.6 (233) and the Picard  2.6.0 SamToFastq tool, 
then were remapped to GRCh37(hs37d5.fa) using BWA 0.7.15 (224). The BAMs mapped 
GRCh38 for the 1000GP were available from 2017. Hence, three sets of joint calls were 
generated from the three Y chromosome datasets below: 
1. 1000 Genomes Project (1243 males, Y mean coverage ~ 4.7x) and Himalayan 
samples in assembly GRCh38  
2. 1000 Genomes Project (1243 males, Y mean coverage ~ 4.7x) and Himalayan 
samples in assembly GRCh37 
3. Simon Genome Diversity Project (184 males, Y mean coverage ~ 20x) and 
Himalayan samples in assembly GRCh37 
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The all-sites calling was performed for all male samples using bcftools 1.6 mpileup 
and call flags for the ~10.3Mb callable regions, setting the ploidy argument to 1, using –
m (multiallelic-caller) and setting the minimum base quality (-Q) and the minimum 
mapping quality (-q) to 20. Further filters applied are missingness less than 30% across 
the samples and the same read depth filter as for autosomal SNPs for the high coverage 
datasets (SGDP + Himalaya). This resulted in a dataset of 36,691 SNPs for the joint call set 
of SGDP and Himalayan samples and 73,493 SNPs for the call set of 1000GP and 
Himalayan ones.  
 
Sample Population Country X Y mtDNA 
BUM1919 Bumthang Bhutan 18.21 18.69 1250.59 
BUM1922 Bumthang Bhutan 18.04 18.64 846.74 
BUM1932 Bumthang Bhutan 19.04 19.43 1512.02 
BUM1933 Bumthang Bhutan 17.32 17.53 802.45 
KUR1554 Kurtöp Bhutan 19.42 19.86 914.57 
KUR1568 Kurtöp Bhutan 19.4 19.75 1129.61 
KUR1576 Kurtöp Bhutan 19.91 19.87 1186.23 
KUR1579 Kurtöp Bhutan 20.38 20.61 1425.07 
LAY1973 Layap Bhutan 16.66 16.96 390.75 
LAY1987 Layap Bhutan 16.5 16.82 1565.87 
LAY1989 Layap Bhutan 16.14 16.48 1573.06 
LAY1993 Layap Bhutan 17.55 17.82 1681.35 
LHP1013 Lhokpu Bhutan 17.89 18.44 569.51 
LHP1027 Lhokpu Bhutan 16.13 16.44 605.89 
LHP1034 Lhokpu Bhutan 18.61 18.75 750.06 
LHP1052 Lhokpu Bhutan 18.89 19.5 681.26 
MON1226 Mönpa Bhutan 18.55 17.85 717.45 
MON1228 Mönpa Bhutan 17.51 17.81 873.78 
MON1306 Mönpa Bhutan 19.08 19.57 1123.45 
MON1310 Mönpa Bhutan 18.31 18.61 946.15 
TSH0963 Tshangla Bhutan 17.76 18.32 1464.57 
TSH0966 Tshangla Bhutan 17.81 18.22 1494.11 
TSH0992 Tshangla Bhutan 18.43 18.63 781.27 
TSH1137 Tshangla Bhutan 18.17 18.23 1098.75 
TOT1094 Toto India 18.95 19.41 659.27 
TOT1124 Toto India 18.4 18.76 1271.01 
TOT1125 Toto India 19.32 19.73 991.7 
TOT1126 Toto India 17.42 17.78 872.5 
CHE0774 Chepang Nepal 16.23 16.43 651.82 
CHP0782 Chepang Nepal 17.05 17.15 1517.9 
CHP0785 Chepang Nepal 16.03 16.32 1323.53 
CHP0826 Chepang Nepal 16.15 16.4 1056.94 
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CHE0020 Chetri Nepal 15.71 15.63 3302.36 
CHE0043 Chetri Nepal 16.54 15.42 4418.68 
CHE0047 Chetri Nepal 17.65 17.82 4263.63 
CHE0133 Chetri Nepal 17.6 18.01 3011.62 
GHL0693 Ghale Nepal 17.89 18.22 1186.29 
GHL0696 Ghale Nepal 18.93 19.27 1158.02 
GHL0935 Ghale Nepal 19.26 19.72 782.08 
GHL0937 Ghale Nepal 16.3 16.78 704.95 
LIM0052 Limbu Nepal 16.05 15.05 1961.5 
LIM0053 Limbu Nepal 15 14.03 2469.55 
LIM0063 Limbu Nepal 14.38 13.61 3466.27 
LIM0071 Limbu Nepal 17.04 16.41 2214.74 
MGR0389 Magar Nepal 14.08 14.08 2511.06 
MGR0482  Magar Nepal 17.91 18.61 974.87 
MGR0488 Magar Nepal 17.79 18.65 1142.74 
MGR0511 Magar Nepal 18.04 18.48 893.7 
SHE0298 Sherpa Nepal 16.53 16.85 3997.17 
SHE0635 Sherpa Nepal 18.69 19.07 1184.35 
SHE0838 Sherpa Nepal 18.49 19.01 1312.03 
SHE0841 Sherpa Nepal 14.44 14.37 1439.25 
THK0424 Thakali Nepal 18.54 19.04 1269.93 
THK0427 Thakali Nepal 18.47 17.9 635.28 
THK0437 Thakali Nepal 18.22 18.64 933.74 
THK0439 Thakali Nepal 19.08 19.74 954.2 
THR0641 Tharu Nepal 17.82 18.26 829.59 
THR0788 Tharu Nepal 17.02 17.31 1115.18 
THR0795 Tharu Nepal 20.29 20.68 629.63 
THR0816 Tharu Nepal 18.82 19.26 471.09 
Tib1 Lhasa Tibet 22.29 23.18 1887.49 
Tib10 Lhasa Tibet 22.19 22.39 2003.88 
Tib13 Lhasa Tibet 20.26 20.28 1791.99 
Tib14 Lhasa Tibet 19.49 19.49 1877.85 
Tib15 Lhasa Tibet 21.68 21.99 1661.93 
Tib16 Lhasa Tibet 14.35 14.42 1744.9 
Tib18 Lhasa Tibet 18.8 19.03 2655.86 
Tib21 Lhasa Tibet 13.99 14.03 2004.54 
Tib22 Lhasa Tibet 16.85 16.98 2022.63 
Tib24 Lhasa Tibet 21.08 20.96 2287.29 
Tib25 Lhasa Tibet 21.09 21.29 3690.96 
Tib26 Lhasa Tibet 19.86 20.07 1954.41 
Tib28 Lhasa Tibet 22.41 22.42 1392.1 
Tib29 Lhasa Tibet 18.43 18.7 1799.37 
Tib3 Lhasa Tibet 22.73 22.89 3180.15 
Tib30 Lhasa Tibet 17.89 18.06 1659.34 
Tib31 Lhasa Tibet 26.23 26.32 2610.96 
Tib32 Lhasa Tibet 19.89 19.86 2634.09 
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Tib33 Lhasa Tibet 19.26 19.31 1861.72 
Tib34 Lhasa Tibet 24.35 24.46 2283.43 
Tib35 Lhasa Tibet 20.65 20.91 1590.91 
Tib4 Lhasa Tibet 21.12 21.27 2287.49 
Tib5 Lhasa Tibet 20.57 20.78 3407.48 
Tib6 Lhasa Tibet 20.57 22.36 3034.15 
Tib7 Lhasa Tibet 18.75 19.09 2587.84 
Tib8 Lhasa Tibet 17.48 17.47 2280.84 
Tib9 Lhasa Tibet 19.9 20.01 3705.23 
 
Table 3. 1 Read depth estimated from BAM files. The table reports average read depth for each of the 
Himalayan samples of chromosome Y, X and mtDNA.  
 
3.2.2.1.4 mtDNA 
 
All the reads that mapped to the mitochondrial DNA (mtDNA) were extracted from 
the whole-genome Himalayan BAM files. The read depth was calculated (Table 3.1) and 
all mitochondrial positions were called similarly to the Y chromosome using bcftools 
mpileup, and then merged with the 1000 Genomes Project Phase 3 mtDNA calls (2,534 
individuals) with bcftools merge as suggested by the HaploGrep 2.0 programme (234). 
Mitochondrial DNA calls from the 1000 Genomes Project have been curated by removing 
nuclear mitochondrial DNA variants (NUMTs) and resolving heteroplasmies (66).  All the 
positions showing mitochondrial heteroplasmy in the Himalayan individuals were 
removed for downstream analyses. This resulted in a dataset of 3,911 SNPs.  
 
3.2.2.3 CNVs 
 
A CNV call set from the Himalayan samples was generated by senior 
bioinformatician in our team, Yuan Chen, using GenomeSTRiP 2.0 
(http://software.broadinstitute.org/software/genomestrip/genome-strip-20). The 
software discovers and genotypes CNVs using sequencing data (235). GenomeSTRiP was 
run following the standard pipeline, which has three steps: SVPreprocess, CNVDiscovery, 
GenerateHaploidCNVGenotypes. In total, 9,322 CNVs were called in the Himalayan 
dataset, 20 of which were filtered out using a genotype quality cutoff (GQ) > 20 with 
vcftools 0.1.14  (--minGQ 20), or for violating Hardy-Weinberg equilibrium (hwe > 
0.00001), with PLINK 2.0 (https://www.cog-genomics.org/plink/2.0/). A final dataset of 
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9,302 CNVs was considered for further analyses. Out of these, 9,072 located on autosomes 
and 230 found on the sex chromosomes, X and Y. The dataset contains 4,497 deletions 
(delCNV) and 1,654 duplications (dupCNV) and 3,151 multi-allelic variants (mCNV). The 
functional impacts of CNVs were predicted using the Ensembl Variant Effect Predictor 
(VEP) (54, 189).  
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3.2.3 QC 
 
3.2.3.1 SNPs 
 
3.2.3.1.1 Concordance with SNP genotypes 
 
Twenty-six out of the 87 sequenced samples have been also genotyped and 
analysed in the previous chapter. The SNP genotypes from these 26 samples were 
converted to GRCh38 and compared with the genotypes called from the whole genome 
sequencing data for the same sample. Shared genomic positions were extracted and the 
genotypes compared within the two datasets with a custom script.  The genotype 
concordance was calculated counting the number of concordant genotypes (ref/ref, 
ref/alt and alt/alt genotypes) and divided it by the total number of genotypes (Table 3.2) 
(236) . 
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Individual Country SNP-chip ID Sequencing ID Concordance 
BUM1919 Bhutan HPG5196910 ERS724833 0.998 
BUM1922 Bhutan HPG5196913 ERS724834 0.998 
BUM1932 Bhutan HPG5197099 ERS724835 0.997 
BUM1933 Bhutan HPG5197100 ERS724848 0.998 
LAY1973 Bhutan HPG5197102 ERS724857 0.997 
LAY1987 Bhutan HPG5197200 ERS724858 0.996 
TSH0963 Bhutan HPG5197075 ERS724873 0.998 
TSH0966 Bhutan HPG5197078 ERS724874 0.998 
TSH1137 Bhutan HPG5197117 ERS724876 0.998 
CHE0774 Nepal HPG5197047 ERS724853 0.993 
CHP0782 Nepal HPG5197050 ERS724854 0.995 
CHP0785 Nepal HPG5197053 ERS724855 0.996 
CHP0826 Nepal HPG5197061 ERS724856 0.995 
CHE0020 Nepal HPG5196735 ERS724849 0.997 
CHE0043 Nepal HPG5196746 ERS724850 0.996 
CHE0047 Nepal HPG5196749 ERS724852 0.997 
CHE0133 Nepal HPG5196819 ERS724851 0.998 
LIM0052 Nepal HPG5196753 ERS724861 0.998 
LIM0063 Nepal HPG5196764 ERS724863 0.998 
LIM0071 Nepal HPG5196772 ERS724864 0.998 
MGR0389 Nepal HPG5196934 ERS724865 0.997 
MGR0482 Nepal HPG5196978 ERS724866 0.996 
MGR0488 Nepal HPG5196984 ERS724867 0.997 
MGR0511 Nepal HPG5196990 ERS724868 0.985 
SHE0635 Nepal HPG5197013 ERS724869 0.999 
SHE0838 Nepal HPG5197067 ERS724870 0.997 
 
Table 3. 2 Genotype concordance between whole-genome sequencing and SNP array genotypes in 26 
Himalayan samples. 
 
3.2.3.1.2 Ti/Tv 
 
The quality of the Himalayan SNP dataset was also assessed using the GATK 
VariantEval tool and the vcflib package popStats (237). In total, 8,264,072 (82%) SNPs 
are in the Single Nucleotide Polymorphism database (dbSNP) 146 with the same 
alternative alleles with consequent concordant rate of 99.14. The heterozygous/non-
reference homozygous ratio (Het/Hom Alt ratio), which can be an indicator of potential 
sample contamination if it is greater than two, was 1.26 for SNPs in the Himalayan dataset 
compared to 1.24 in dbSNP. The transition/transversion ratio (Ti/Tv ratio) for whole-
genome sequences should be around 2.1, and the Himalayan dataset follows this criterion 
for the known variants, although it is lower when the novel sites are considered. This 
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could be due to the occurrence of false positives within the novel sites and extra care is 
needed when including these variants in downstream analyses (Table 3.3).    
 
Novelty nSamples nSNPs concordance Rate SNPNoveltyRate TiTvRatio 
All 87 9938079 99.14 16.12 2.09 
Known 87 8335797 99.14 0 2.14 
Novel 87 1602282 0 100 1.86 
 
Table 3. 3 SNP call set QC metrics. Al l= all variants in the Himalayan dataset. Novel = variants found in the 
Himalayan dataset only. Known= variants present in dbSNP 146. 
 
3.2.3.1.3 Singleton counts 
 
Singletons are variants with only one alternative allele in all of the samples, and 
the number of singletons per sample is often used as a metric to assess dataset quality. 
Random sequencing errors are often seen as singletons and an elevated number could 
indicate sequencing errors. The total number of singletons for SNP variants in the 
Himalayan individuals using vcftools 0.1.14 was 2,781,024. The distribution of singletons 
per individual in each population was plotted (Figure 3.4A) and the correlation between 
the number of singletons and the mean coverage of depth per individual was analysed. 
Chetri and Tharu show the highest number of singletons, and Lhokpu the lowest number, 
but these are not due to differences of sequencing coverage (Figure 3.4B). Overall, 
Bhutanese populations are characterised by the lowest number of singletons, whereas 
Nepalese ones have higher proportions (Figure 3.4A and B). Finally, the genome-wide 
distribution of singletons was also plotted and it showed that they were uniformly 
distributed across the genome (Figure 3.4C). 
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Figure 3. 4 The distribution of singleton SNPs in the Himalayan dataset.  A. Total number per individual in 
each of the Himalayan populations. B. The correlation between the number of singleton SNPs and the 
average sequence coverage of each individual. C. Genome-wide distribution of all SNP singletons in the 
Himalayan dataset. 
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3.2.3.1.4 Site Frequency Spectrum (SFS) 
 
The site frequency spectrum at bialleic sites across all 87 samples using frequency 
bins of 0.05 was calculated with vcflib popStats (237) (Figure 3.5). The allele frequency 
is the number of non-reference alleles divided by the total number of alleles. The 
distribution is as expected, with a large excess of rare variants (<0.05) and small excess 
of high frequency variants (>0.95).  
 
 
 
Figure 3. 5 Site frequency spectrum (SFS) of the Himalayan SNP dataset.  The x-axis reports the allele 
frequency bins and the y-axis shows the proportion of the variants.  
 
3.2.3.1.5 PCA and ADMIXTURE analyses 
 
Principal component analyses (PCA) of the Himalayan dataset using both common 
(MAF> 0.01) and rare (MAF< 0.01) SNPs were carried out using PLINK 1.92 on an LD 
pruned file. The number of common variants used was 1,223,478, whereas the number 
of rare variants was 1,319,138. A PCA with the dataset including Himalayans and 1000 
Genomes Project individuals (worldwide dataset) was also computed using EIGENSOFT 
6.0 (157, 159). For this, I computed the eigenvectors with global diversity, and then the 
Himalayan individuals were projected onto it.  ADMIXTURE v1.2 (74) analyses were run 
on the Himalayan SNP dataset using the cross validation (CV) error to identify the best K 
value.  
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3.2.3.2 INDELs 
 
The quality of the INDEL calls was assessed similarly to the SNP dataset, and 
206,659 (22%) novel INDELs in the Himalayan dataset were identified that were absent 
in dbSNP 146. The Het/Alt Hom ratio was 1.37 for INDELs in the Himalayan dataset 
compared to 1.34 in dbSNP. 
 
Novelty nSamples nINDELs INDELNoveltyRate 
All 87 1043093 18.59 
Known 87 836434 0 
Novel 87 206659 100 
 
Table 3. 4 INDEL call set QC metrics. All = all variants in the Himalayan dataset. Novel = variants found in 
the Himalayan dataset only. Known = variants present in dbSNP146. 
  
The frequency distributions of the different INDEL lengths for novel and known 
INDELs in the Himalayan dataset were calculated, showing an overall slightly higher 
proportion of novel deletions compared to known ones. In contrast, there are slightly 
more known duplications than novel ones. Interestingly, at the extreme tails of the length 
distribution on both sides there are only novel INDELs, perhaps reflecting improvements 
in read length and INDEL calling compared with the dbSNP average (Figure 3.6).  
 
115 
 
 
 
 
 
Figure 3. 6 INDEL frequency distribution in the Himalayan dataset. The plot reports the novel and known 
INDELs in the Himalayan dataset compared to dbSNP 146. The x-axis shows the INDEL length in bins and 
the y-axis reports the INDEL frequency in the Himalayan populations. 
 
The total number of INDELs is 262,472. Similarly to SNPs, Chetri and Tharu show 
the highest number of singletons, and Lhokpu the lowest number; singletons are 
uniformly distributed across the genome. 
The whole-genome site-frequency distribution (SFS) of INDELs resembles the SNPs SFS, 
with a large excess of rare variants and slight excess of high-frequency variants (Figure 
3.7; compare with Figure 3.5).  
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Figure 3. 7 Observed folded site frequency spectrum (SFS) distribution of the Himalayan INDEL dataset. 
The x-axis reports the minor allele frequency and the y-axis the proportion of variants.  
 
A PCA using LD-pruned INDELs was carried out using PLINK 1.92. 
  
3.2.3.3 CNVs 
 
PCA was performed on both deletions and duplications using PLINK 2.0, and the 
results were compared. CNV discovery is a difficult process and there is concern that very 
rare and singleton variants can be enriched for artefacts. In previous studies, it has been 
reported that deletions identified by GenomeSTRiP showed an estimated FDR of 2.9% 
and this value is overall higher for rare variants (238, 239). Thus, I compared common 
Himalayan CNV intervals (MAF > 0.01) with the ones present in the 1000 Genomes 
Project individuals (GRCh38 LiftOver) with bedtools 2.22.0 (intersect argument) (240) to 
test if Himalayans carried novel common CNVs. Bedtools intersect searches for overlaps 
between two sets of genomic regions. I set the minimum overlap required at 0.3 as 
described in the SGDP data publication (241) (-f flag) and the fraction of overlap required 
as reciprocal for the two sets of intervals (-r flag).  Thus if two CNVs share at least 0.3 of 
their length, they are considered to belong to the same CNVR. Finally, I set a “left outer 
join” (-loj flag) to report both overlaps and no overlaps in the output.  
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3.2.4 Datasets  
 
3.2.4.1 Phasing and pruning 
 
The SNP call set on GRCh38 for Himalayan populations was phased with Eagle v2.4 
(242, 243) using the LiftOver 1000 Genomes Project data to GRCh38 as a reference panel. 
The new version incorporated a new pipeline developed by Giulio Genovese which 
includes extra processing steps applied to the 1000 Genomes Project LiftOver data to 
remove duplicated and multi-allelic variants. 
 
I have also generated two pruned datasets by filtering out SNPs and INDELs in 
high LD (r2 > 0.5) using PLINK 1.92, resulting in a dataset of 2,669,936 SNPs and 462,049 
INDELs.   
 
3.2.4.2 Datasets used for the analyses 
   
Several combination datasets were generated for different analyses because the 
comparison datasets were mapped to different human reference genomes (Table 3.5). 
Overall, the data mapped to GRCh38 were used for most of the analyses. A merged SNP-
only dataset of Himalayan samples plus the LiftOver version of the 1000 Genomes Project 
Phase 3 individuals (GRCh38), which contained 2,591 individuals and 9,636,923 SNPs, 
was used for most population demographic history analyses. The merged datasets of the 
LiftOver to GRCh37 and filtered Himalaya SNP dataset described earlier with the 1000 
Genomes Project samples or SGDP data were generated for the analyses of the Y 
chromosome, archaic ingression as well as for FineMAV for positive selection (244) .  
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Dataset Reference mapped to Analysis 
Himalaya (SNPs, INDELs, CNVs) GRCh38 Population structure and 
demography 
Himalaya + 1000GP low coverage 
data* 
GRCh38 Population  structure and 
demography, Y chromosome and 
MtDNA phylogenies 
Himalaya + 1000GP high 
coverage data 
GRCh38 Effective population size, 
population split time (MSMC2) 
Himalaya* + 10000 GP low 
coverage data 
GRCh37 FineMAV, Y chromosome phylogeny 
Himalaya* + SDGP GRCh37 Archaic introgression, Y 
chromosome phylogeny 
  
Table 3. 5 Different datasets used for the different analyses. The table reports the reference genome of the 
samples and the analyses performed with each dataset. *Data that have been lifted over and not directly 
mapped onto the reference genome reported in the table. This does not apply to the Y chromosome. 
 
3.2.5 Genetic variation analyses 
 
The genome-wide observed heterozygosity rate per individual was calculated 
using PLINK 1.92 (--het argument). For each sample, PLINK computes method-of-
moments F coefficients from observed and expected autosomal homozygous genotype 
counts: 
 
F = (Observed hom. count - Expected count) / (Total observations - Expected count) 
 
Thus heterozygosity rate was derived from PLINK’s output using the formula: 
 
Het = (N(NM) − O(Hom))/N(NM) 
 
where N(NM) is the number of non-missing genotypes and O(Hom) denotes the number 
of observed homozygous genotypes per individual (156). A pruned dataset (LD, r2 > 0.5) 
with only common variants (MAF >0.01) was used to detect Runs of Homozygosity (ROH) 
with PLINK 1.92. To maximize the detection of autozygous segments in the Himalayan 
populations (169), the parameter settings were:  the minimum number of SNPs to call an 
ROH was 100, the heterozygote allowance was zero, the missing SNP allowance was less 
than 5, and the window threshold to call an ROH was 0.05. Identity-by-descent (IBD) 
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tracts for each unphased individual within a single population were estimated using the 
IBDSeq programme (245). 
Pairwise population Fixation Index (FST) values were calculated for the Himalayan 
and worldwide datasets using EIGENSOFT 6.0 with 1000 Genomes Project admixed 
American populations removed. 
 
Phylogenetic relationships and gene flow between Himalayans and other 
worldwide populations were studied using TreeMix 1.12 (77), again with the sequencing 
data. Genetic affinity to other worldwide populations, in particular other South and East 
Asian individuals, was tested by computing outgroup f3 statistics with the phylogeny f3(X, 
Y; YRI), where X is each of the Himalayan populations and Y are the 1000 Genomes Project 
populations except admixed Americans and the Yoruba (YRI) used as an outgroup, using 
the qp3Pop function in the ADMIXTOOLS v5.0 package (82). Outgroup f3 statistics was 
computed separately for 6,106,953 common SNPs (MAF > 0.01) and 3,823,094 rare SNPs 
(MAF < 0.01) using the dataset of Himalayans and 1000 Genome Project individuals. Local 
ancestry was inferred using phased data with PCAdmix 1.0 (79). Phased VCFs were first 
converted to Beagle (246) format with a custom script as an input for PCAdmix. The South 
and East Asian populations in the 1000 Genomes Project were used as parental 
populations and Himalayan populations modelled as a mixture of them.  
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3.2.6 Demographic analyses 
 
The fine-scale demographic history of the Himalayan populations was 
investigated using several statistical approaches. 
 
3.2.6.1 Rare variant sharing 
 
Rare variants are informative about recent population demographic events and 
fine population structure. f2 variants are the rarest shared variants, with only two 
alternative alleles in the samples considered (177). Three different sharing patterns were 
analysed using custom scripts; the admixed American populations in the 1000 Genomes 
Project were excluded from these analyses: 
1. Singletons discovered in Himalayan populations shared with variants at any 
frequency in the 1000 Genomes Project.  
2. f2 variants in the merged 1000 Genomes Project and Himalayan dataset. Singletons 
discovered in Himalayan populations shared with singletons discovered in the 1000 
Genomes Project dataset. 
 
3.2.6.2 Effective population size and population split times 
 
Effective population size (Ne) and population split time were investigated using 
the multiple sequentially Markovian coalescent approach (MSMC2) (84) and SMC++ 
(247) . Single sample consensus calls and mask files with the callable region for each 
individual were generated from both Himalayan and the high coverage 1000 Genomes 
Project (remapped to GRCh38) BAMs using a combination of samtools, bcftools and the 
bamCaller.py as explained in the manual of MSMC2 and MSMC tools. The phased VCFs 
were used as input for MSMC2, which was run as explained in the MSMC tutorial with 
default parameters for both Ne and split time estimation (time segment patterning: 
1*2+25*1+1*2+1*3).  A generation time of 30 years and a genome-wide average mutation 
rate of 1.25e-8 per base pair per generation were used (84).  SMC++ for Ne estimation was 
run with the default parameters using the VCF dataset including Himalayan and 1000 
Genomes Project individuals, varying the pair of distinguished lineages for forming 
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composite likelihoods as reported in the SMC++ manual. A mask file to filter out large 
uncalled regions of the genome was used.  
 
3.2.6.3 Y chromosome and mtDNA phylogeny analyses 
  
The haplogroups for Y chromosomes were defined using yHaplo (248) . A fasta 
format of Y SNPs was generated using vcf-to-tab in vcftools and custom scripts, and used 
as an input to construct a phylogenetic tree with RAxML (version 8.2) using GTRCAT as 
the substitution model(249). The phylogenetic tree from RAxML was then manually 
rooted and visualised using FigTree v.1.4.3 (http://tree.bio.ed.ac.uk/software/figtree/). 
The ages of internal nodes were estimated based on the SNP branch length (250) using 
the mutation rate 0.76×10−9/site/year (95% C.I. 0.67–0.86 × 10−9/site/year) (153). 
 
mtDNA haplogroups were defined using HaploGrep 2.0 . The mtDNA phylogenetic 
tree was constructed and the ages of the internal nodes estimated in the same way as for 
the Y chromosome, but using a mutation rate of 2.53 × 10−8/site/year (95% highest 
posterior density: 1.76–3.23 × 10−8) (153). The possible functional consequences of 
mtDNA heteroplasmic variants were predicted by running the Variant Effect Predictor 
(VEP). 
 
3.2.6.4 Archaic introgression 
 
Introgression maps for the Himalayan individuals were generated by Dr. Laurits 
Skov using a method he has developed and published (222). The method does not use the 
genome of an archaic sample, but instead searches for genomic regions with a high SNP 
density in the test sample of SNPs not seen in a reference population assumed to be 
unadmixed. A dataset including modern Himalayan and other worldwide individuals 
from the SGDP mapped to GRCh37 was used for this analysis, with non-African 
populations as the test and Africans as the unadmixed reference. High coverage archaic 
genomes from Denisovans (4) and the Altai (231) and Vindija (251) Neanderthals were 
used to assign introgressed segments to these species.  Only segments with mean 
probability ≥ 0.8 (corresponding to 5% FDR) were retained. Himalayan-specific 
introgressed segments were identified by comparing Himalayan segments with those in 
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other populations using bedtools 2.22.0 (intersect argument) with the minimum overlap 
at 0.5 (-f flag) and the fraction of overlap required to be reciprocal for the two sets of 
intervals (-r flag) and a “left outer join” (-loj flag) to report both overlaps and no overlaps 
in the output. These introgressed regions then were annotated using BEDOPS v2.4.35 
(252) from regulatory annotations in Ensembl GRCh37 Release 93 (54) and only those  
falling within a gene or regulatory features (distance =0) were retained. 
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3.2.7 Fine mapping of positive selection 
 
We took the advantage of the whole genome sequencing data which provide a full 
catalogue of genetic variation, both coding and non-coding, free from ascertainment bias 
to further refine the signals of selection in the Himalayan populations using three 
approaches:  
 
 Genome-wide single locus estimates of FST (253) between low and high altitude (> 
2500 meters above sea level) populations for SNPs, INDELs and CNVs respectively 
with PLINK 1.92. Variants showing FST values > 0.3 were considered significant.  
Single locus FST for the EPAS1 region between the Tibetans sequenced here and 
Chinese Han (CHB) sequences from the 1000 Genomes Project was calculated as 
a positive control for highly differentiated SNPs. Variants with FST values > 0.8 
where considered highly differentiated between Han Chinese and Tibetans. LD 
blocks within the EPAS1 region were estimated using PLINK 1.92 via Haploview 
with default parameters (58, 181). 
 The Fine-Mapping of Adaptive Variation (FineMAV) algorithm (244). FineMAV is 
specifically designed to localise a signal of population-specific selection to a single 
most likely variant, and thus to differentiate between selection-driving and 
passenger variants for functional follow-up studies. A FineMAV score is calculated 
for the derived allele of each SNP by combining its Derived Allele Purity (DAP), 
Derived Allele Frequency (DAF) and functional prediction (the CADD PHRED-
scaled C-score)(190). Thus it assigns high scores for derived alleles that are 
common, population-specific and have a strong predicted functional effect. Firstly, 
the population genetic component of FineMAV (DAPxDAF) is calculated, which 
summarises population differentiation. Then DAPxDAF is combined with the 
measure of functionality (CADD) as implemented in FineMAV to further prioritise 
highly differentiated variants and elucidate the most likely functional targets of 
selection. DAP, DAF and FineMAV values were calculated for derived and 
ambiguous alleles (annotated accordingly to Ensembl Compara) (54) using a 
custom script (SNPs only; INDELs were omitted).  
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The FineMAV analyses were performed in the following contexts:  
1. Himalayan high altitude populations (> 2500 meters above sea level) vs 
low altitude populations to explore differentiation between different 
Himalayan groups; n=2, x=4.96.  
2. Comparison between Himalayan high altitude and AFR, EAS, EUR, SAS 
(the1000 Genomes Project data) to explore high altitude specific signals; 
n=5, x=2.98.  
3. Comparison between Himalayan low altitude and AFR, EAS, EUR, SAS 
(the1000 Genomes Project data) to explore low altitude specific signal;  
n=5, x=2.71 
The top 100 outlier SNPs in the whole-genome FineMAV distribution were 
reported and some of the strongest hits commented. FineMAV analyses were run 
by Dr. Michal Szpak. 
  
 Hypoxia responsive element analysis. The EPAS1-encoded protein, HIF-2α, binds 
to a specific sequence motif called a hypoxia responsive element (HRE). To test 
whether any variant in the high altitude individuals was lying in a HRE and 
putatively affecting HIF-2α binding, possible binding motif regions for HIF2-α 
from the HOCOMOCO v11 Human TF collection (254, 255) were predicted using 
PWMScan (256) from PWMTools with default parameters (Ambrosini G., 
PWMTools, http://ccg.vital-it.ch/pwmtools) for the human reference genome 
(GRCh38). The Position Weight Matrix Logo for HIF-2α was generated by 
PWMScan only for the regions of interest: the regions with ENCODE Project data 
(GRCh38) (257) for DNA accessibility (DNase-seq) which are associated with 
transcription factor (TF) binding and histone modifications in aorta and lung 
tissues. Then the highly differentiated variants (FST >0.8-between Tibetans and 
Han Chinese) within these regions were identified.  
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3.3 Results 
 
3.3.1 A large high-quality sequencing dataset of 
Himalayan populations 
 
3.3.2.1 SNPs and INDELs 
 
The dataset of 87 individuals from 16 populations contained 9,938,079SNPs, 
1,602,282 novel. After filtering, there are 1,043,093 INDELs in total in the Himalayan 
dataset, 206,659 of which are novel. Deletions make up 54.2%, duplications 40.2%, and 
5.6% are classified as sequence alterations. As expected, the majority of INDELs fall 
within intronic and intergenic regions. However, 6,302 INDELs lie within coding 
sequences with different functional consequences (Figure 3.8).  
 
 
 
Figure 3. 8 Functional consequences of INDELs in the coding sequence. The pie chart reports the proportion 
of variants falling in different functional categories retrieved using VEP.   
 
 
 
 
INDELs coding sequence functional consequences
Frameshit variants Inframe deletions Inframe insertions
Coding sequence variants Stop gained Protein altering variants
Start lost variants Stop lost variants Stop retained variants
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The total of low frequency SNP variants (MAF < 0.01) was 2,961,006 SNPs and 
267,175 INDELs. The majority of these were extremely rare: 2,892,999 singletons SNPs 
and 262,472 INDELs, respectively. No correlation between number of singletons and 
depth of coverage was identified in any of the samples, and singletons were randomly 
distributed across the genome. 
 
PCA using the Himalayan samples together with other worldwide populations 
from the 1000 Genomes Project (Figure 3.9A) showed similar structures to those with 
SNP genotype data from the last chapter. Himalayan individuals lie on a cline within other 
South and East Asian populations, with Chetri and Tharu clustering with South Asians 
and the rest of the Himalayan populations genetically closer to East Asians. PCA of the 
Himalayan samples alone using only common variants displays a clear population 
separation, with the first two components of the PCA showing strong sub- clustering, with 
the Chetri plus one Tharu individual and Lhokpu populations forming outliers (Figure 
3.9B). The PCA using rare variants shows that the first two principal components 
separate the majority of the Himalayan populations from the four Chetri and one Tharu 
individuals that are extreme outliers (Figure 3.9C) due to their excess of singletons 
compared to other Himalayan populations. PCA computed using INDELs replicated the 
SNP results with Chetri, Tharu, Toto and Lhokpu forming outliers and the rest of the 
populations forming sub-clusters (Figure 3.9D).  
 
The ADMIXTURE analysis using the SNPs from the Himalayan dataset displays 
patterns consistent with the PCA, with different proportions of ancestral components 
between Nepal, Bhutan, North India and Tibet. Using the best number of ancestral 
components according to the cross-validation error (K=2), the Bhutanese, Tibetan and 
Sherpa populations are mainly represented by the red component, while other Nepalese 
populations show a mixture of green and red components. Outlier populations (Lhokpu, 
Toto, Chetri and Tharu) are characterised by the green component. The increase of one 
additional component (K=3) leads to the separation of Lhokpu and Mönpa characterised 
by the green component, and Toto, Chetri and Tharu by an additional yellow component 
(Figure 3.10). 
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Figure 3. 9 Principal component analyses (PCA). A.  PCA of the world dataset. Each dot represents a sample, 
coded by region as indicated. The Himalayan region samples lie between other East Asian and South Asian 
samples. B. PCA of the Himalayan populations alone for common SNPs variants. Chetri, Lhokpu and Toto 
act as outliers.  C.  PCA of the Himalayan populations alone for rare SNPs variants. Chetri, and one Tharu 
individuals act as extreme outliers. The rest of the samples are indistinguishable. D. PCA of the Himalayan 
populations alone for INDELs. The pattern of variation is similar to the PCA on common SNPs.  
 
 
 
 
Figure 3. 10 ADMIXTURE (K value of 2 and 3) analysis of the Himalayan samples. Purple= Bhutan, orange= 
India, Nepal=green, Gold= Tibet  
 
3.3.2.2 CNVs 
 
CNVs were investigated in the Himalayan populations, and compared with other 
worldwide populations from the 1000 Genomes Project. After CNV discovery and 
filtering, 9,302 CNVs were analysed: 9,072 located on autosomes and 230 on the X and Y. 
The dataset contains 4,497 deletions (delCNV), 1,654 duplications (dupCNV) and 3,151 
multi-allelic variants (mCNV). There are 6,820 common variants (MAF> 0.01). PCA on 
both the all variants and common variants datasets for duplications, deletions and mCNV 
display similar patterns, although duplications detect more detailed substructure. On the 
first principal component, Limbu and one Chetri individual, showing the highest 
proportion of CNVs, are separated from the rest of the populations for both deletions and 
duplications. In the PCA applied to duplications, Limbu outliers lie separated from the 
Chetri individual, and the second principal component splits the remaining samples into 
two groups. Similarly to the PCA performed on SNPs and INDELs, Tibetan, Bhutanese and 
Sherpa from Nepal mostly cluster together, whereas other Nepalese samples tend to form 
a cline and sub-groups (Figure 3.11).  
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Figure 3. 11 PCA on CNVs. The plots show the PCA on deletions (A) and duplications (B). Limbu and one Chetri 
individuals are seen as outliers.  
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GenomeSTRiP produces a high quality CNV call set, yet some further filtering and 
QC are still needed before further population-genetic analyses, as illustrated by the PCA 
plots. Although this is beyond the scope of my thesis, some known interesting CNVs in 
these populations were rediscovered in my dataset. One is a 3.4 kb deletion upstream of 
TMEM247 near EPAS1 in Tibetans (258). High altitude populations show the highest 
frequency of this deletion, with Tibetans (overall frequency 0.83) showing 19 
homozygotes and seven heterozygotes. The deletion is present in the other high altitude 
populations (Ghale, Kurtöp, Layap, Thakali and Sherpa) with an allele frequency ranging 
from 0.5 to 0.625.  The second is the alpha-thalassemia deletion in the Tharu (7) and 
Ghale. All the four Tharu individuals in the dataset carry heterozygous –α3.7 deletions, 
thus with an allele frequency of 0.5. Surprisingly, three out of four Ghale and one Tshangla 
individuals also carry the deletion, with one Ghale individual homozygous for it and the 
other three heterozygous. All the other samples in the dataset are homozygous for the 
reference allele.  
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3.3.2 Recent demographic history – genetic structure 
 
3.3.2.1 Genetic similarity and gene flow in the Himalayas 
 
The genetic structure and relationships between Himalayan populations and 
other worldwide populations were investigated using several metrics. Firstly, the aim 
was to explore the genetic relationship of the three new populations in this dataset, 
Tharu, Ghale and Lhokpu to the other Himalayans, and more generally to compare the 
patterns to those from the genotype data analysed in the previous chapter. Secondly, I 
was interested in understanding why the Tharu, Lhokpu and Chetri appeared as extreme 
outliers in the PCA.  
 
The phylogenetic tree reconstructed using TreeMix on the worldwide dataset 
displays long branches for Lhokpu, Toto, Mönpa and Chepang, in agreement with the 
genetic drift patterns. It also shows that Chetri and Tharu form separate branches from 
the rest of the Himalayan populations, and that the populations from higher-altitude, such 
as Lhasa, Layap and Sherpa cluster together, in agreement with the SNP-genotype 
analysis (Figure 3.12). This genetic pattern was also confirmed by the pairwise 
population FST analysis, which shows Lhokpu and Toto having the highest FST values in 
comparison with the other populations, and the Tibetan and Bhutanese populations 
showing more genetic affinity. These analyses thus confirmed the results from the SNP-
genotype data. 
 
The position of Chetri and Tharu as outliers in PCAs might be due to their different 
genetic affinity with other South and East Asian populations, or to gene flow events into 
these individuals. To distinguish between these two hypotheses, the Himalayan 
populations were compared with 1000 Genomes Project individuals using: 1) Pairwise 
FST; 2) TreeMix migration edges; 3) f3-outgroup statistics; and 4) local ancestry analyses 
using PCAdmix. 
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Figure 3. 12 TreeMix results from the worldwide dataset. The tree displays a phylogeny of the Himalayan 
and other worldwide populations. The x-axis represents the amount of genetic drift. The tree shows long 
branches for Toto, Mönpa, Lhokpu and Chepang, in agreement with their strong genetic drift patterns.   
 
The pairwise FST shows five clusters with high genetic affinity that reflect 
geographical distributions: the first one including African populations, the second one of 
Europeans, the third of East Asians, the fourth one of South Asians and the last one 
including 6 Himalayan populations. Interestingly, this last one includes populations from 
all the three geographical areas (Nepal, Bhutan and the Tibetan plateau). Subsequently, 
genetic affinity is also found between South Asians and Europeans, and within Himalayan 
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populations. Most of the Himalayan populations show higher genetic affinity to East 
Asians. On the other hand, Chetri and Tharu have higher genetic affinity with South 
Asians. Chetri and Tharu show also genetic similarity to Europeans. Lhokpu, followed by 
Toto and Chepang show higher genetic differentiation from the rest of the Himalayan 
populations sequenced here (Figure 3.13). 
 
 
Figure 3. 13 Heatmap of pairwise FST values for the worldwide dataset. The amount of genetic divergence 
is indicated by the colour scheme at the top left corner. 
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TreeMix analysis indicates possible gene flow into Tharu and Chetri from other 
South Asian, European and the Nepalese Limbu populations. Migration edges from 
European individuals could be due to European admixture into South Asian individuals 
or shared ancestral components (194). Finally, it is possible to detect gene flow from 
Chetri and Tharu ancestries into Toto individuals (Figure 3.14).  
 
 
 
Figure 3. 14 Migration edges for the worldwide dataset from the Treemix analysis. The colour intensity of 
the arrows indicates the migration weight.  
 
136 
 
 
 
The f3-outgroup statistics based on the phylogeny f3(X, Y; YRI) for both rare and 
common variants shows that the Chetri and Tharu share less genetic affinity with East 
Asian individuals (common variants: 0.155 <f3< 0.172, rare variants: 0.027 <f3< 0.037 ) 
compared to other Himalayan populations (common variants: f3>0.189, rare variants: 
f3>0.070), with Tibetans, Bhutanese, Limbu and Sherpa from Nepal showing the highest 
genetic affinity to East Asian individuals (Figures 3.15 and 3.16).  On the other hand, 
Chetri and Tharu display more genetic similarity to South Asians and Chetri show an 
excess of genetic sharing with European individuals. Interestingly, for rare variants, other 
Nepalese populations, Toto from India and Tshangla from Bhutan show more genetic 
similarity to South Asians compared to other populations.  Moreover, rare variants also 
give more detailed sharing with East Asians: Himalayan populations display more genetic 
sharing with CHB compared to CDX and KHV (Figure 3.15).  Finally, all Himalayan 
populations show a similar pattern of genetic drift when Bengali population (BEB) is used 
as a proxy for South Asia (Figure 3.15 and 3.16). This could be due to the potential 
admixture of Bengali individuals with East Asians (259, 260).  
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Figure 3. 15 Common variant outgroup f3 statistics for the Himalayan samples. The plot shows the amount 
of genetic affinity (x-axis) of each Himalayan population (y-axis) to each of the worldwide populations 
(individual panels). 
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Figure 3. 16 Rare variant outgroup f3 statistics for the Himalayan samples. The plot shows the amount of 
genetic affinity (x-axis) of each Himalayan population (y-axis) to each of the worldwide populations 
(individual panels). 
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This pattern of genetic affinity to South and East Asians is confirmed when these 
populations are used as sources in PCAdmix analysis. Tharu and Chetri individuals show 
the highest proportion of South Asian ancestry haplotypes, whereas Tibetans, display the 
lowest values. Bhutanese populations and the Nepalese Limbu and Sherpa have a low 
proportion of shared South Asian ancestry comparable to the Tibetans (Figure 3.17).  
 
 
 
Figure 3. 17 Local ancestry PCAdmix analysis. The plot shows the genome-wide proportion of South Asian 
ancestry haplotypes for each Himalayan individual.  
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3.3.2.2 Himalayan genetic variation  
 
Heterozygosity rate, runs of homozygosity (ROHs) and identity-by-descent (IBD) 
are standard parameters to study population demography. Heterozygosity is indicative 
of the genetic variation in the population and very low levels of heterozygosity are 
indicative of reduced genetic variation, for example due to events such as population 
bottlenecks and genetic drift that have severe effects on population sizes. In contrast, high 
heterozygosity suggests high levels of genetic variability, and gene flow may have played 
an important role by introducing new alleles. Himalayan populations show different 
degrees of heterozygosity, with Lhokpu, Monpa and Toto having the lowest values 
whereas Chetri and Tharu have the highest (Figure 3.18). 
 
 
 
Figure 3. 18 Heterozygosity rate in the Himalayan populations. The plot shows the genome-wide 
heterozygosity rate for each population. 
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Compared to other South and East Asians populations, Himalayan individuals 
show values of heterozygosity similar to their neighbours and in agreement with 
previous estimates (261, 262). In particular, most Nepalese, Bhutanese and Tibetan 
populations show similar levels of heterozygosity to other South Asians, whereas Lhokpu, 
Mönpa, Toto and Chepang show values similar to other East Asians, who have an overall 
lower heterozygosity rate than other 1000 Genome Project populations (heterozygosity 
ratio ≈1.4) (261)). Chetri and Tharu show the highest heterozygosity rates even 
compared to other South-East Asian samples. This could be due to the excess of rare 
heterozygous variants in these populations (Figure 3.19).  
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Figure 3. 19 Heterozygosity rate in the Himalayan populations compared to other worldwide populations.  
 
The number and length of ROHs and IBD tracts are strong predictors of population 
isolation, genetic drift and inbreeding. Similarly to the results in the previous chapter, 
ROHs are widely distributed across human populations but, generally, isolated 
populations show higher numbers of ROHs whereas large and admixed populations have 
fewer and shorter ones (263).  Similarly, IBD is a useful measurement of relatedness 
between individuals and thus used to estimate population bottlenecks and substructure 
(264). In agreement with the analyses performed in the previous chapter, Bhutanese 
populations overall show the highest proportion of ROHs whereas Tibetans have the 
143 
 
 
 
lowest. Lhokpu, Kurtöp and Thakali are characterised by the highest number and longest 
ROHs (Figure 2.6A).  
 
 
 
Figure 3. 20 Heatmap of shared IBD tracts. The plot shows the number of shared IBD tracts between 
different Himalayan individuals. The number of tracts is shown by the colour scheme in the top left corner. 
 
Lhokpu, Mönpa, Layap and Toto also show the highest number and longest IBD 
tracts, while the Nepalese Magar, Chetri and Tharu show the lowest. The pairwise matrix 
of shared IBD tracts in the Himalayan populations replicates many of the patterns of 
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genetic similarity found with previous analyses. Populations showing signatures of 
genetic drift and isolation, Lhokpu, Chepang, Mönpa and Toto, share the highest number 
of IBD segments within individuals of the same population (Figure 3.20). Tibetan, Sherpa 
and other Bhutanese populations form a cluster in agreement with the PCA, ADMIXTURE 
and FST analyses.  Another smaller cluster is formed by individuals from the Nepalese 
Ghale and Magar.  
 
3.3.2.3 Rare variant sharing 
 
The singletons (Figure 3.4) found in the Himalayan dataset tend to be shared with 
the East and South Asian populations in the 1000 Genome Project: Tibetans from Lhasa 
share the most with East Asians, and Tharu and Chetri with South Asians (Figure 3.21). 
More detailed information is gained by looking at f2 variants in all the individuals from 
the Himalayas and the 1000 Genomes Project. f2 variants tend to be shared more between 
individuals from the same population or geographical group, or between recently 
admixed groups (177) (Figure 3.22). However, within the Himalayan populations, sub-
clusters of f2 variant sharing were observed. Himalayan populations share f2 variants at 
three levels: within each population, between different Himalayan populations and with 
other South and East Asians. Magar, Ghale, Thakali and Chepang form a clear cluster, 
while Tibetans, Tharu, Chetri, Toto, Lhokpu and Mönpa form a second cluster. An 
additional cluster was formed by Tshangla, Bumthang Limbu and Kurtöp. This is 
consistent with the recent shared ancestry of the Himalayan populations within 
themselves and with other neighbouring populations. Interestingly, f2 variant sub-
clusters do not follow geographical proximity; populations that are physically distant 
group together (Figure 3.23). Finally, the sharing of the subset of f2 variants with one 
alternative allele found in Himalayan populations and one in the 1000 Genomes Project 
populations showed that, overall, all Himalayan populations share singletons mostly with 
South and East Asian individuals. Tibetans from Lhasa have the highest number of 
singletons shared with East Asians, in particular with Chinese Han (firstly CHB and 
secondly CHS), in agreement with the known recent shared demographic history of 
Tibetans and Chinese Han individuals (50).  It is important to note that the overall higher 
number of shared singletons in Tibetans compared to other Himalayan populations may 
be due to the larger sample size (27 vs 4). Chetri and Tharu display higher singleton 
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sharing with South Asians compared to other Himalayans and, overall, all Himalayan 
populations share more singletons with the Bengali populations, confirming the pattern 
of the outgroup f3 statistics. Intriguingly, Chetri and secondly Tharu show higher variant 
sharing with African populations. Chetri and Tibetan individuals show a slightly 
increased sharing with Europeans (Figure 3.18).  
 
 
 
Figure 3. 21 Heatmap of singleton sharing between Himalayan and 1000 Genomes Project individuals. The 
plot shows sharing of variants that are singletons in both the Himalayan and 1000 Genomes Project 
datasets. 
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Figure 3. 22 Heatmap of f2 variant sharing in the worldwide dataset. The highest f2 variant sharing is within 
populations of the same geographical region. 
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Figure 3. 23 Zoom showing the Himalayan samples from the heatmap of f2 variants in Figure 3.22. 
Himalayan populations share f2 variants within themselves and with other East and South Asian 
populations. 
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3.3.2.4 Recent population expansion 
 
3.3.2.4.1 Coalescent based demographic inference 
 
The effective population size (Ne) history of Himalayan populations was 
investigated using three methods: MSMC2 and SMC++. MSMC2 estimates effective 
population size in older times, whereas in more recent times (<~1e+04 years) it loses 
resolution because there are few very recent coalescences. SMC++ is somewhat more 
accurate in estimating Ne in recent times as it incorporates allele frequencies from a 
larger number of individuals, but it requires a considerable sample size to attain this 
potentiality. MSMC2 and SMC++ gave similar results for Ne values of the Himalayan 
populations, and in a similar time frame, with some showing an increase of Ne in more 
recent times but others maintaining low Ne. In MSMC2 runs, most of the populations 
show a Ne curve similar to other East Asian individuals, with the exceptions of Chetri and 
Tharu who display higher Ne than other Himalayan populations, and similar Ne curves to 
other South Asians (Figure 3.24). 
 
 
Figure 3. 24 MSMC2 Ne plot. The plot shows the Ne for the different Himalayan individuals for each 
population compared to other European, South and East Asians. The x-axis shows the time in years, and the 
y-axis the Ne values. 
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 Within the Himalayan samples, Chepang, Lhokpu, Mönpa and Toto show the 
lowest values of recent Ne, in agreement with a scenario of population isolation and 
genetic drift, which also supports the results from the heterozygosity rate, ROHs and IBD 
analyses. On the other hand, Chetri, Tharu and Lhasa show the highest recent Ne values 
within the Himalayas, in agreement with their recent population growth (Figure 3.25).   
 
 
 
Figure 3. 25 MSMC2 Ne plot. The plots show the Ne for the different Himalayan individuals coloured by 
country. The x-axis shows the time in years and the y-axis the Ne values. A. Nepal, B. Bhutan, C. Tibet, D. 
India. 
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Overall, SMC++ runs display comparable results to MSMC2, with generally low 
recent Ne values across Himalayan populations. Chetri, Tharu and Tibetans from Lhasa 
show the highest Ne compared to other Himalayans. The higher Ne and different curve 
shape in Tibetans may be due to the bigger sample size. Lhokpu show the lowest Ne 
together with Mönpa and Toto (Figure 3.26). It is important to note that the low sample 
sizes for most Himalayan populations prevent reliable estimates in recent times and the 
drop in Ne in recent times in some curves may be affected by this technical limitation. 
 
 
 
Figure 3. 26 SMC++ Ne plot. The plots show the Ne for the different Himalayan individuals, together with 
CEU, CHB and GHI. The x-axis shows the time in years and the y-axis the Ne values. 
 
3.3.2.4.2 Y chromosome and mtDNA demographic inference 
 
The Y chromosomes and mitochondrial DNA (mtDNA) of 87 Himalayan 
individuals were studied and compared with other worldwide populations to understand 
the patterns of population structure and migration as reflected by uniparental makers. 
Both Y chromosome and mtDNA haplogroups of the Himalayan individuals show a 
mixture of South and East Asian lineages. The most common haplogroups for the Y 
chromosome are D1 and O2. The O2 lineage, common in South-East Asian populations 
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(265, 266), is the most widespread in the Himalayan region (Figure 3.27). Except for 
Layap, at least one individual from each population belongs to the O2 lineage.  Within O2, 
O2a1 and the O2a2b1 form two separate clades (Figure 3.27). 
 
 
 
Figure 3. 27 Map of Y chromosome haplogroups. The circle areas are proportional to the sample size 
(Bhutanese, Nepalese and Indian = 4, Lhasa=27). 
 
The phylogenetic tree of the Himalayan Y chromosomes plotted together with the 
SGDP samples showed the expected structure, with the Himalayan individuals closely 
clustered with either East or South Asians (Figure 3.28). The most striking feature is the 
star-like expansion of O2a2b1 lineages. Its TMRCA is around 1000 years ago, suggesting 
an enormous male population expansion at this time (Table 3.6). In addition, smaller star-
like expansions are seen in D1a2a1 and R1a1a1b2. The D lineage, that is common in 
Tibetan and Japanese and Andamanese populations (267), is present in Tibetan, Sherpa 
and Layap individuals with the haplogroup D1a2a, whereas the D1a1a is shared between 
Tibetans, one Mönpa and one Limbu individuals. It is interesting to note that the D1a2a1 
cluster contains all high altitude populations (Tibetans, Sherpa and Layap), resembling 
the pattern seen before in this chapter from autosomal data (Figure 3.28). The split time 
for the D lineages are very recent with a TMRCA around 600 years ago (Table 3.6). These 
times are consistent with one another and with the recent split time between the high 
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altitude populations (see the section below). Although the O2 and D haplogroups, that 
indicate an East Asian genetic substrate, are the most prevalent in the samples, South and 
Central Asian haplogroups are also present: the R1a1* haplogroup in Chetri, Layap and 
Tharu individuals showing recent split times although older than O2a2b1 and D1a2 
lineages (TMRCA ~5800 years ago) (Table 3.6) and the R2a* in Chetri and Tshangla that 
are mostly prevalent in the Indian sub-continent (268).  
 
Haplogroup TMRCA  (years ago) 95% C.I. TMRCA (years ago) 
O2a2b1 ~ 1,100 ~980-1,250 
R1a1a1b2 ~5,800 ~5,100-6,600 
D1a2a1 ~580 ~500-640 
 
Table 3. 6 Y chromosome split times within Himalayan individuals. The table reports the TMRCA   and their 
95% C.I. for most prevalent lineages in the Himalayas.  
 
The phylogenetic tree reconstructed using the 1000 Genomes Project samples, 
both GRCh37 and GRCh38, show a very similar phylogeny to the one reconstructed with 
the Simon Diversity Project individuals. (APPENDIX A).  
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Figure 3. 28 Phylogenetic tree of the Y chromosomes 
of Himalayan and worldwide (SGDP) samples. The 
branches are coloured to indicate the haplogroup and 
the triangles represent SGDP lineages absent from 
the Himalayan individuals. The high altitude 
indivduals are coloured in green. 
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The mtDNA analysis shows substantial haplogroup variability, with a mixture of 
East and South Asian lineages (Figure 3.29). The most common lineages are M and the D.  
However, a clear separation between haplogroup distributions is noticeable. The D 
haplogroups, prevalent in North and Eastern Asia (269), are mostly seen in Nepal and the 
region neighbouring it, where Lhokpu and Toto live. The M lineage is widespread in South 
and East Asia with M2, M3, M4 and M5 mostly present in South Asia (270) and also found 
in lowland Himalayan populations.  In contrast, high altitude populations from Tibet, 
Bhutan and the Sherpa show mainly M9a that previously has been associated with 
hypoxic adaptation in Tibetans (271). Sherpa also carry lineages within the A and C 
haplogroups which have previously been reported to be Sherpa-specific (117). 
 
 
 
Figure 3. 29 Map of mtDNA haplogroups. The circle areas are proportional to the sample size (Bhutanese, 
Nepalese and Indian = 4, Lhasa=27). 
 
In contrast to the Y chromosome, Himalayan mtDNAs do not form large clades on 
the phylogenetic tree, but tend to be dispersed with other worldwide individuals, in 
particular from South and East Asia. A main cluster of Himalayans is formed by 
individuals of the haplogroup M9a1a (Figure 3.30).  
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Figure 3. 30 Phylogenetic tree of mtDNA of 
Himalayan samples and other worldwide 
individuals from the 1000 Genomes 
Project. The branches are coloured to 
indicate the haplogroup.  Zooms of the 
M9a1a and D4 haplogroups are indicated 
in the boxes. 
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Some of the terminal branches in the different haplogroups, in particular M, 
include two or more Himalayan individuals with identical sequences, and thus indicate 
very recent divergence. The oldest pairwise split time is dated around 4,700 years (95% 
C.I. 3,700-6,800 years) between one Magar and one Tharu individuals belonging to the 
haplogroup U. I found 25 heteroplasmies that, according to VEP, are all intergenic and 
without any identifiable functional consequences. 
The analyses of the Y chromosome and mtDNA in the Himalayans show that both are 
characterised by South and East Asian lineages. The most striking feature is that Y 
chromosome haplogroups D, R1a and especially O2 are widespread and common in the 
region and show signatures of a strong recent male-specific expansion. (Figure 3.28 and 
3.30, Table 3.6).  
 
3.3.3 Long term demographic history 
 
3.3.3.1 Population split times from other Asians 
 
Population split times were estimated using MSMC2, taking the 50% cross-
coalescence rate as the point estimate for the split time. All of the Himalayan populations 
split from Africans around 50,000-60,000 years ago (Figure 3.31A), as expected. Chetri 
shows less than full separation from the Africans at the most recent times, which could 
be due to the gene flow from Africans, as also seen in ALDER results in the previous 
chapter (Figure 2.10). This is also true for the split time with Europeans which is around 
25,000-35,000 years ago for all the Himalayan populations, but incomplete for Chetri 
(Figure 3.31B).  All of the Himalayan populations split from South Asians around 10,000-
20,000 years ago, with Chetri, Tharu, and Toto splitting most recently at around 10,000-
11,000 years ago and also showing recent gene flow from South Asians. Ghale also display 
recent gene flow from South Asian populations (Figure 3.31C). All of the Himalayan 
populations have recent split times from East Asians at 10,000 years ago or less (Figure 
3.31D); the Tibetans from Lhasa and other high altitude populations split from the 
Chinese Han around 9,000 years ago. 
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Figure 3. 31 MSMC2 analysis of split times. The x-axis shows the time and the y-axis the cross-coalescence 
rate. A rate of 0.5 is taken as indicative of population separation. The curves represent the split time for 
each Himalayan population with the continental populations indicated in the legend. A. Africa, B. Europe, 
C. South Asia, D. East Asia  
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Himalayan populations separated from each other between 3,000 and 10,000 
years ago, and many of them are not clean splits (Figures 3.32, 3.33, 3.34 and 3.35). High 
altitude populations show very similar and recent split times, and lack of full separation 
for many of them, emphasising their genetic similarity and the idea of a single ancestral 
high altitude population that split from East Asians and then diverged into the current 
communities (Figure 3.32A). When comparing populations from Tibet and Bhutan, all 
with a high proportion of East Asian ancestry, Tharu, Chetri and Toto split from Tibetans 
at an earlier time (Figure 3.32B). Although these estimates cannot be interpreted too 
literally because splits are complicated by gene flow, admixture and possible technical 
biases due to phasing, they nevertheless provide important insights into their population 
demography.  
 
 
 
Figure 3. 32 MSMC2 analysis of split times between Himalayan populations.  A. High altitude Himalayan 
populations split times from Tibetans (Lhasa). B. Split times between Chetri, Tharu and Toto from Tibetans.  
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Figure 3. 33 MSMC2 analysis of split times between Himalayan populations.  A. Himalayan populations split 
times from Toto. B. Himalayan populations split times from Tibetans (Lhasa). C. Split from Tharu D. Split 
from Thakali. 
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Figure 3. 34 MSMC2 analysis of split times between Himalayan populations.  A. Split from Chetri B. Chepang 
C. Ghale D. Limbu E. Magar F. Sherpa 
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Figure 3. 35 MSMC2 analysis of split times between Himalayan populations.  A. Split from Bumthang B. 
Kurtöp C. Layap D. Lhokpu E. Mönpa F. Tshangla 
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3.3.3.2 Archaic introgression landscape in the Himalayas 
 
Denisovan and Neanderthal introgressed genetic material in present-day 
Himalayans was investigated using a novel method that does not require an archaic 
reference and is thus more powerful in finding intregressed segments, but allows 
subsequent mapping to these archaic genomes (222). Compared with other worldwide 
individuals from the SGDP, the genome-wide distribution of Neanderthal segments in the 
Himalayans is similar, as expected from a model of shared Neanderthal ancestry in all 
non-African populations due to a single admixture event soon after the exit from Africa 
(contributing approximately 2%) (272) (Figure 3.36). Each Himalayan individual carries 
around 200-260 Neanderthal regions (Vindija + Altai Neanderthals) with a mean 
probability ≥ 0.8. The number and distribution of introgressed segments from the Vindija 
and Altai Neanderthals were very similar across all the individuals tested. Each 
Himalayan individual carries around 50-60 additional Denisova segments, a lot less than 
in Melanesians, as expected (Figure 3.36). The genome-wide distribution of Denisovan 
introgressed segments in Himalayans is similar to those in other East Asian populations 
and more than in South Asians. A total of 2,635 Denisova introgressed segments were 
inferred in the Himalayan individuals, 479 of which are not shared with other SGDP 
worldwide individuals (minimum overlap within segments set at 0.5 to call a shared 
segment). Overlapping the introgressed segments with known gene and regulatory 
annotations from Ensembl revealed 239 to explore for the possible functional impact.  
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Figure 3. 36 Comparison of archaic introgressed segments in different populations. The green and blue 
segments are Neanderthal (most of the blue are covered by green ones as shared between Altai and 
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Vindija), and the red segments Denisovan. The height of the coloured bar is proportional to the number of 
individuals carrying the segment. A. Nepal, B. Bhutan, C. Tibet, D. India, E. East Asia, F. Melanesia 
 
Because the introgressed regions potentially contain a mix of modern human, 
Neanderthal and Denisovan variants, I specifically extracted SNPs predicted to be 
Denisovan-like by the method. Within these 239 regions, 1,060 SNPs are Denisovan 
specific. I ran VEP on these variants to predict specific function and most likely gene 
association for each of them. Six variants were predicted to be missense and nine 
synonymous, 164 fall within regulatory regions and three are splice region variants 
(APPENDIX B). Possible evolutionary implications of these variants are described later in 
this chapter. 
EPAS1 has been widely studied in Tibetans because they carry an extended 
introgressed Denisovan haplotype associated with high altitude adaptation (104). Thus, 
I have explored this region in more detail, comparing Himalayans with other worldwide 
populations from the SGDP dataset. The introgressed EPAS1 region is widespread across 
the Himalayan populations (127) but mostly absent from other worldwide populations. 
In particular, all Melaneasian individuals examined lack the introgressed EPAS1 region, 
supporting the idea of two pulses of Denisovan introgression, one involving both 
Melanesian and East Asian and a second affecting only East Asians (36). Nevertheless, the 
absence of the EPAS1 introgressed region from Melanesians could also be the result of 
negative selection in this region. Within Himalayans, the region extends over more than 
~350 kb including sequences both upstream and downstream of EPAS1 (Figure 3.38). 
Although the Denisovan segments differ between individuals, EPAS1 and the downstream 
region are present in the majority of Himalayans and include six genes with a complicated 
LD pattern (Figure 3.37). 
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Figure 3. 37 Archaic 
segments near EPAS1. 
Each horizontal lines 
represents an 
individual; black dots 
show archaic SNPs and 
the colour the 
geographical origin of 
the individual.  The two 
black vertical lines 
show EPAS1 gene. 
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3.3.4 Fine-scale positive selection signals  
 
Positive selection in the Himalayan populations was investigated using three 
major approaches to look for new candidate signals and refine the ones reported in the 
previous chapter. Genome-wide single-locus FST (60) between low and high altitude 
Himalayan populations for SNPs and INDELs replicated two regions reported in the last 
chapter, EPAS1 on chromosome 2 and HLA-DQ on chromosome 6 with FST > 0. 3, and also 
discovered a new region on chromosome 7 overlapping the gene ArfGAP With Dual PH 
Domains 1 (ADAP1) with FST between 0.25 and 0.32 (Figures 3.38A and B). ADAP1 is 
involved in the B Cell Receptor signalling and Arf6 signalling pathways. Single locus FST 
of deletions and duplication only replicated the known Tibetan-specific deletion around 
EPAS1 with FST of 0.45 between high and low altitude populations, and found one 
duplication on chromosome 17 (chr17: 46262318-46270696) with derived allele 
frequency of 0.23 in the low altitude populations and absent in high altitude populations 
(Figure 3.38C). This duplication overlaps with a promoter region and it was also found at 
frequency of 0.48 in South Asians in the 1000 Genomes Project (chr17:46264046-
46289131), so the presence for this duplication in Chetri, Toto, Chepang and Tharu could 
be explained by their South Asian genetic background and admixture. 
 
 
 
 
 
 
167 
 
 
 
 
Figure 3. 38 Manhattan plots of genome-wide FST between low and high altitude Himalayan populations. 
The x-axis shows the genomic positions and the y-axis the FST values. Each dot is a variant. A. SNPs B. INDELs 
C. CNVs (duplications and deletions). 
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Single locus FST values for the EPAS1 region between Tibetans and Chinese Han 
are very high: In a region of more than 300 kb containing 1,558 SNPs, 95 showed FST ≥ 
0.8, and of which 455 are derived variants in the Denisova genome (Figure 3.39). Variants 
with the highest FST values lie within EPAS1 (FST ≥ 0.9), followed by the region 
downstream of TMEM247 and ATP6V1E2 (FST ≥ 0.8). It is difficult to identify the positively 
selected target variant(s) from these numbers alone, although one of them, rs150877473 
(chr2:46360880-46360880, FST of 0.91), is predicted to fall into a splice site with a 
derived allele frequency of 0.85 in Tibetans and 0.01 in Han Chinese(132).  The derived 
allele (G) has also been associated with Primary familial polycythemia (273).   
 
Figure 3. 39 Manhattan plot of single-locus FST values around EPAS1 between Tibetans and Han Chinese. 
The x-axis shows the genomic positions and y-axis the FST value. Each dot is a variant. The green dots are 
derived variants in the Denisova genome. The black and red lines represent LD blocks within the region. 
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In the attempt to narrow down casual variants, the FineMAV algorithm was 
applied to compare low versus high altitude Himalayan populations, and low and high 
altitude Himalayan populations, to other worldwide populations (1000 Genomes 
Project). FineMAV picked up a strong peak underlying selection in EPAS1 in high altitude 
populations compared to low altitude ones, with the strongest hit being an intronic 
variant rs141366568 (Figure 3.40A). Out of 100 top outliers, almost half (47) fall in or 
nearby EPAS1. This is similar to a pattern of multiple selection candidates observed for 
other adaptively introgressed genomic regions in Europeans (244). The second strongest 
peak in high altitude populations was observed on chromosome 6 in high altitude 
populations and included a missense variant (rs11551421) in HLA-DPB1 as the top 
scoring candidate, followed by variation in Collagen Type XI Alpha 2 Pseudogene 1 
(COL11A2P1) and Orofacial Cleft 1 Candidate 1 (OFCC1) (Figure 3.40A, APPENDIX C) 
(FineMAV score ≥ 3) (Figure 3.41A). On the other hand, no convincing low altitude 
specific adaptation signals were observed. The strongest hits included a missense variant 
on chromosome 2 in the Tenascin N (TNN) gene (rs4894028) previously associated with 
skeletal and cardiac myopathy (274, 275) and two synonymous variants on chromosome 
11 in the Neuron Navigator 2 (NAV2) gene (rs1867115), and on chromosome 5 in the 
DEAD-Box Helicase 41 (DDX41) gene (rs148853192) respectively (APPENDIX C) Figure 
3.40B). However, the derived allele frequency of these variants in low altitude 
populations is around 015-0.20, as seen in other South Asian populations (~0.10-0.25); 
therefore the observed signals illustrate differentiation between high and low altitude 
populations, rather than strong positive selection specific to lowlanders. 
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Figure 3. 40 Manhattan plot of genome-wide FineMAV scores in Himalayans. FineMAV scores calculated for 
genome-wide SNPs in: A. High altitude populations (run against low altitude populations); B.  Low altitude 
populations (run against high altitude populations). Each dot in the Manhattan plots represents a single 
SNP plotted according to coordinates in GRCh37. The threshold (dashed lines) was set to include the top 
100 variants. 
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Subsequently, high and low altitude Himalayans were compared to worldwide 
populations from 1000 Genomes Project phase 3 (AFR, EAS, EUR and SAS) to detect high 
and low latitude specific signals, respectively (Figure 3.41 A and B). Apart from a strong 
EPAS1 signal in highlanders, we also detected a peak on chromosome 22 underlying the 
Von Willebrand Factor Pseudogene 1 (VWFP1), the TPTE Pseudogene 1 (TPTEP1) and the 
XK Related 3 (XKR3) genes found in both high and low altitude populations. This signal is 
shared by both high and lowlanders, therefore was not picked up in the previous 
analyses, and appears to be specific to Himalayan region (found at ~0.7 frequency in 
Himalaya but rather rare elsewhere). However, the function of those genes remains 
enigmatic. Other Himalayan-specific signals shared across altitudes include an intronic 
variant in the Myomesin 2 (MYOM2). MYOM2 is expressed in heart and skeletal muscles 
and interconnects the major structure of sarcomeres (276). Similarly, a signal underlying 
the Serine and Arginine Rich Splicing Factor 10 (SRSF10) on chromosome 1 was picked 
up, a gene that plays a crucial role in cell survival under stress conditions by inhibiting 
the splicing machinery (277). Variants in genes linked to pain perception, thermal 
sensitivity and olfaction were also picked up (CACNA2D3, TXNDC15, TAAR5). Two of the 
top scoring candidates were described as disease associated: missense rs140598 in 
Fibrillin 1 (FBN1) associated with cardiovascular abnormality and Marfan syndrome 
(278), and splice donor rs143909348 in Serine Protease 1 (PRSS1) associated with 
pancreatitis (279). One of the top scoring variants (rs608415) in lowlanders is intronic 
and lies within the Killer Cell Immunoglobulin Like Receptor, Three Ig Domains and Long 
Cytoplasmic Tail 1 (KIR3DL1) gene, involved in the immune response. FineMAV has also 
picked-up well know East Asian signals of selection which are shared with Himalayans, 
namely causal SNPs in ABCC11, EDAR, FUT2, PCDH15, PRSS53 and ZAN (244). However, 
the strength of the signal on those SNPs is reduced by allele sharing with the EAS used in 
this analysis (Figures 3.41 A and B, APPENDIX C). 
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Figure 3. 41 Manhattan plot of genome-wide FineMAV scores in Himalayans. FineMAV scores calculated for 
genome-wide SNPs in: A. High altitude populations (run against 1000GP populations); B. Low altitude 
populations (run against 1000GP populations). Each dot in the Manhattan plots represents a single SNP 
plotted according to coordinates in GRCh37. Yellow dots represent known candidates of positive selection 
in East and South Asians. The threshold (dashed lines) was set to include the top 100 variants. 
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Finally, I investigated whether any of the highly differentiated variants between 
Tibetans and Chinese Han (FST ≥ 0.8) fell within an HIF-2α (EPAS1) binding motif, hypoxia 
responsive element (HRE). The HIF-2α core binding motif is ACGTG with a 2 bp flanking 
region at each side making the extended motif (Figure 3.42). PWMScan predicted 13,198 
genome-wide HIF-2α binding sites on both DNA strands with a p-value threshold of 
1.000e-05 and a cut-off percentage of 99.59%. A total of 1,254 SNPs found in Tibetan 
samples fell within these regions, of which 75 overlapped with broad peaks and 45 with 
narrow peak intervals in aorta tissue, while 81 lay in broad peak regions and 41 in narrow 
peaks in lung tissue. However, only one SNP (chr10: 1056621: C/G), falling in a broad 
peak in aorta tissue, is highly differentiated between Tibetans and Chinese Han. It is fixed 
in Tibetans and absent in Chinese Han (FST =1) and it overlaps with a promoter region 
according to Ensembl Regulatory features. The predicted HIF-2α binding motif is 9 bp on 
chromosome 10:1056617-1056626 (zero-based coordinate system: first base is 0) falling 
in the WD Repeat Domain 37 (WDR37) gene and overlapping with a promoter region.  
 
 
 
Figure 3. 42 HIF-2α Position Weight Matrix Logo. The height of each letter represents its specific weight or 
importance within the motif.  
 
WDR37 is member of a family of genes involved in gene regulation, signal 
transduction and cell cycle progression. The highly differentiated variant is at position 4, 
within the binding core motif (Figure 3.42) and a change from C->G is predicted to 
strongly affect the binding and potentially disrupt the binding site.  However, this variant 
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is present also in most of the other Himalayan individuals and is not highly differentiated 
between low and high altitude populations.  
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3.4 Discussion 
 
This study further refines the Himalayan population demographic history using 
both autosomal and uniparental markers of SNPs, INDELs and CNVs.  It also attempts to 
refine the signals of positive selection to pinpoint the potential functional variants.  
 
In the broadest sense, all the Himalayan populations share proportions of their 
ancestry with other South and East Asian individuals (Figure 3.9A). Nevertheless, within 
Himalayans, population structure is present with Chetri, Tharu, Lhokpu and Toto forming 
outliers in the PCA for both SNPs and INDELs, and in the ADMIXTURE analysis. Tibetan, 
Bhutanese and Sherpa samples cluster together replicating the pattern seen in the 
previous chapter (Figures 3.9 B, C, D and 3.10).  On a finer scale, Himalayan populations 
are described by different proportions of South and East Asian genetic background and 
gene flow from them (Figures 3.15, 3.16 and 3.17). Chetri and Tharu show more genetic 
affinity with South Asians compared to other Himalayan populations and this can explain 
their outlier status in the PCA (Figure 3.9B, C, D). The genetic affinity to South Asians is 
also supported by the high rare variant sharing (f2 and singletons) between Chetri and 
Tharu with South Asian individuals (Figures 3.21, 3.22 and 3.23). Overall, Himalayan 
populations share rare variants within themselves and with neighbouring populations 
suggesting that the connection between these populations extends into very recent times 
(Figures 3.21, 3.22 and 3.23) (280). However, Himalayan populations showed very 
diverse demographic histories. Lhokpu and Toto, followed by Chepang and Mönpa, 
showed extreme genetic drift, replicating the conclusions of the previous chapter, 
characterised by long branches in TreeMix analysis, lower heterozygosity rates (Figure 
3.12) and an increased number of ROHs and shared IBD segments (Figure 3.20), as well 
as very low effective population sizes (Figures 3.25 and 3.26).  In contrast, Chetri and 
Tharu show higher heterozygosity than other populations and carry a significantly higher 
proportion of singletons (Figures 3.4, 3.18 and 3.19), as well as a recent increase of 
effective population size detectable by MSMC2 and SMC++ (Figures 3.25, 3.26), which can 
be explained by very recent gene flow with South Asians. Tibetans are the closest 
population to East Asians (Figure 3.21), in particular Han Chinese (CHB), as expected 
(Figure 3.31) (50, 99).  
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Himalayan populations show recent split from one another in the last 5,000-9,000 
years. Some of the populations are not completely separated, and show signatures of gene 
flow (Figures 3.32, 3.33. 3.34 and 3.35). In particular, high altitude population show very 
recent split times (between 3,000 and 5,000 years ago) and several are not completely 
separated (Figure 3.32, 3.33, 3.34, 3.35). This supports the hypothesis that high altitude 
populations derive from a single ancestral population that separated from lowland East 
Asians in the last 10,000 years, and then spread and diverged into different populations 
across the Himalayan region in recent times. On the other hand, Chetri and Tharu split 
first from other Himalayan populations in agreement with their lower genetic affinity to 
other Himalayans and higher affinity to South Asians (Figure 3.32B, 3.33, 3.34, 3.35).  
 
The presence of South and East Asian admixture and the recent split times within 
Himalayans is also supported by the Y chromosome and mtDNA analyses (Figures 3.28 
and 3.30), and many lineage split times within the last 5,000 years (Table 3.6). The 
widespread distribution of O2, R1a and D Y chromosome haplogroups, the strong 
clustering of these on the tree and the recent split times within them suggest rapid 
spreading within the region driven by males (Figures 3.27, 3.28 and Table 3.6).    
 
Himalayan populations show a distribution of archaic introgressed tracts similar 
to other South-East Asian populations. However, they carry 239 segments not present in 
other populations (SGDP), some of which overlap with genes and contain Denisovan-
specific SNPs (Figure 3.36). Within the regions overlapping genes, a missense variant 
(rs35211496) has been found in TNFRSF11A on chromosome 18 and a missense and 
synonymous variants (rs76335535, rs139705553) in CYP2F1 on chromosome 19. 
TNFRSF11A codes for a receptor that is essential for osteoclast and lymph node 
development, and been associated with bone pathologies such as arthritis (281). CYP2F1 
codes for a member of the cytochrome P450 superfamily of enzymes and catalyses 
reactions involved in drug metabolism. These genes are involved in immune response 
(282) and xenobiotic biotransformation (283) respectively, and introgressed segments 
in these genes could have played an important role in the adaptation to new 
environments and against pathogens (284-286). The EPAS1 introgressed region is 
widespread across Himalayan individuals and spans over 300 kb downstream and 
partially upstream of EPAS1 (Figures 3.37 and 3.39). EPAS1 itself and the downstream 
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region are enriched of Denisova-specific variants (Figures 3.37 and 3.39). Melanesian 
individuals do not carry the EPAS1 introgressed region, supporting the idea of two pulses 
of Denisovan admixture in Melanesian and East Asians (36).  
 
The high altitude signals of selection in EPAS1 and HLA-DP/DQ from the previous 
chapter were replicated here, and an additional novel region identified (Figure 3.38, 
Figure 3.40A) on chromosome 7 near ADAP1 using both SNPs and INDELs.  ADAP1 is 
regulated by ERB44, which is a direct regulator of HIF-1α and is necessary for the 
transcription of known HIF-1α target genes.  ADAP1 is involved in intracellular signalling 
and microtubule regulation (287, 288). No low altitude specific signal was detected. The 
extensive shared ancestry and gene flow with surrounding populations have decreased 
differentiation and, thus, population-specific derived allele frequency (Figure 3.40B). 
Interestingly, positive selection signals shared between low and high altitude populations 
(Himalayan-specific) were identified. The KIR3DL1 gene is involved in viral immunity and 
it has been linked with immune response against malaria in individuals living in the 
Solomon Islands (Melanesia) (289) (Figure 3.41 A and B).  This gene represents one of 
the highest FineMAV scores in lowlanders and it could be associated with resistance 
against malaria in populations living at the foothills of Himalayas, in the Terai tropical 
forest. Although many highly differentiated variants have been discovered in the EPAS1 
locus, sequence variation data alone were not sufficient to pinpoint the functional 
variants due in part to the complicated LD patterns in the region. Thus, in vitro functional 
exploration of the EPAS1 region is needed to understand the molecular mechanism of 
high altitude adaptation and narrow down the important functional variants within the 
EPAS1 locus. 
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4. Functional investigation of EPAS1 in high 
altitude adaptation 
4.1 Introduction 
 
The first genome-wide surveys of high altitude adaptation in Tibetans were 
carried out in 2010. In one study, using a cohort of Tibetans, the authors found a cluster 
of 31 EPAS1 SNPs in high linkage disequilibrium that correlated significantly with lower 
haemoglobin concentration in these individuals (145). In a second study, using 50 exome 
sequences from individuals of Tibetan ancestry, the authors reported that variants in 
EPAS1 exhibited the strongest signal for high altitude adaptation followed by those in 
other genes associated with the response to hypoxia (99). Several SNPs in and around 
EPAS1 on chromosome 2 had a striking allele frequency difference between highland 
Tibetans and lowland dwelling Han Chinese samples (99). Subsequently,  a more detailed 
analysis of the EPAS1 region by sequencing the whole region of 40 Tibetans and 40 Han 
Chinese samples found that the region had an unusual haplotype structure that could be 
accounted for introgression of DNA from an archaic human species, the Denisovans, into 
modern humans (104). The authors reported that the core Denisovan haplotype in 
EPAS1, which was characterized by five derived alleles of closely linked SNPs (AGGAA) 
lay within a ~32.7 kb introgressed region. Several SNPs in this region were highly 
differentiated and included those with the highest FST value between Tibetans and Han 
Chinese, so this region was therefore considered the best candidate for contributing to 
the high altitude adaptation phenotype in Tibetans (104). 
High coverage whole genome sequencing of 87 Himalayan samples has, as 
discussed in the previous chapter, now shown that the total length of the introgressed 
region spans a ~300 kb genomic region that includes six genes and has an extended LD 
pattern that makes it difficult to narrow down putative functional variants (119). The 
highest FST values between Tibetans and Han Chinese are within the previously reported 
~32.7 kb region; within this region, the five SNPs of the Denisovan core and a candidate 
regulatory variant (rs370299814) upstream it are within the highest differentiated 
between Tibetans and Han Chinese and, thus, they are good functional candidates for 
being positively selected (127). The availability of a testable phenotype described in the 
first chapter, such as the low red blood cell count and low haemoglobin levels in Tibetans, 
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and these genetic candidates make it possible to investigate the underlying biological 
function of high altitude adaptation in Himalayans at a molecular level. A first attempt at 
understanding the role of EPAS1 in high altitude adaptation indicated that the gene was 
somehow downregulated in Tibetans which was in agreement with the low red blood cell 
count in this population (209). However, the experimental conditions used in this study 
could confound results related to hypoxic adaptation, as they compared expression 
profiles of lowlanders sampled at only low altitude with Tibetans samples only at high 
altitude without having reciprocal controls. Moreover, its population samples were not 
properly genetically classified prior to inclusion, with no genotype data available. So, I 
have attempted to address these issues by conducting in-silico analyses and in vitro 
experiments to study the expression levels of EPAS1 at different levels of oxygen in the 
human lymphoblastoid cell lines (LCLs) with and without the introgressed haplotype 
from the 1000 Genomes Project. 
The aims in the chapter, were first to develop a hypoxic protocol that could be 
used to test if the commercially available LCLs could be used as a cellular model for 
studying EPAS1 gene expression. If so, the differentiation of gene expression in the cell 
lines with and without the introgressed haplotype was assessed using both quantitative 
PCR (qPCR) and RNA-sequencing (RNA-Seq).  
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4.2 Material and methods 
 
4.2.1 Samples 
 
Twelve human LCLs and one human lung epithelium cell line (A549) were used in 
this study (290). LCLs grow in suspension and tend to form clusters of cells in culture, 
while the A549 cell line is derived from adenocarcinomic human alveolar basal epithelial 
cells and the cells form a monolayer adherent to the culture flask (291). The LCLs were 
from the 1000 Genomes Project populations (177) and obtained from the NHGRI 
Repository at the Coriell Institute for Medical Research. These included ten cell lines 
belonging to the Chinese Dai population from Xishuangbanna (CDX), China and one 
control sample of European ancestry (CEU) and an additional control sample of Mexican 
ancestry (MXL) which was only used for the RNA-seq experiment (Table 4.1). Four of the 
LCLs are heterozygous for the derived alleles of the five core SNPs in the intogressed 
haplotype (AGGAA) within the EPAS1 region. Within these, three out of four are 
heterozygous for rs370299814. The A549 cell line is commercially available and vials 
were provided by another laboratory (Team 147, Paul Kellam’s lab) within the Wellcome 
Sanger Institute.  
 
 
  
 
 
1
8
2
 
  EPAS1 EGLN1 ATP6V1E2 
  Core SNPs in the introgressed haplotype (“AGGAA”)    
  rs115321619 rs73926263 rs73926264 rs73926265 rs55981512 rs370299814 rs186996510 rs12097901 rs12986653 
Pop Cell line G/A A/G A/G G/A G/A G/A G/C C/G G/A 
CDX HG00844 G/G A/A A/A G/G G/G G/G G/G C/G G/G 
CDX HG01031 G/G  A/A A/A G/G G/G G/G G/C G/G G/G 
CDX HG00881 G/G A/A A/A G/G G/G G/G G/G C/C G/G 
CDX HG00978 G/A A/G A/G G/A G/A G/A G/G G/G G/A 
CDX HG02390 G/G A/A A/A G/G G/G G/G G/G C/G G/A 
CDX HG02396 G/A A/G A/G G/A G/A G/G G/G C/G G/G 
CDX HG02397 G/A A/G A/G G/A G/A G/A G/G C/G G/A 
CDX HG02190 G/G A/A A/A G/G G/G G/G G/G G/G G/G 
CDX HG02187 G/A A/G A/G G/A G/A G/A G/G C/G G/A 
CDX HG02153 G/G A/A A/A G/G G/G G/G G/G C/G G/G 
CEU GM12878 G/G A/A A/A G/G G/G G/G G/G C/C G/G 
MXL GM19661 G/G A/A A/A G/G G/G G/G G/G C/C G/G 
 
Table 4. 1 EPAS1 genotypes of the LCLs used in this study.  The table contains genotypes for the 12 LCLs analysed as anc/der alleles. Three of them carry the derived 
alleles for both the 5 core SNPs and the putative functional one (rs370299814) while the fourth one only carries the derived alleles of the 5 core SNPs. All other eight 
LCLs are ancestral homozygous for these 6 SNPs.  
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4.2.2 Methods and protocols used for the analyses 
 
4.2.2.1 In silico analysis of 1000 Genomes Project cell line 
sequences 
 
The ~32.7 kb EPAS1 region was compared between 1000 Genomes Project 
individuals and four high coverage Tibetan whole genome sequences (Tib8, Tib14, Tib29, 
Tib34 which have mapped to the same reference sequence), discussed in the previous 
chapter (4). To retrieve haplotype information, the genomic region was phased with 
SHAPEIT using the 1000 Genomes Project data as a reference panel (177, 292). 
Comparison between sequences were performed using a combination of custom scripts 
and vcftools 0.1.14 (230). The haplotype network, which represents the relationships 
between the different haplotypes in the dataset, was generated using the haploNet 
function implemented in the pegas R package (293, 294).  
The genotypes for interesting variants previously associated with high altitude 
adaptation were also retrieved from the 1000 Genome Project samples. Those include 
two variants in EGLN1 (126) and  one in  ATP6V1E2 from the Himalayan SNP-chip data 
(Table 4.1). Likewise, the genotypes for the 4 bp deletion located in the second intron of 
EPAS1 were inspected (50). This small INDEL was reported to have a derived allele 
frequency of 0.629 in Tibetans and 0.08 in Han Chinese. It overlaps the binding sites of 
three transcription factors: the polymerase subunit POLR2A, the HIF co-activator EP300, 
and GATA2 which controls erythroid differentiation. It also lies within an activating 
H3K27Ac mark in seven cell lines (50). 
 
4.2.2.2 In silico analysis of publicly-available RNA-seq data 
 
The expression profile of EPAS1 in different tissues was retrieved from the GTEx 
Portal (198) and ENCODE human RNA-seq data (257, 295). For ENCODE data, gene 
quantification for all RNA-seq (polyA RNA-seq) experiments mapped to build GRCh38 
were downloaded. The EPAS1 expression across all tissues and cell lines available was 
compared with each other as well as with the expression of the HIF-1α, HIF-3α and EGLN1.  
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In addition, Tibetan placenta RNA-seq data from a previous study were analysed 
(209). In this study, 63 term placental samples from highland Tibetans were compared 
with 14 specimens from Han Chinese and tested for EPAS1 differential expression. 
According to their results, both Tibetans and Han Chinese show relatively similar low 
levels of EPAS1 expression. After downloading paired-end reads (fastq files), two 
independent analyses were performed:  
 
1) Variant calling from RNA-seq data. The GATK pipeline for variant calling using 
RNA-seq was followed (225, 227). Aligned reads generated with STAR 2.5.2b 
(296) were processed with Picard 2.6.0 for adding read group information, 
sorting, marking duplicates and indexing. The GATK tool specifically developed for 
RNA-seq data, SplitNCigarReads, was used to split reads into exon fragments and 
hard-clip any sequences overhanging into intronic regions. Finally, variant calling 
was performed using GATK HaplotypeCaller with the –dontUseSoftClippedBases 
argument, which is a new functionality taking into account the information about 
intron-exon split regions from the previous step (225, 227).  The called positions 
were merged with Tibetan and Han Chinese genomic sequences from the previous 
chapter. Principal component analysis (PCA) was performed calculating the 
eigenvectors from the whole-genome sequencing samples and projecting the 
RNA-seq individuals onto the plot to check the ancestry of these samples.  
2) Expression quantification and differential expression. Genomic indexing and 
mapping were generated with STAR 2.5.2b (296) using the GRCh38 human 
reference genome and Ensembl gene annotation files version 88 (54). Gene and 
transcript assembly and quantification was performed with the Cufflinks pipeline 
(297). Cufflinks reports expression levels in Fragments Per Kilobase of transcript 
per Million mapped reads (FPKM), a normalised estimation of gene expression. 
FPKM are estimated from the number of reads mapped to each particular gene 
sequence taking into account the sequencing depth and gene length. A FPKM 
method was applied to the data to see if it was possible to retrieve similar results 
to the original paper using HTseq for transcript quantification which counts the 
number of reads mapping to each specific genomic feature from aligned 
sequencing reads and a file of genomic features (298).  
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4.2.2.3 In silico analysis of EPAS1 evolutionary conserved 
regions 
 
Evolutionarily conserved regions (ECRs) in EPAS1 were compared across 
different species using the ECR Browser from NCBI Dcode.org Comparative Genomics 
Development with the default parameters (ECR length=100 bp and ECR 
similarity=70%)(299). SNPs within these regions were overlapped with the FST results 
between Tibetans and Han Chinese discussed in the previous chapter. A list SNPs showing 
highly differentiation (FST values ≥ 0.5) was retrieved.  
 
4.2.2.4 Cell culture  
 
Cells were routinely cultured in RPMI 1640 medium with L-glutamine (Thermo 
Fisher Scientific, Cat No. 11875093), penicillin and streptomycin (Thermo Fisher 
Scientific, Cat No. 10378-016) and 15% foetal bovine serum (FBS) (Thermo Fisher 
Scientific, Cat No. 10500-056) at 37⁰C in a 5% carbon dioxide 95% air mixture. LCLs were 
passaged or sub-cultured at confluency (1-1.5x106 cells/ml). Similarly, A549 were 
passaged when confluence was reached. Cells were washed with the Dulbecco's 
phosphate-buffered saline solution (DPBS, Thermo Fisher Scientific, Cat No. 14190144), 
detached from the flask surface using phenol red Trypsin-EDTA (0.25%) (Thermo Fisher 
Scientific, Cat No. 25200-056), split in a 1:5 ratio and sub-cultured. All cell lines were 
tested for mycoplasma contamination and resulted negative.  
Eleven LCLs (ten CDX and one CEU) were karyotyped by the Cytogenetic Core 
Facility at the Wellcome Sanger Institute to check potential chromosomal abnormalities 
(300).  Ten randomly selected metaphases from each cell line were karyotyped by M-
FISH and DAPI-banding. The nomenclature of chromosomal aberrations used is in 
agreement with the International System for Human Cytogenetic Nomenclature (301). 
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4.2.2.5 Hypoxic protocol 
 
A hypoxic protocol designed to be performed in a standard cell culture incubator 
(Panasonic MCO-19MUV-PE) was developed (APPENDIX D). Hypoxic conditions (1% O2) 
were reached by controlling the nitrogen levels in the incubator (APPENDIX D). Three 
key points for the success of the protocols are: 1) The use of conditioned medium for 
culturing LCLs; 2) Overnight medium O2 degasification; and 3) Use of six-well plates with 
a small culture volume. Medium degasification and the culturing volume are very 
important for O2 diffusion in the medium. O2 concentration in the gas phase it is different 
from the one experienced by cells at the bottom of a culture flask or plate. To have 
efficient gas diffusion in the medium in both normoxic and hypoxic conditions, I used six-
well plates with a total volume of ~4 ml to reduce diffusion distance and have better 
oxygen diffusion in the liquid phase via overnight medium incubation to degasify hypoxic 
medium and have a stable O2 supply in normoxia.  
LCLs require a quite high cell density to grow properly, and have different lengths 
of the lag phase. The latter is the period of the cell growth cycle where cells adapt to the 
culture conditions and its length depends upon the growth phase of the cell line at the 
time of subculture and the seeding density. Conditioned medium is exhausted medium 
harvested from cultured cells mixed with fresh medium. It contains growth factors, 
metabolites and extracellular matrix proteins secreted into the medium by the cultured 
cells and it considerably helps cell growth. So I used conditioned medium and seeded 
plates to have around 1.5-2x10-6 cells at each time point of the experiment.  
A549 cells were used as positive control as they are widely used to test hypoxic 
conditions (302, 303). It is known that in A549 the HIFs (HIF-1α and EPAS1) are induced 
by acute hypoxia at 4 h and hypoxic factors are constitutively expressed in lung tissues 
(198, 304-306). Different time points (4h, 16h, 24h, 48h, 72h) were used to check for 
EPAS1 expression in LCLs and whether EPAS1 expression was induced similarly to A549, 
or whether it needed chronic exposure to hypoxic conditions (APPENDIX D).   
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4.2.2.6 Gene expression profiling methods 
 
Expression profiling is the measure of the gene activity at a specific time and can 
assay the expression of a few or thousands of genes at once. The quantitative polymerase 
chain reaction (qPCR), also known as real-time PCR, monitors the amplification of a 
targeted DNA molecule during the PCR. Quantitative reverse transcription PCR (RT-
qPCR) is used to quantify gene expression and the starting material is RNA. RNA is first 
retro-transcribed into its complementary DNA (cDNA) by reverse transcriptase. Then, 
the cDNA is used as the template for the qPCR reaction. It can be one-step or two-step, 
with the retro-transcription and quantification being performed in one or two separate 
reactions. Gene expression is detected by using fluorescent molecules such as SYBR 
green, a fluorescent double-stranded DNA (dsDNA)-binding dye. As the PCR reaction 
progresses, at each cycle of amplification SYBR Green dye binds to dsDNA as it 
polymerizes, resulting in an increase in the level of fluorescence at the end of each 
extension step. The quantity of dsDNA product in the reaction is proportional to the 
amount of fluorescence (307, 308). This approach gives a very accurate estimation of 
gene expression for specific target genes, but it is not feasible for a genome-wide screen 
of expression levels.  High throughput measurements, such as RNA-seq, can estimate the 
presence and quantity of thousands of genes in a biological sample at a given time, 
providing a detailed view of gene expression, alternative splicing, and allele-specific 
expression. After RNA extraction and QC steps, barcoded sample libraries are prepared. 
These pools of samples are then sequenced using one of the high throughput platforms 
(309). 
 
4.2.2.7.1 Quantitative reverse transcription PCR (RT-qPCR) 
 
Before conducting RNA-Seq, I carried out preliminary work to establish whether 
EPAS1 could be detected in LCLs and whether its expression was modified in LCLs with 
the introgressed EPAS1 haplotype. A two-step RT-qPCR was performed on the samples 
challenged with hypoxia to assay EPAS1 and other genes (EGLN1, HIF-1α) involved in the 
hypoxic pathway. Expression of target genes was compared between normoxic and 
hypoxic samples and between samples with and without the introgressed haplotype. To 
calibrate target gene expression, housekeeping gene (TUBB) expression was assayed 
(310, 311). RNA extraction was carried out using the QIAGEN RNeasy Mini Kit (QIAGEN, 
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Cat No. 74104) with the RNase-Free DNase Set (QIAGEN, Cat No. 79254). RNA was 
quantified using Nanodrop N80. Subsequently, 500 ng of RNA per sample was reverse 
transcribed into cDNA and used for RT-qPCR (APPENDIX D).  
Primer sequences for qPCR were designed with NCBI Primer-BLAST from the 
NCBI Reference Sequence (RefSeq) for each gene (312) (Table 4.2). I set the minimum 
primer melting temperature (Tm) at 60oC, the optimum at 62oC, the max at 64oC and the 
max Tm difference at 1oC. The amplicon size (PCR product) was set between 70-150 bp 
(optimal length around 100 bp). To avoid amplification of contaminating genomic DNA, 
the primers were designed to span an exon/exon junction. The GC content was around 
40-60% to ensure maximum product stability and each pair of primers had low self-
complementarity to decrease the possibility of primer-dimer formation (313-315).  
 
   Gene                    Primer pair Primer sequences 
  Forward  Reverse  
EPAS1 
 
01 TTCCTGCGAACACACAAGCT TCGGCTTCGGACTCGTTTT 
02 CATGCGCTAGACTCCGAGAAC TACCTGACCCTTGGTGCACAA 
EGLN1 01 CAAAGTTAATTTCTATGCCTGGAAGA CAGGCCCTGCCAGACTTCTA 
HIF-1α 01 ATGTGACCATGAGGAAATGAGAGA TTTTGTTCTTTACCCTTTTTCACAAG 
TUBB 01 TGTATTTGGTCAGTCTGGGGCAG GCAGGCAGTCACAGCTCTCT 
ATP6V1E2 02 AGCCATCCTCTCGGCCTCTA AGAGTTCAGGCCTCCCTTTTGG 
TMEM247 01 ACCTTCCCCAAGATGGTGCC GGACTCTGCCTCCAGATAAGCC 
CRIPT 01 GAACCGTCGTGGGGAAGGAT GCTTTCTTCCACCACTTTCTGTG 
PIGF 01 TAGCTTTGTAGGAGCATGGCTTG GAGATGGGCCATACCTGCCA 
 
Table 4. 2 Primer sequences used for RT-qPCR analyses. 
 
Gene expression was quantified by qPCR with KAPA SYBR FAST (Kapa Biosystems, 
Cat No. KK4604) using an ABI StepOne Plus thermocycler. SYBR Green, together with the 
set of target gene primers (Table 4.2), binds to the DNA and emits a green light detectable 
by the qPCR machine (APPENDIX D).  Target genes were standardised to the 
housekeeping gene TUBB and the gene expression level was calculated as the 
standardised gene expression value: 
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2−ΔΔCT = [(CT gene of interest – CT internal control) hypoxia – (CT gene of interest – CT 
internal control)normoxia] (307) 
 
where CT is the cycle threshold. CT is inversely related to the amount of amplicon in the 
reaction. Thus, the lower the CT, the greater is the gene expression (greater amount of 
amplicon). Differential expression was also assessed as ΔCT=CT (normoxia) -CT (hypoxia) for each 
gene in the PCR reaction (307).  
 
4.2.2.7.2 RNA-seq 
 
RNA-seq analysis was carried out on samples from the experiment performed 
with the hypoxic protocol previously described. A total of 12 lymphoblastoid cell lines 
and a A549 cell line were cultured under normoxic (state conditions) and  hypoxic 
conditions over 72 hours and samples collected at five different time points (4h, 16h, 24h, 
48h and 72h). Two technical replicates for all samples were used. RNA-seq was 
performed by the Wellcome Sanger Institute core facility. Briefly, lysed cells in 350µl of 
QIAGEN buffer RLT (QIAGEN, Cat No. 79216) were provided to the facility where 
automated RNA extraction was performed for all 260 samples. Of these, 257 RNA samples 
passed automated QC step (Qubit 4 Fluorometer). Sequencing libraries were constructed 
for these 257 samples via the New England BioLabs (NEB) RNAseq-AUTO library 
preparation procedure using 100 ng of total RNA in 50 µl water with a RIN (RNA Integrity 
number) of >6. The 257 samples were sequenced using paired end (PE) 75 bp reads over 
4 lanes using an Illumina HiSeq 4000 platform. The raw reads (fastq files) were mapped 
to human reference genome GRCh38.p10 using STAR_2.5.3a (296), incorporating 
GENECODE v27 human gene annotations (gtf file) (316). Sample QC was performed with 
FastQC 0.11.5 and multi-sample aggregation with MultiQC v1.3 (317) and QTLtools 1.1 
bamstat (318). Transcript quantification was performed using featureCounts 1.6.2  (319). 
The Deseq2 1.6.3 R package (320) was used for data exploration following its tutorial 
(https://www.bioconductor.org/packages/release/bioc/vignettes/DESeq2/inst/doc/D
ESeq2.html), to test sample-to-sample distances using PCA and whether it was possible 
to detect differential expression in the dataset between hypoxia and normoxia and 
between introgressed and non introgressed samples (Figure 4.1).  
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Figure 4. 1 Workflow of RNA sequencing experiment. 
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4.3 Results 
 
4.3.1 The EPAS1 introgressed haplotype in the 1000 
Genomes Project data 
The EPAS1 ~ 32.7 kb introgressed region (104) was compared between samples 
from the 1000 Genomes Project, Tibetan and Densiovan (GRCh37, chr2:46567917-
46600661; GRCh38, chr2: 46340778-46373522). Four Tibetan high coverage whole 
genome sequences generated and analysed in the previous chapter were also mapped to 
GRCh37 (Tib8, Tib14, Tib29, Tib34) who have  high sequence similarity to the 
Denisovans. The individual showing the smallest number of sequence differences with 
the Denisovan is Tib29 (8 single nucleotide differences). Out of all the 1000 Genome 
Project individuals, 10 carry the full Densivan-core (AGGAA) haplotype (Table 4.3), 
wheareas 29 individuals carry a partial haplotype (3-4 of the core alleles). Of these 29 
samples, 28 are of African ancestry (6 YRI, 2 MSL, 5 LWK, 4 GWD, 6 ESN, 3 ASW, 2ACB) 
and one of Han Chinese (CHB) ancestry. Three of four inviduals carrying the full 
Denisova-core haplotype, also have the putative functional variant A at rs370299814 
(Table 4.3).  
 
A haplotype network was generated from phased data of all the 39 individuals for 
the ~32.7 kb introgressed region (Figure 4.2). The Tibetans show both haplotypes closest 
to the Denisovan.  The CDX individual HG00978 displays the closest haplotype to the 
Tibetan, followed by other South-East Asian samples carrying the full Denisovan-core 
(Figure 4.2). African samples show many single nucleotide differences in the entire ~32.7 
kb region. Partial core Denisovan haplotypes in Africans can be explained by the presence 
of these alleles in the modern human gene pool before the introgression event (inherited 
from the modern human/Denisovan common ancestor). In contrast, the hypothesis of 
incomplete lineage sorting (ILS) between modern humans and Denisovans for the full 
EPAS1 region seems unlikely (286). A more plausable explanation is an introgression 
event followed by strong positive selection on the haplotype that led to an extended 
haplotype with derived allele frequency > 0.8 in Tibetans and with very strong LD.  
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Other intersting variants in the region around EPAS1 were also screened in the 
1000 Genomes Project samples. The variant in ATP6V1E2, rs12986653, highlighted in the 
positive selection scans discussed in the second chapter, was present in all four 
introgressed cell lines used in the functional analyses (Table 4.1). This variant is an eQTL 
in different tissues including lung and arterial tissues (198, 305). Furthermore, the 4 bp 
deletion in the second EPAS1 intron has an allele frequency of 0.85 in Tibetans, and 
between 0.38 and 0.63 in other high altitude populations. It shows low frequency (0-0.25) 
in low altitude Himalayans. All four introgressed CDX cell lines were heterozygous for 
this deletion. A cell line, HG02390, that does not carry the introgressed haplotype is 
heterozygous for this deletion. The deletion was also heterozygous in the other 1000 
Genomes Project individuals carrying the full Denisovan core (HG00625, NA18566, 
NA18643, HG01847, HG02026, HG03814, HG03931) (Table 4.3). All the other individuals 
in 1000 Genomes Project were homyzygous for the ancestral allele. Two EGLN1 variants, 
rs186996510 and rs12097901, with high derived allele frequency in Tibetans have been 
suggested to promote increased HIF factor degradation under hypoxic conditions (126). 
Surprisingly, these variants are present in both introgressed and non-introgressed 
samples. The derived allele of rs186996510 is found in only one heterozygous individual 
(HG01031) among those used for functional analysis. On the other hand, the derived 
allele of rs12097901 is present in all CDX cell lines in the heterozygous or homozygous 
state (Table 4.1).  
 
  
  
  
 
 
1
9
3
 
 
    EPAS1 
       Core Denisovan haplotype (“AGGAA”)   
  rs115321619 rs73926263 rs73926264 rs73926265 rs55981512 rs370299814 
Pop Cell line G/A A/G A/G G/A G/A G/A 
CDX HG00978 G/A A/G A/G G/A G/A G/A 
CDX HG02396 G/A A/G A/G G/A G/A G/G 
CDX HG02397 G/A A/G A/G G/A G/A G/A 
CDX HG02187 G/A A/G A/G G/A G/A G/A 
CHB NA18643 G/A A/G A/G G/A G/A G/A 
CHS HG00625 G/A A/G A/G G/A G/A G/G 
KHV HG01847 G/A A/G A/G G/A G/A G/A 
KHV HG02026 G/A A/G A/G G/A G/A G/A 
BEB HG03814 G/A A/G A/G G/A G/A G/A 
BEB HG03931 G/A A/G A/G G/A G/A G/A 
 
Table 4. 3 The 1000 Genomes Project samples carrying the EPAS1 Denisovan-core introgressed haplotype. The table reports individuals with the Denisovan haplotype. 
Eight out of ten carry also the putative functional variant rs370299814. 
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Figure 4. 2 Haplotype network of the ~32.7 kb EPAS1 introgressed region. The Tibetan individuals show the 
closest haplotype to the Denisovan sample. African haplotypes show large number of differences from the 
Denisovan haplotype. 
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4.3.2 Re-analysis of EPAS1 expression from publicly 
available data 
 
EPAS1 expression was investigated in human tissues and cell lines available in the 
GTex Portal and ENCODE database (257).  According to GTE, EPAS1 is highly expressed 
in lung tissue followed by aortic and adipose tissues (Figure 4.3). Regarding ENCODE 
data, tissue-specific gene quatifications for EPAS1 were compared in order to detect 
where the gene is most highly expressed. Aorta, lung, cardiac tissues, endothelial cells 
and placenta show the highest expression. LCL of GM12878 shows low constitutive levels 
of EPAS1 expression, at a level similar to bronchial fibroblast and certain nervous system 
tissues (Figure 4.4).    
 
 
 
Figure 4. 3 EPAS1 expression across different tissues in the GTEx Portal. On the x-axis are indicated the 
different tissues and on the y-axis are indicated the levels of expression in FTPM (Transcript Per Million). 
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Figure 4. 4  EPAS1 expression across different tissues in the ENCODE database. On the y-axis are indicated 
the different tissues and on the x-axis are indicated the levels of expression in FPKM.  
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EPAS1 expression was compared with other hypoxic factors to see whether their 
expression patterns were similar across the different tissues. HIF-1α shows considerable 
expression across different tissues, with myoblasts from skeletal musculature (LHCN-
M2) and fibroblasts showing the highest values. On the other hand, EPAS1 expression is 
more localised in specific tissues compared to HIF-1α. Overall, HIF-3α has lower 
expression across multiple tissues and is absent from many of them. HIF-1β and EGLN1 
show broad expression patterns across tissues although at very low levels (Figure 4.5). 
EPAS1 and HIF-1α share high sequence homology and can both dimerize with HIF-1β in 
hypoxia and modulate gene expression. However, the two hypoxic factors regulate 
distinct sets of target genes (142). HIF-1α is broadly expressed and probably activates a 
general hypoxic response across tissues, whereas EPAS1 seems to have an action in 
specific tissues (141). There is evidence of temporal organisation of HIF-1α and EPAS1 
hypoxic responses. It seems that the activation of target genes in acute hypoxia is 
primarly by HIF-1α (few hours after hypoxia exposure), whereas in response to chronic 
hypoxia EPAS1 seems to exert a major role. This would explain the broader tissue 
expression of HIF-1α compared to EPAS1 (141) (Figure 4.5). 
 
EPAS1 expression was also investigated in publicly-available Tibetan placental 
villus parenchymal RNA-seq data (209). In the original paper, 63 Tibetan samples and 14 
Han Chinese were sequenced and 72 samples of the 77 were availalble for download. 
However, they do not provide any genotype calls for the Tibetan and Han samples and 
only report the number of Tibetan individuals carrying the adaptive haplotype (Adaptive 
haplotype homozygous= 34, Adaptive haplotype heterozygous= 26, Wild-type haplotype 
homzygous=3). Thus, I performed variant calling from the RNA-seq data according to the 
GATK best practice and merged these genotypes with the Tibetans and Han Chinese 
individuals (CHB from the 1000 Genomes project) described in the previous chapter. PCA 
on these combined samples was performed, projecting the RNA-seq samples onto 
eigenvectors estimated from the Tibetan and Chinese Han sequences to check the 
ancestry of the RNA-seq samples (Figure 4.6A). PC1 separates Tibetans from Han Chinese 
and all RNA-seq samples lie together with Tibetans. The second PC divides Tibetans into 
subsclusters, with the RNA-seq samples mostly grouping with them. None of the RNA-seq 
samples cluster with Han Chinese (Figure 4.6A).   
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Figure 4. 5 Comparison of the hypoxic factors expression levels in different human tissues. The y-axis 
reports the tissues in the ENCODE database, and the x-axis the five major hypoxic genes. Expression levels 
(FPKM) are represented by the different colours as indicated in the legend.  
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After that, I tested EPAS1 differential expression between individuals in the two 
main clusters of RNA-seq samples from the transcript quantifications performed with 
Cufflinks (297). In agreement with the original paper, EPAS1 does not show differential 
expression within the  samples (Figure 4.6B).  However, it is important to note that only 
Tibetans seem to have been sampled for RNA-seq analysis (at least among the 72 
available), so no comparison between Tibetans and Han Chinese was possible.  
 
 
Figure 4. 6 Analysis of publicly-available Tibetan placental RNA-seq data. A. PCA of RNA-seq samples from 
(209) and Tibetan and Han Chinese whole-genome sequencing data. B. EPAS1 differential expression across 
some of the RNA-seq samples. All individuals show similar levels of EPAS1. 
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4.3.3 Sequence conservation patterns in the EPAS1 
locus 
 
Evolutionarily conserved regions (ECRs) were  investigated in the EPAS1 locus 
using the NBCI ECRs  Browser.  Overall,  the entire EPAS1 region shows a high degree of  
similarity  to  other primates, in particular Chimpanzee (panTro3) with > 98% sequence 
identity. Genomic similarity decreases with the increase of phylogenetic distance. ECRs 
are found both at the protein-coding (exon) level and in introns, UTRs,  simple repetitive 
elements and transposons, and intergenic regions (Figure 4.7). Compared with 
Chimpazee, three large ECRs spanning the entire EPAS1 locus with identity > 98.1% have 
been identified (ECR1 = chr2:46293668-46296898; ECR2 = chr2:46296963-46381755; 
ECR3 = chr2:46381818-46386697). The ~32.7 kb introgressed region falls within ECR2. 
Within these ECRs, 737 SNPs have been found.  In particular,  20 SNPs lie in ECR1,  670 in 
ECR2 and 47 in ECR3. Of these, 54 SNPs show high FST values (FST ≥0.5) between Tibetans 
and Han Chinese. All variants are categorised as non-coding by VEP (189). One, 
rs7557402, falls within a splice region and has previously been associated with 
polycythemia and familial erythrocytosis (Illumina Clinical Services Laboratory).  This 
variant has a derived allele frequency (DAF) for the G allele of 0.83 in Tibetans and 0.18 
in Han Chinese. 
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Figure 4. 7 EPAS1 evolutionarily conserved regions (ECRs). The plot shows the proportion of sequence 
identity between humans and other species (tetNig=tetraodon, danRer=zebrafish, fr=fugu, xenTro=frog, 
galGal=chicken, monDom=opussum, mm=mouse, rn=rat, bosTau=cow, canFam=dog, rheMac=rhesus, 
panTro=chimpanzee). Orange= intronic regions, blue= protein-coding exons, green= transposons and 
single repeats,   yellow= UTRs, red= intergenic regions. EPAS1 transcripts and SNPs within the locus are 
also indicated. 
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4.3.4 Cell line karyotyping 
 
The karyotypes of the eleven LCLs were determined. This has been done to 
characterize any additional chromosomal abnormalities, particularly involving 
chromosome 2, that could confound the results. Seven cell lines do not show any 
chromosomal aberration. The other four cell lines display different chromosomal 
aberrations, although none involving chromosome 2 (Table 4.4).  
 
Cell line Karyotype [number of cells] % Cells 
HG00844 46,XY[10] 100% 
HG00881 46,XY[10] 100% 
HG02187 
46,XX[4] 40% 
46,XX,del(9),der(18)t(9;18), 
der(19)t(10;19)[6] 
60% 
HG02190 
46,XX[9] 90% 
46,XX,del(7)[1] 10% 
HG02397 46,XY[10] 100% 
GM12878 
46,XX[9] 90% 
46,XX,t(3;6)[1] 10% 
 
 
                 HG02396 
46,XY [8] 80% 
46,XY,dup(4)[1] 10% 
 47,XY,t(2;3),+14[1] 10% 
HG01310 46,XY [10] 100% 
HG02390 46,XY[10] 100% 
HG02153 46,XX[10] 100% 
HG00978 46,XX[10] 100% 
 
Table 4. 4 Cell line karyotypes. Del = deletion, dup = duplication, t = translocation, der = a derived 
chromosome, + = additional copy of chromosome.  
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4.3.6 EPAS1 expression profiles 
 
The expression of EPAS1 and other genes involved in the hypoxic molecular 
pathway was assessed in LCLs with or without the introgressed haplotype.  The cell 
lines were grown under normoxic (21% O2) and hypoxic (1% O2) conditions for 
different time points up to 72 hours (4h, 16h, 24h, 48h, 72h) and gene expression 
quantified by qPCR and RNA-seq.  
 
4.3.6.1 Hypoxic protocol optimisation 
 
Pilot studies using three LCLs with introgressed haplotype and three without 
together with the A549 cell line were set up to check the effectivness of the hypoxic 
protocol described previously and identify appropriate time points for assessment of 
changes in EPAS1 and other genes (EGLN1 and HIF-1α) expression under hypoxia in 
the different cell lines.  Previous studies showed that two hours of hypoxic exposure 
was deemed to be a too short time to obtain reliable induction of hypoxia in LCLs and 
A549 cell culture. Hence, 4h was selected as the first time point for acute hypoxic 
exposure as in previous studies (304, 306). A second 8h time point was assessed, but 
did not show substantial differences (ΔCT values) in gene expression from the 4 h one. 
EPAS1 differential expression in LCLs was also detected at 24h and 48h of hypoxic 
exposure. Hence, the 4h and 24h time points were used to optimise the protocol. 
Subsequently, I set up an intermediate time point at 16h to investigate the induction 
of EPAS1 expression. I also added a 72h time point to explore putative change in 
EPAS1 expression under chronic hypoxic exposure. This led to a final 5 time point 
experiment (4h, 16h, 24h, 48h, 72h) that was performed and RNA from these 
experiments were sent for RNA-seq. 
 
4.3.6.2 RT-qPCR 
 
RT-qPCR was initially carried out to establish whether  EPAS1 was expressed 
in human LCLs and, if expressed, whether there were differences between the LCLs 
with and without the introgressed haplotype. The total RNA was manually extracted, 
retrotrascribed and qPCR of EPAS1 and other genes (EGLN1 and HIF-1α) involved in 
the hypoxic response was performed at time point of 4 and 24 hours.  
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The shape of the amplification curves passing the CT threshold is similar across 
samples and two time points (Figure 4.8), indicating similar PCR efficiency (307). The 
qPCR results show detectable tested and control gene expression, indicating that the 
LCLs can be a suitable in-vitro model for understanding the role of EPAS1 in hypoxia.  
 
 
Figure 4. 8 qPCR amplification plot of target genes. The amplification plot shows the variation of log 
(ΔRn) with PCR cycle number.  Rn is the reporter signal normalized to the fluorescence signal of the 
reference dye (ROX). ΔRn is Rn minus the baseline. All tested genes show an expression profile that 
passes the CT threshold (dashed line). Each colour represents the row of the input plate. There no 
association between sample conditions and row.   
 
Primer melting curves were inspected for single peaks of amplification around 
the primer melting temperature, indicating the likely amplification of a single product. 
Primer pairs showing multiple peaks were excluded to avoid biases in the 
interpretation of expression quantifications (Figure 4.9). In fact, the number of peaks 
is commonly used to determine the purity of qPCR products (315). EPAS1 expression 
was compared with HIF-1α, EGLN1 and TUBB in LCLs and A549.  The housekeeping 
gene TUBB does not show a change in expression across conditions and, thus, can be 
used as standard control. Slight variation in the cycle threshold (CT) can reflect 
pipetting errors, due to the manual preparation of the qPCR plate and the limited 
precision of the pipette (Figure 4.9). Target genes were standardised to the 
housekeeping gene TUBB and gene expression profiling was calculated as 
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standardised gene expression (2−ΔΔCT = [(CT gene of interest – CT internal 
control)hypoxia – (CT gene of interest – CT internal control)normoxia]) (307). Differential 
expression was also assessed as ΔCT= CT(normxia) – CT(hypoxia). Each cycle change 
corresponds to a two-fold change in expression (307).  
 
 
 
Figure 4. 9 Primer melting temperature curves. The plots show example of melting curves for each 
primer pair across samples. Each colour represents the row of the input plate. There is no association 
between sample conditions and row. The x-axis reports the temperature whereas the y-axis shows the 
rate of the fluorescence variation. The plots report melting curves of two sets of EPAS1 primers. A. 
Example of a good single peak trace. B. Example of a bad melting curve with multiple peaks. 
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Figure 4. 10 CT differences between normoxia and hypoxia at 4 hours. The plot shows the CT for each 
gene across introgressed and non introgressed cell lines. The lower the CT, the higher the expression. 
ΔCT values are also reported for each sample between normoxia and hypoxia. LCLs with the 
introgressed core Denisovan haplotype are indicated in red.  
 
At 4 hours of hypoxic exposure, EPAS1 is highly expressed in A549 cell lines 
(EPAS1_01 ΔCT(normoxia-hypoxia) = 5; EPAS1_02 ΔCT(normoxia-hypoxia) = 6), but it shows very 
low levels in LCLs. Furthermore, no differential expression between the LCLs with and 
without the introgressed haplotype is detectable (Figure 4.10 and 4.11). This 
confirms that the peak of hypoxic factors expression in A549 is around 4 hours.  
Changes in expression between hypoxia and normoxia (ΔCT=4-5) was 
observed for HIF-1α and EGLN1. Both genes showed higher expression (ΔCT) in 
hypoxia in three non introgressed samples (HG02153, HG00881, A549) whereas all 
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introgressed and GM12878 do not show increased EGLN1 and HIF-1α expression in 
hypoxia compared to normoxia. 
 
 
 
 
 
Figure 4. 11 EPAS1 expression at 4 hours hypoxic exposure. The plot reports the standardised gene 
expression for the target genes.  EPAS1 shows high expression in the A549 cell line but not in LCLs. No 
significant differences between the LCLs with and without the introgressed haplotype are detectable.  
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EPAS1 shows an increase in expression at 24h of hypoxic exposure, when the 
differential expression between the LCLs with and without the introgressed 
haplotype was observed. This was further confirmed in different biological samples 
(three LCLs with introgressed haplotype), technical replicates as well as by two 
different pairs of primers for EPAS1 (EPAS1_01 and EPAS1_02). Specifically, in the 
LCLs without the introgressed haplotype, EPAS1 expression increases under hypoxic 
conditions, whereas it does not in the ones heterozygous for the introgressed 
haplotype. Another pilot experiment showed that introgressed cell lines carriyng the 
rs370299814 (HG00978, HG02187, HG02397) and the one without it (HG02396) 
show the same steady EPAS1 expression between normoxia and hypoxia.  Thus 
rs370299814 might not be the functional variant associated with this phenotype. At 
24 hours, A549 does not show high EPAS1 expression or any differential expression 
between normoxia and hypoxia (Figure 4.12 and 4.13). Small changes in expression 
between hypoxia and normoxia (ΔCT=1-3) was observed for HIF-1α and EGLN1.  
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Figure 4. 12 CT differences between normoxia and hypoxia at 24 hours. The plot shows the CT for each 
gene in LCLs with and without the introgressed haplotype. The lower the CT, the higher the gene 
expression. ΔCT values between normoxia and hypoxia are also reported. The LCLs with the 
introgressed haplotype are in red.  
 
This could mean that in this cell line at 24h, the downstream hypoxia response 
has already been triggered.  Small changes in expression between hypoxia and 
normoxia (ΔCT=1-3) was observed for HIF-1α and EGLN1 but it was lower than at the 
4 hours time points and there was no differential expression between the LCLs with 
and without the introgressed haplotype. (Table 4.1, Figure 4.13).  
 
210 
 
 
 
 
Figure 4. 13 EPAS1 expression at 24 hours hypoxic exposure. The plot reports the standardised gene 
expression for the target genes.  EPAS1 shows differential expression between introgressed and non-
introgressed cell lines. Cell lines in red are introgressed cell lines.  
 
The expression of all the genes lying in the ~300 kb introgressed region was 
assessed (EPAS1, TMEM247, ATP6V1E2, PIGF and CRIPT).  EPAS1 was the only one 
showing a significant change of expression between normoxia and hypoxia and a 
differential expression between LCLs with and without the introgressed haplotypes. 
However, this conclusion needs to be interpreted cautiously because of the extremely 
low expression of some of the genes in the LCLs, where in some of the samples the 
expression level remained undetermined (CT too high), and the results are not 
discussed further or presented here because an improved approach is being pursued, 
as described in the next section.  
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4.3.6.3 RNA-seq 
 
The analysis of the RNA-seq data is ongoing and is currently in its preliminary 
phase. The quality of the data was evaluated and basic analyses to assess the success 
of the experiment were carried out.  
 
4.3.6.3.1 Data QC   
 
The quality of RNA-seq data was assessed using FastQC and samtools flagstat. 
The samples were sequenced over two runs (run one with one lane, run two with 3 
lanes), and QC was performed per lane to identify and exclude possible technical 
biases. Per sample FastQC results were aggregated using Multi QC v1.3. The total 
number of mapped reads per sample ranged between ~5 and 7 million (Figures 4.14 
and 4.15). In all samples, most of the reads were uniquely mapped and most onto 
exons (Figures 4.14 and 4.15 A,B). Most of the samples have around 50% duplicated 
reads, which may be due to the high abundance of a small number of genes rather 
than an indication of PCR over-amplification or low library complexity. Per base 
sequence mean quality score (the range of quality values across all bases at each 
position)) is above 30 for all samples. All reads show good average quality score (per 
sequence quality score > 27); no reads have poor quality. None of the samples show 
adapter contamination. Finally, the N content across all bases was very low across all 
samples.  
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Figure 4. 14 Total number of reads sequenced in the first run (26520). The x-axis shows the total 
number of reads, the y-axis the sample sequenced  (first element = run ID, last element= name of the 
sample representing each cell line (1-13), the replicate (A,B), the condition (N, H) and the time point 
(4,16,24,48,72). 
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Figure 4. 15 Total number of reads sequenced in the second run (26660). The x-axis indicates the total 
number of reads, the y-axis the sample sequenced (first element = run ID, last element= name of the 
sample representing each cell line (1-13), the replicate (A,B), the condition (N, H) and the time point 
(4,16,24,48,72).  
 
No significant differences between the two runs were detected. Both runs 
show samples with a similar number of uniquely mapped reads with most of the reads 
mapping on exonic regions (Figure 4.16) and similar QC results.  
 
 
Figure 4. 16 Proportion of exonic reads in the samples. Most of the reads map to exons for both runs. 
Mean (blue) and median (red) values are indicated on the plots. A Plot for samples in the first run (1 
lane). B Samples in the second run (3 lanes).  
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4.3.6.3.2 Gene expression in hypoxia and normoxia 
 
Expression quantification was performed with featureCounts. The 
quantification matrix was analysed using Deseq2.  PCA using whole-genome 
expression data shows that the samples are clustering for technical replicates and by 
the presence of the introgressed haplotype rather than the oxygen concentration 
exposure (normoxia versus hypoxia) (Figure 4.17 A and B).  
 
 
 
Figure 4. 17 PCA on whole-genome expression in LCL samples. A. 4 hour time point B. 24 hour time 
point.   
 
To test the effectivness of the experiment, I explored differential expression in 
genes between hypoxia and normoxia at the 4 and 24 hours time points. Gene 
expression is known to be regulated by the oxygen levels in the enviroment: in 
particular, expression of hypoxic factors (HIFs) is boosted by hypoxia and, 
consequently, the expression of their target genes. Importantly, response to hypoxia 
depends also on the cell type and the heterogeneity of gene regulation responses 
reflects the different cellular requirements (321, 322). Therefore, I estimated 
differential expression (log2 fold change) from normalised read counts between 
normoxic and hypoxic LCL introgressed and non introgressed samples at 4 and 24 
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hours to see whether I could detect genes that are differentially expressed. Inclusion 
of A549 in preliminary analyses would bias differential expression results due to 
differences in basal gene expression between LCLs and A549. The normalised gene 
read counts for hypoxic conditions were higher than normoxia, supporting possible 
higher gene expression in hypoxia and the activation of set of genes (Figure 4.18).  
 
 
Figure 4. 18 Normalised read count between normoxia and hypoxia. The plot shows the gene read 
counts for all samples in hypoxia and normoxia. Hypoxic samples show higher read count and thus 
possible higher expression of a set of genes.  
  
LCLs across the different time points do show differentially expressed genes 
between normoxia and hypoxia and between introgressed and non introgressed cell 
lines, confirming that the hypoxic condition in the cells was reached throughout the 
experiment (Figure 4.16).  EPAS1 does not show statistically significant differential 
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expression (pvalue adjusted < 0.1) between the samples. However, EPAS1 is not 
highly expressed in LCLs compared to other genes and this could affect the detection 
of its expression using Deseq2 (323) (Figure 4.19 A and B). Different filtering and 
normalisation methods are needed to test reliable detection of differentially 
expressed genes.  
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Figure 4. 19 Differential gene expression between normoxia and hypoxia and introgressed and non 
introgressed samples. The y-axis shows the log2 fold change between the different conditions, the x-
axis the average of the read counts normalized by size. Each gene is represented with a dot. Genes with 
a pvalue adjusted < 0.1 for a significant difference are shown in red. In gold is indicated EPAS1. A. 4 
hour time point B. 24 hour time point. 
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4.4 Discussion 
 
In this study, in silico and in vitro work on understanding the underlying 
biological function of high altitude adaptation in Himalayans has been reported. 
Although the Denisovan introgressed region spans over ~300 kb and contains 
multiple genes and variants, the EPAS1 ~32.7 kb region with the introgressed core, 
together with the adjacent SNP rs55981512, have previously been proposed as 
candidates for involvement in the high altitude phenotype (104, 119). This conclusion 
is supported by multiple lines of evidence presented in this study. Firstly, as seen in 
the previous chapters, the highest FST values between Tibetans and Han Chinese are 
reported for several variants within this region. Secondly, the genomic region around 
the EPAS1 locus shows high evolutionary conservation of  DNA sequence across 
different species with three ECRs (Figure 4.7) that span both intronic and exonic 
regions, suggesting an important role of EPAS1 during development, hypoxic 
response and diseases (132, 142, 324, 325). Lastly, the importance of this locus is 
supported by the preliminary functional results showing differential expression of 
EPAS1 between hypoxia and normoxia and between introgressed and non 
introgressed samples (Figures 4.12 and 4.13). 
We do not know if the Denisovan population was adapted to live at high 
altitude and if the EPAS1 haplotype was selected in Denisovans for this function. It 
could be also that this haplotype carried out a different function in Denisovan 
physiology, unrelated to high altitude adaptation. Thus, the biological functional 
consequences of EPAS1 of the Denisovan haplotype are unknown. Initial attempts at 
characterizing the EPAS1 molecular function showed its downregulation in Tibetans 
and has been tentatively interpreted as agreement with the Tibetan phenotype of low 
red blood cell count (209). However, the published study had many limitations and 
the necessity for new functional studies stimulated the development of the hypoxic 
protocol and experiments described in this chapter. The detection of expression of 
EPAS1 in human LCLs makes them a usable model for hypoxic experiments. The 
comparison of EPAS1 expression levels in LCLs together with a positive control lung 
cell line, A549, confirmed that EPAS1 expression is induced at different time points in 
different cell lines and, thus, can play a role in response to hypoxia (Figures 4.10-
4.13).  
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Analyses of publicly available RNA-seq data show that EPAS1 expression is 
more localised to specific tissues than HIF-1α, which seems to have a more generalist 
function in the hypoxic response (141, 302) (Figure 4.2). In particular, expression of 
EPAS1 shows very high levels in endothelial, cardiac and lung tissues (Figures 4.3and 
4.4).   The differential expression of EPAS1 in LCLs with or without the introgressed 
haplotype supports the hypothesis that this gene is critical for the adaptive response 
to hypoxia (Figures 4.12 and 4.13). However, all cell lines with the introgressed 
haplotype used in this study show similar haplotypes for the entire ~32.7 kb core 
region, which makes it difficult to pinpoint the exact functional variant(s) (Figure 4.2). 
Other genes such as EGLN1 have also been implicated in the high altitude adaptation 
of Tibetans.  The qPCR results show differences in expression of EGLN1 and HIF-1α at 
4 hours of hypoxic exposure although this variability involve only two non 
introgressed LCLs (HG02153 and HG00881) and A549 (Figures 4.9 and4.10). HIF-1α 
expression at 4 hours can support the idea that this gene plays central role in the acute 
phase of hypoxic exposure (141, 306). Particularly, EGLN1 differences in expression 
seem to not correlate with the presence of rs186996510 and rs12097901 suggesting 
that these variants do not have large effects on expression levels, consistent with their 
annotation as missense variants (Table 4.1, Figures 4.10 and 4.11).  
RNA-seq data generated by this study will provide a better understanding of 
the molecular pathway of high altitude adaptation in the Himalayan populations. The 
preliminary QC and analyses of the data show that their quality is sufficiently good 
(Figure 4.13, 4.14 and 4.15). They also show that the hypoxic condition in cell culture 
was reached, and differential expression between hypoxia and normoxia is detectable 
(Figure 4.16 and 4.17). Further comprehensive analyses of the RNA-seq data will 
provide some insight of the possible underlying biological function which could 
hopefully explain some aspects of the mechanism of high altitude adaption of the 
introgressed haplotype in EPAS1 gene. 
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5. General discussion 
5.1 Summary 
 
The geographical structure of the Himalayan region has played a strategic role 
in shaping the genetic, cultural and ethno-linguistic mosaic of South and East Asia. 
Isolation, genetic drift and natural selection have all potentially moulded the genetics 
of populations residing in this area. All these factors make the Himalayan populations 
exceptional candidates for understanding human evolutionary dynamics in a complex 
area.  Although many genetic studies have been published on the Himalayan region, 
most of them have focused on specific populations such Tibetans and Sherpa, or the 
surrounding regions, or on the relationship between Tibetans and Han Chinese (50, 
99, 117, 119).  
In a previous collaborative study, we carried out the first genetic study of a 
broad number of Himalayan populations using autosomal STRs, and highlighted the 
high genetic complexity of the region (111). However, a comprehensive survey of the 
genetic variability and the broad population history of the Himalayan region has been 
missing. In this dissertation, I describe the work done on the genetic characterisation 
of 52 autochthonous groups from Nepal, Bhutan, North India, and the Tibetan Plateau 
in China, and have carried out a preliminary exploration of the biological mechanism 
underlying the genetic adaptation in these populations. Firstly, I elucidated their 
genetic structure and population demography using a combination of SNP-genotype 
data and high coverage whole-genome sequences. All the Himalayan populations 
share ancestry with their geographical neighbours in South and East Asia. 
Nevertheless, Himalayans share a common ancestral population that is abundant in 
most Himalayans, but rare elsewhere, followed by the development of local fine 
structure which is influenced by both language and geography.  An exception, 
however, is that all of the high altitude populations from Tibet, Bhutan and Sherpa 
from Nepal showed a high genetic affinity with recent split times from one another 
during the last 5,000 years, regardless of their geographical and linguistic 
distribution. This conclusion is in contrast to a previous study which suggested a 
geographical cline within high altitude populations, with geographically closer 
populations having more genetic affinity (120) which could be due to the limited 
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number of populations included and lack of Bhutanese populations. The high genetic 
similarity of high altitude populations could be explained by archaeological evidences 
of permanent settlement at extreme high altitudes, above 3000 meters, only from 
~3,600 years ago. The agricultural shift from a millet based economy to a barley one 
seems to have played a role in this transition to higher altitudes. Barley can bear 
better hypoxic conditions, has a longer growing season and it is more frost-hardy 
compared to millet (326, 327). This agricultural shift together with sheep husbandry 
may have allowed people to thrive at extreme high altitudes only in very recent times 
(327). This would support our results suggesting that high altitude adaptation 
originated in a single ancestral population and subsequently spread widely across the 
Himalayas, illustrated by the presence of a shared high altitude genetic component 
correlating with altitude reported here, and the EPAS1 adaptive haplotype being 
widely distributed across the region in an altitude-dependent manner as described 
previously (127). The archaeological evidences would also explain our results of the 
very recent split times within the different high altitude populations.  
It has been suggested that the Himalayas were a corridor for human 
migrations from the Tibetan plateau to South Asia in ancient times, or alternatively 
have represented a natural barrier to gene flow between South and East Asia and 
remained uninhabited until more recent times (105-107, 328). Archaeological 
evidences for intermittent human presence in the Tibetan Plateau date back from at 
least 40,000-30,000 years ago (110, 329). These mostly include human handprints 
and footprints, animal bones and stone artefacts (327). It is plausible that these 
remains are traces of early waves of people reaching those altitudes, possibly tracking 
game. However, it is unlikely these early people would have been the first permanent 
dwellers of the Himalayan region. The population split times between Himalayan and 
South and East Asian populations, as well as their genetic affinities, can shed light on 
the settling and the movements of people in the region. Himalayan populations 
separated first from South Asians between 20,000 and 10,000 years ago and 
subsequently from East Asians around 9,000 years ago. Himalayas also show different 
proportions of South and East Asian recent admixture among themselves. These time 
estimations suggest that the ancestors of present-day Himalayans probably arrived 
through waves of migration during the early Neolithic. Previous studies reported that 
the Tibetans have a high genetic affinity with East Asians and gene flow, in particular 
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to Han Chinese, with a population split time around 7,000-9,000 years ago (118, 119). 
Here, I have further shown that other high altitude populations within this region also 
have a high affinity to East Asians, with a more recent split from East Asian 
populations in comparison to South Asians. This is again supported by archaeological 
evidences that report the establishment of the first villages at elevated altitudes 
(~2,500 m) in the north-eastern Tibetan Plateau, along the Yellow river, from around 
5,200 years ago, possibly due to population expansion from neighbouring areas. It is 
plausible that from these areas populations expanded further up in altitudes and 
colonised the Himalayan arc. As previously mentioned, permanent settlements at 
altitudes greater than 3,000 meters were probably allowed thanks to a shift in the 
agro-pastoral economical system in the last ~3,600 years (327). Although high 
altitude populations are genetically closer to East Asians, they also show different 
degrees of South Asian admixture, like other Himalayan populations probably due 
recent admixture events.  
In contrast, some Nepalese populations (for example, Chetri and Tharu) 
showed a higher proportion of South Asian admixture with an earlier population split 
time from East Asians compared to the South Asian populations. This could suggest 
extensive admixture with other South Asians populations in recent times: This 
hypothesis is supported by the analyses of autosomal markers, Y chromosomes and 
mtDNA. The patterns of rare variant sharing (singletons and f2 variant sharing) and 
admixture analyses such ALDER, highlighted that these gene flows occurred recently, 
between 2,000 and 200 years ago. The Y and mtDNA lineages in the Himalayans are 
commonly found in South and East Asia, and are widespread across the region. The Y 
chromosomes of the Himalayans, however, often form distinct Himalayan-specific 
clusters with very short branches, suggesting a rapid male expansion across the 
region around 1,000 years ago. This could suggest a second hypothesis of the 
colonisation of the Himalayan region: Populations in the South Asian side of the 
Himalayan foothills settled in the area in older times and then mixed with the people 
expanding from East Asia in more recent times. This could explain the later population 
split time from South Asian populations compared to the East Asians. It would also 
explain the rapid male expansion seen in the Y chromosome, comprising mostly East 
Asian haplogroups (O2 and D). Demographic model simulations and additional 
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research on these populations is needed to further understand the peopling of the 
Himalayan region. 
Overall, the genetic evidence supports the hypothesis of the Himalayas being 
used as a corridor for human migration with bidirectional gene flow. The Himalayas 
could also possibly have been used by archaic populations as a corridor between 
South and East Asia. However, further research is needed to understand the area 
occupied by archaic humans such as Denisovans (330, 331).  
The current work thus provides a comprehensive description of the genome-
wide genetic variation and fine-scale population structure in the previously 
underrepresented Himalayan region. The data generated here fill a gap in South and 
East Asia genetic variability and can be used as a reference panel for the region. 
Furthermore, the study highlights how the complex geography and culture in the 
Himalayan region have shaped the evolutionary and population-genetic dynamics. 
Different populations show different degrees of isolation and genetic differentiation 
within the same region. For example, Lhokpu, Mönpa and Toto showed the highest 
genetic drift. Others such as Chetri and Tharu show high population growth and high 
heterozygosity which can be explained by admixture with South Asians. Socio-
cultural structures such as language and the caste system might also have played an 
active role in shaping the population structure in present day Nepal.  
Himalayan populations reside at a broad range of altitudes and in different 
environments, ranging from tropical forest to some of the world’s highest mountain 
peaks, which make them ideal to study genetic adaptation. Several statistical 
frameworks were applied to both SNP-genotype data and whole-genome sequences 
to explore the genetic adaptation at both high and low altitudes. The most convincing 
example of positive selection for low altitude adaptation was the α-thalassaemia 
variant in the Tharu population that is reportedly protective against malaria (46, 
223). High altitude adaptation in Himalayans has been of great interest in the past 
decade and many candidate genes have been associated with it in studies of Tibetans 
and Sherpa. The availability of populations living at a wide range of different altitudes 
gave additional power to validate known loci and identify novel candidates associated 
with high altitude adaptation. EPAS1 selection, its relevance to high altitude 
adaptation, and introgression from Denisovans have previously been reported (99, 
104). However, functional studies of EPAS1 variants has not been systematically 
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carried out and it is still unknown which variants are key and what their underlying 
biological mechanism is. The complicated linkage disequilibrium pattern of the EPAS1 
region, together with the length of over 300 kb of the introgressed region, makes it 
hard to prioritise functional variants. The previous work and studies reported in this 
thesis have together highlighted 14 potential drivers (Figure 5.1, Table 5.1).  
 
Variant Genomic location 
(GRCh38) 
Gene Present in four 
introgressed cell lines 
rs370299814 chr2: 46334261 EPAS1 YES* 
rs115321619 chr2: 46340777 EPAS1 YES 
rs73926263 chr2: 46341541 EPAS1 YES 
rs73926264 chr2:46341878 EPAS1 YES 
rs73926265 chr2:46342631 EPAS1 YES 
rs55981512 chr2: 46343203 EPAS1 YES 
rs150877473 chr2:46360880 EPAS1 YES 
rs141366568 chr2:46366983 EPAS1 YES* 
rs1868092 chr2:46387063 EPAS1 YES** 
rs12986653 chr2:46490951 ATP6V1E2 YES** 
rs982414 chr2:46618437 CRIPT NO 
4bp deletion chr2:46350662-
46350664 
EPAS1 YES*** 
TED (3.4 kb deletion) chr2:46467138-
46470544 
TMEM247 YES**** 
NOTE: * derived allele absent in HG02396, ** present in various 1000 Genomes Project samples, *** 
present in the four introgressed cell lines and HG02390, **** present in various 1000 Genomes Project 
samples but not in HG02396. 
 
Table 5. 1 Potential drivers of selection in the EPAS1 region. In bold are the variants falling within the 
highly differentiated ~32.7 kb region in EPAS1. 
 
EPAS1 plays an important role not only in response to physiological hypoxia, 
but also in development and diseases like cancer. It is essential for correct heart 
development during embryonic stages (132, 324, 332). Understanding the genetics 
and physiology of high altitude adaptation is important not only for those interested 
in human adaptation and evolution, but can be also medically relevant for 
understanding mountain sickness and chronic obstructive pulmonary disease, and for 
cancer development mechanisms and angiogenesis. So understanding the molecular 
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mechanisms and validating variants of EPAS1 for high altitude adaption is a key step 
and in vitro work on EPAS1 differential expression between cell lines with and without 
the introgressed core Denisovan haplotype under hypoxic condition could potentially 
shed light on this. I developed an optimised protocol to carry out the hypoxic 
experiments in normal cell culture incubators. The protocol is user-friendly and can 
be used across different laboratories on any available cell lines. The steady and low 
expression of EPAS1 in introgressed cell lines under hypoxic condition is in agreement 
with the physiological response and phenotype in Himalayans, which is characterized 
by low red blood cell count that is tightly regulated by erythropoietin (EPO).  In light 
of these results, among the potential drivers of selection, I could exclude rs370299814 
and rs141366568 because there was not a difference in EPAS1 expression between 
cell lines with the introgressed haplotype carrying those alleles (HG00987, HG02187 
and HG02397) and the one (HG02396) ancestral for them. Likewise, the TED deletion 
downstream of EPAS1 has been detected in multiple individuals of the 1000 Genomes 
Project, yet is absent in HG02396.  I could also exclude rs982414 because this variant 
was not present in the cell lines used for this study. Furthermore, because change in 
expression levels between introgressed and non-introgressed cell lines only involved 
the EPAS1 gene and not the neighbouring genes (TMEM247, ATP6V1E2, CRIPT, PIGF), 
it is also likely that rs12986653 is not the responsible variant for the assessed 
phenotype. Finally, the 4bp deletion is carried by all four introgressed cell lines 
together with HG02390, a cell line that does not carry the derived state of the other 
variants. Further analyses of RNA-seq and qPCR profiles could help to understand if 
this deletion could be functional in HG02390 and the other introgressed cell lines. On 
the other hand, candidates supported for being potential drivers of the adaptive 
phenotype are the SNPs within the core Denisovan haplotype (rs115321619, 
rs73926263, rs73926264, rs73926265, rs55981512) and the nearby variant 
predicted to affect splicing (rs150877473). All four introgressed cell lines used in this 
project carried all these variants that lie in the ~32.7 kb which includes the most 
highly differentiated variants between Han and Tibetans (FST > 0.85).  
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Figure 5. 1 Genomic location of potential drivers of selection in EPAS1 region. In red are indicated 
variants falling the highly differentiated ~32.7 kb region in EPAS1. 
 
Further studies to understand whether the EPAS1 differential expression 
observed between the introgressed and non-introgressed LCLs involves a cis or trans 
regulation, and to further narrow down the functional variants are still required. 
Furthermore, exploring the potential interaction of EPAS1 with the other candidate 
genes associated with high altitude adaptation would help to identify the molecular 
cascade activated in response to hypoxia in Himalayans.  
In conclusion, the combination of SNP genotyping with whole-genome 
sequences is a powerful approach to study population demographic history and 
genetic adaptation; functional studies are essential to further understand the 
underlying biological mechanism of the genetic adaption to high altitude living in the 
Himalayas.  
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5.2 Next steps 
 
In-depth analyses of the RNA-seq data generated for the introgressed and non-
introgressed cell lines cultured under normoxic and hypoxic conditions will be the 
next steps. These include analysing differential expression of EPAS1 and other genes 
involved in the hypoxic pathway and estimating the impact of specific variants in 
splicing and predicting possible eQTLs, as well as genome-wide changes of expression 
levels in both acute (4 hours) and chronic hypoxia (72 hours) in LCLs and the A549 
cell line. These should allow the understanding of differential response in cell lines 
with and without the EPAS1 core Denisovan introgressed haplotype and other 
variants. Any potentially interesting differentiated genes discovered from RNA-seq 
analyses can subsequently be validated using qPCR. 
The population-genetic studies presented in this thesis have identified several 
other candidates for positive selection at high altitude. A similar approach of 
pinpointing likely functional variants in the sequence data and further exploring their 
function in cell lines can potentially be applied in a systematic way. 
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5.3 Future research 
 Himalayan populations have been poorly represented in genome-wide studies 
of human variation, and even fewer studies of various diseases in populations residing 
at high altitude have been published. The genetic and physiological changes that 
enabled adaption to the harsh environment at high altitude, which include increased 
ultraviolet radiation, hypobaria and hypoxemia, may have altered the susceptibility 
to diseases and innate defence mechanisms against microbial infection in these 
populations. It has been reported that people living in high altitude environments 
have a higher incidence of digestive system disease; the gut wall is an essential barrier 
for preventing bacterial infection and endotoxin entering human organs (333). 
Tibetans have evolved a mechanism of protection against intestinal injuries by 
downregulating EGFR, GRB2, and PTPN11 genes, but have a higher prevalence of 
congenital heart disease in children (334). It has also been reported that young 
children and infants at high altitudes have higher rates of hospitalization for 
bronchiolitis and pneumonia due to respiratory syncytial virus (RSV) infection, and it 
is suggested that physiological adaptation to altitude leads to more severe 
consequences in RSV infections (335). These, together with other reports suggest that 
there are differences in predisposition to diseases and in the immune response to 
pathogens in the high altitude populations (336-339).  Both genome-wide association 
and functional genomic studies are very much needed in these populations to both 
better understand the consequences of high altitude adaptation and improve health 
care for these populations. Some of the Himalayan populations have experienced 
severe bottlenecks and it is important to understand the resulting genetic burden of 
these events. 
A lot more work is needed to further understand the detailed biology and 
function of EPAS1 and the underlying mechanism of high altitude adaptation. Since 
the first reports of EPAS1 being under strong positive selection in Tibetans, it has been 
widely accepted that this gene was associated with high altitude adaptation in this 
population and it was from an introgression event from the Denisovans into modern 
humans (99, 104, 145). Reduced oxygen levels and hypobaric hypoxia can 
considerably challenge the normal life and reproduction of different species and thus 
acting as selective pressure (340). However, EPAS1 plays a plethora of roles in 
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different biological pathways, including immunity against pathogens and athletic 
performance that would have played a key role to escaping predators (341-343). 
Hypoxia inducible factors play an important role regulating both innate and adaptive 
host immune response (344). Oxygen deprivation can dramatically affect running and 
physical resistance performance and hypoxic factors play an important role in 
regulating hypoxic levels in tissues (345). Currently, we do not know which function 
EPAS1 had in the Denisovan population and if the original purpose of the introgressed 
haplotype was to give advantage to live at extreme altitudes. Consequently, we could 
argue that the primary function of EPAS1 was not related to high altitude adaptation. 
High altitude adaptation in humans is an example of convergent evolution in three 
main populations: Himalayans, Andeans and Ethiopians (131, 133, 346). This 
adaptation involves both a set of shared and unshared genes between populations: 
five genes (EDN1, EDNRA, EGLN1, NOS1 and VEGFA) but not EPAS1 are shared across 
the three continental areas suggesting their essentiality in high altitude adaptation 
(Figure 1.1). This could suggest that EPAS1 represents a secondary candidate to high 
altitude adaptation. 
 Despite the original function of EPAS1, more work is needed to understand the 
role of the introgressed haplotype and EPAS1 function in high altitude adaptation. 
First, the differential expression of EPAS1 and other hypoxic factors at the protein 
level should be investigated in cell lines with and without the introgressed haplotype 
under hypoxic conditions. This will need an optimised protocol for protein extraction 
from samples exposed to hypoxia, as hypoxia inducible factors (HIFs) get quickly 
degraded when exposed to normoxia via the VHL-mediated ubiquination pathway 
(347). A potential way around this would be to use proteasome inhibitors such as 
MG132, which is an oxygen scavenger and stabilises the hypoxic condition (347), 
although it can also be toxic to the cells. If the in-depth analyses of the RNA-seq data 
fail to identify plausible functionally important variants in the 300 kb positively 
selected haplotype, an alternative approach would be to sequentially delete sections 
of the introgressed genomic region in suitable cell lines using CRISPR-Cas9 genome 
editing in order to potentially narrow down to the critical genomic area containing 
the functional variants. Subsequently, the variants within the candidate region could 
be further explored at the single point mutation level using the same approach.  
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Many population-genetic studies have identified candidate regions/variants of 
positive selection in different human populations, yet their relevant biological 
function and mechanism in improving reproductive fitness usually remains unknown 
or under-studied. Large-scale functional studies of all variants positively selected in 
any population will provide a comprehensive picture and full understanding of the 
molecular mechanisms and biological interaction network of human adaption and 
their potential health consequences. 
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APPENDIX A 
 
Y chromosome tree of 1000GP and Himalayan 
individuals (GRCh38) 
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APPENDIX B 
 
List of Denisovan introgressed SNPs  
 
Denisovan SNPs within Himalaya- specific introgressed 
tracts  
 
CHR    - chromosome 
POS    -genomic position 
SNP    - SNP rs number 
ALLELE   - archaic allele  
HGNC   -gene name 
CONSEQUENCE  - functional prediction (VEP) 
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Denisova introgressed SNPs 
CHR POS SNP ALLELE HGNC CONSEQUENCE 
1 6354421 rs568534004 G - open_chromatin_region 
1 6367361 rs538578120 C - open_chromatin_region 
1 6389990 rs545807707 G - enhancer 
1 6390320 rs562430899 A - enhancer 
1 6438420 rs577801293 A - CTCF_binding_site 
1 6536773 rs544195746 T - CTCF_binding_site 
1 14049383 rs74557977 T - promoter_flanking_region 
1 14050239 rs78095306 G - promoter_flanking_region 
1 14050615 rs77986549 A - promoter_flanking_region 
1 14060211 rs114023548 C - promoter_flanking_region 
1 14079247 rs532546078 C - promoter_flanking_region 
1 14118977 rs116702257 C - open_chromatin_region 
1 33631004 rs142594804 C - open_chromatin_region 
1 33642134 rs3766817 C - open_chromatin_region 
1 33752272 rs77880723 G - open_chromatin_region 
1 33766943 rs146318909 T - open_chromatin_region 
1 33801928 rs117765738 T - promoter_flanking_region 
1 33804437 rs117836468 C - promoter_flanking_region 
1 113245618 rs368840677 T RHOC splice_region_variant,intron_variant 
1 113250043 rs375619655 A - promoter 
1 167683557 rs376459065 C - promoter_flanking_region 
1 167774578 rs150219328 C - enhancer 
1 167786711 rs147629796 A - TF_binding_site 
1 229477835 rs571590141 A - promoter 
1 232645738 rs7552486 C - open_chromatin_region 
1 232649763 rs766435961 G SIPA1L2 synonymous_variant 
2 21242771 rs200868559 C APOB synonymous_variant 
2 21264999 rs531023775 A - TF_binding_site 
2 21266363 rs570818403 T - promoter_flanking_region 
2 21266980 rs547640128 T - promoter_flanking_region 
2 23265626 rs75127632 T - open_chromatin_region 
2 33363144 rs140066553 C - promoter_flanking_region 
2 33370502 rs79979829 G - open_chromatin_region 
2 33371346 rs79037232 A - open_chromatin_region 
2 45464590 - G,A - promoter_flanking_region 
2 46406589 rs1968635 G - enhancer 
2 46406619 rs1530668 G - enhancer 
2 46409146 rs3754559 T - open_chromatin_region 
2 46412422 rs2278773 G - CTCF_binding_site 
2 46456816 rs79136032 A - promoter_flanking_region 
2 46495437 rs368889159 A - promoter_flanking_region 
2 46521270 rs373013254 T - CTCF_binding_site 
257 
 
 
 
CHR POS SNP ALLELE HGNC CONSEQUENCE 
2 46533730 rs375877310 T - promoter_flanking_region 
2 46558530 rs375418933 C - promoter_flanking_region 
2 46561400 rs370299814 A - promoter_flanking_region 
2 46561659 rs368706892 T - promoter_flanking_region 
2 46577808 rs555698019 A - promoter_flanking_region 
2 47570709 rs554756783 C - CTCF_binding_site 
2 47630045 rs786202645 T - promoter 
2 47766727 rs538742577 T - CTCF_binding_site 
2 47796858 rs370357176 A - promoter_flanking_region 
2 47798125 rs541185621 T - promoter_flanking_region 
2 47799856 rs570702589 G AC138655.1 missense_variant 
2 97007908 rs774996456 T - open_chromatin_region 
2 101554875 rs78527344 A - open_chromatin_region 
2 101558505 - T,A - open_chromatin_region 
2 109165478 rs199597739 C - open_chromatin_region 
2 109196758 rs143717707 T - enhancer 
2 109253205 rs201901817 T - promoter_flanking_region 
2 167011292 rs3886534 T - TF_binding_site 
2 211442785 - G - CTCF_binding_site 
2 231973651 rs760260232 T HTR2B synonymous_variant 
2 231975795 rs907215603 C - open_chromatin_region 
2 231988965 rs888680018 G - promoter_flanking_region 
2 232011670 rs1042559328 G - open_chromatin_region 
2 232018264 rs764590208 G - open_chromatin_region 
2 232025455 rs1042480674 T - promoter_flanking_region 
2 232035351 rs751952582 G PSMD1 synonymous_variant 
2 232037004 rs1030146827 G - open_chromatin_region 
2 232037080 rs949733786 A - open_chromatin_region 
2 232049910 rs955445159 T - enhancer 
2 232063420 rs980173749 A - promoter 
2 232077473 rs890075866 A - open_chromatin_region 
2 232092252 rs924574717 T - CTCF_binding_site 
2 232100085 rs370669179 T - open_chromatin_region 
2 233791484 rs144485640 G - promoter_flanking_region 
2 234091138 rs70940832 T INPP5D synonymous_variant 
3 15351858 rs139347281 T - promoter_flanking_region 
3 45970944 rs13099120 G - CTCF_binding_site 
3 186710784 rs542973619 T - enhancer 
4 3419093 rs16844311 T RGS12 splice_region_variant,intron 
4 186578505 rs2306704 G - enhancer 
5 67111452 rs117153929 A - open_chromatin_region 
5 77353203 rs117785921 T - open_chromatin_region 
5 142077223 rs117020353 A - promoter_flanking_region 
258 
 
 
 
CHR POS SNP ALLELE HGNC CONSEQUENCE 
6 7975489 - C - promoter_flanking_region 
6 10521305 rs72821511 C - promoter_flanking_region 
6 10522868 rs72821513 G - promoter_flanking_region 
6 25015153 rs367724830 G - enhancer 
6 30012624 rs114315683 A - open_chromatin_region 
6 35454554 rs75480498 T - promoter_flanking_region 
6 35461867 rs72894781 A - promoter_flanking_region 
6 35471721 rs188389031 C - CTCF_binding_site 
6 56620831 rs145031609 C - enhancer 
6 99958077 rs748665547 A USP45 missense_variant 
6 99964134 rs986920319 T - promoter 
6 100023574 rs330850 C - open_chromatin_region 
6 119631639 - G,T - enhancer 
6 119634071 rs77683431 T - promoter_flanking_region 
6 119634137 rs78585986 G - promoter_flanking_region 
6 119635876 rs3798635 C - promoter_flanking_region 
6 119636240 rs3823001 A - promoter_flanking_region 
6 119636490 rs3798637 A - promoter_flanking_region 
6 119636588 rs3798638 A - promoter_flanking_region 
7 17514707 rs187739737 T - CTCF_binding_site 
7 17514772 rs191428236 A - CTCF_binding_site 
7 80488999 rs79725824 T - open_chromatin_region 
7 80506633 rs138238608 A - TF_binding_site 
7 80513534 rs186257173 G - promoter_flanking_region 
7 149510149 rs740112 T - CTCF_binding_site 
7 149519760 rs202144866 C - open_chromatin_region 
7 149559072 rs200599838 T ZNF862 synonymous_variant 
8 10555301 rs77073793 T C8orf74 missense_variant 
8 21614351 rs559929741 T - enhancer 
8 21614507 rs184078269 T - enhancer 
8 37403652 rs375443835 A - promoter_flanking_region 
8 38446214 rs569518627 A - open_chromatin_region 
8 38483175 rs566392509 G - CTCF_binding_site 
8 53303768 rs1026771210 A - TF_binding_site 
9 36867495 rs17391491 A - CTCF_binding_site 
9 36867507 rs77776435 A - CTCF_binding_site 
9 100871756 rs1035579538 G - promoter_flanking_region 
9 100880885 - A - promoter 
9 113732569 rs16915602 T - open_chromatin_region 
9 138133766 rs940329833 T - CTCF_binding_site 
10 80893337 rs80183004 T - enhancer 
10 112506454 rs531624200 C - CTCF_binding_site 
10 119223386 rs560418517 C - open_chromatin_region 
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CHR POS SNP ALLELE HGNC CONSEQUENCE 
10 119236269 rs533194625 T - open_chromatin_region 
10 126236440 rs17695019 C - open_chromatin_region 
11 8615738 - T - promoter 
11 8634657 - A - open_chromatin_region 
11 8634687 rs181255316 C - open_chromatin_region 
11 29287690 rs183865464 A - TF_binding_site 
11 36399086 rs191868665 T - promoter 
11 36402967 rs117520408 G - promoter_flanking_region 
11 36406842 rs117153510 A - open_chromatin_region 
11 83424833 rs80154930 T - TF_binding_site 
11 83436260 rs180851175 G - CTCF_binding_site 
11 110045286 rs1040021791 G - promoter_flanking_region 
11 113954215 rs118050126 C - promoter_flanking_region 
11 125812061 - G,A - TF_binding_site 
11 131618541 rs570541277 C - CTCF_binding_site 
11 131618935 rs530598977 A - open_chromatin_region 
11 131619057 rs546924141 G - open_chromatin_region 
12 6184143 rs2239155 A - promoter_flanking_region 
12 6187788 rs117115831 A - enhancer 
13 21063533 rs202040300 G - CTCF_binding_site 
13 114880593 rs117295582 T - enhancer 
13 114912023 rs12585992 T - CTCF_binding_site 
13 114944785 rs118122842 T - CTCF_binding_site 
14 53618860 rs561056322 A - promoter 
14 79977041 rs77934216 G - open_chromatin_region 
14 91164759 rs78720229 T - enhancer 
14 96728122 rs34334635 A - open_chromatin_region 
15 28340920 rs180681661 T - promoter_flanking_region 
15 71510985 rs543912832 T - open_chromatin_region 
15 85877075 - A,T - enhancer 
16 3026680 rs4149788 A PKMYT1 synonymous_variant 
16 3027039 rs4149785 A PKMYT1 splice_region_variant,intron_variant 
16 87712807 rs936651169 T - CTCF_binding_site 
16 87715900 - G - open_chromatin_region 
16 87717790 rs753264216 G JPH3 synonymous_variant 
16 87732196 - T - TF_binding_site 
16 87736136 rs1027754692 A - promoter_flanking_region 
17 7034452 - A,C - promoter_flanking_region 
18 22585593 rs79111688 G - open_chromatin_region 
18 47638207 rs138261729 G - CTCF_binding_site 
18 47678309 rs371235559 T - open_chromatin_region 
18 47688484 rs374840270 T - CTCF_binding_site 
18 60021761 rs35211496 T TNFRSF11A missense_variant 
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CHR POS SNP ALLELE HGNC CONSEQUENCE 
19 2043107 rs146470954 C - promoter_flanking_region 
19 41622495 rs76335535 A CYP2F1 missense_variant 
19 41626271 rs139705553 T CYP2F1 synonymous_variant 
20 2723275 rs574706705 G - CTCF_binding_site 
20 18393782 rs143400891 C - promoter_flanking_region 
20 18395092 rs139700575 T DZANK1 missense_variant 
21 17923179 rs78195113 G - open_chromatin_region 
21 17923777 rs79615460 A - open_chromatin_region 
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APPENDIX C 
 
List of FineMAV candidates  
 
100 top scoring SNPs detected by FineMAV  
 
CHR    - chromosome 
POS    -genomic position 
SNP    - SNP rs number 
HGNC   -gene name 
ANC_ALLELE  -ancestral allele 
DER_ALLELE  -derived allele  
FineMAV_POP -FineMAV score in relevant population 
CONSEQUENCE - functional prediction (VEP) 
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High versus low altitude Himalayans 
High altitude 
CHR POS SNP HGNC ANC_ALLELE DER_ALLELE FineMAV_HIM_H CONSEQUENCE 
1 1417587 rs181312132 ATAD3B . T 2.598 missense_variant 
1 9009451 rs2274329 CA6 G C 2.4202 missense_variant 
1 158549492 rs863362 OR10X1 C T 2.4901 stop_gained 
1 230745328 - RP11-
543E8.2 
C T 2.492 downstream_gene_variant 
1 236195728 rs78916782 NID1 C T 3.234 missense_variant 
2 3358295 rs12612251 TSSC1 T C 2.4011 intron_variant 
2 34525050 rs181481277 AC009499.1 G A 2.4622 downstream_gene_variant 
2 46552202 rs149594770 EPAS1 T A 3.3245 intron_variant 
2 46553044 rs113305133 EPAS1 A G 2.4851 intron_variant 
2 46553781 rs369553078 EPAS1 T A 3.219 intron_variant 
2 46558530 rs375418933 EPAS1 G C 2.5049 intron_variant 
2 46568084 rs150049928 EPAS1 C T 2.4673 intron_variant 
2 46569770 rs73926265 EPAS1 G A 3.2876 intron_variant 
2 46576918 rs76242811 EPAS1 T C 2.9492 intron_variant 
2 46577251 rs188801636 EPAS1 T C 6.2474 intron_variant 
2 46577808 rs555698019 EPAS1 T A 7.3718 intron_variant 
2 46583581 rs189807021 EPAS1 G A 3.1901 intron_variant 
2 46588019 rs150877473 EPAS1 C G 4.6218 splice_region_variant,intron_variant 
2 46589032 rs74898705 EPAS1 C T 2.9138 intron_variant 
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CHR POS SNP HGNC ANC_ALLELE DER_ALLELE FineMAV_HIM_H CONSEQUENCE 
2 46598025 rs141426873 EPAS1 C G 3.2968 intron_variant 
2 4660030 rs116611511 EPAS1 A G 4.6302 intron_variant 
2 46600358 rs369097672 EPAS1 A G 6.6004 intron_variant 
2 46656647 rs56048837 TMEM247 G C 2.736 upstream_gene_variant 
2 46675505 rs77111769 TMEM247 T C 4.9108 intron_variant,non_coding_transcript_variant 
2 46681989 rs117115595 TMEM247 C T 3.9203 intron_variant,non_coding_transcript_variant 
2 46689216 rs115350785 TMEM247 A G 2.5145 intron_variant,non_coding_transcript_variant 
2 46690452 rs1868082 TMEM247 C A 2.4279 intron_variant,non_coding_transcript_variant 
2 46693330 rs182127341 TMEM247 C A 3.0291 intron_variant,non_coding_transcript_variant 
2 46693993 rs116871724 TMEM247 T A 3.2155 intron_variant,non_coding_transcript_variant 
2 46699639 rs58143719 TMEM247 T C 2.7582 intron_variant,non_coding_transcript_variant 
2 46702159 rs113190671 TMEM247 T G 3.3463 intron_variant,non_coding_transcript_variant 
2 46706765 rs192690066 TMEM247 C T 2.6154 intron_variant,non_coding_transcript_variant 
2 46707674 rs116983452 TMEM247 C T 4.6567 intron_variant,non_coding_transcript_variant 
2 46710530 rs79542054 TMEM247 C T 5.9521 intron_variant,non_coding_transcript_variant 
2 46718090 rs12986653 ATP6V1E2 G A 6.1156 intron_variant,non_coding_transcript_variant 
2 46720010 rs75483237 ATP6V1E2 T G 3.0471 intron_variant,non_coding_transcript_variant 
2 46720473 rs117677853 ATP6V1E2 C T 2.6394 intron_variant,non_coding_transcript_variant 
2 46720802 rs117446572 ATP6V1E2 G A 2.8891 intron_variant,non_coding_transcript_variant 
2 46733738 rs117128262 ATP6V1E2 T C 7.11 intron_variant,non_coding_transcript_variant 
2 46743164 rs117024627 ATP6V1E2 T C 2.8849 intron_variant 
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CHR POS SNP HGNC ANC_ALLELE DER_ALLELE FineMAV_HIM_H CONSEQUENCE 
2 46745024 rs13010097 ATP6V1E2 G A 2.8206 intron_variant 
2 46752292 rs78082841 ATP6V1E2 G A 2.6724 intron_variant 
2 46752876 rs150798075 ATP6V1E2 G T 4.4883 intron_variant 
2 46754702 rs138754673 ATP6V1E2 C T 4.1626 intron_variant 
2 46768078 rs75498296 RHOQ C T 6.1009 upstream_gene_variant 
2 46772997 rs74869223 RHOQ A G 3.7979 intron_variant 
2 46792633 rs139501481 RHOQ T A 3.2163 intron_variant 
2 46797843 rs78123734 RHOQ C G 3.0458 intron_variant 
2 46809046 rs17035318 RHOQ C T 2.7835 3_prime_UTR_variant 
2 46840552 rs118024480 CRIPT T C 3.0555 upstream_gene_variant 
2 46846131 rs117720191 CRIPT C T 2.7119 intron_variant 
2 46863851 rs75553031 - A C 4.2158 intergenic_variant 
2 59732957 rs17050199 AC007131.2 C T 2.4261 intron_variant,non_coding_transcript_variant 
2 146866679 rs73001881 - G T 2.7397 intergenic_variant 
2 146963473 rs2552554 - A C 3.3969 intergenic_variant 
2 161767360 rs2138438 - A C 2.6471 regulatory_region_variant 
3 9870862 rs2290304 TTLL3 G A 2.9988 missense_variant 
3 130031522 - - A C 2.7672 intergenic_variant 
3 130031531 rs1045982388 - C T 2.7363 intergenic_variant 
3 130361856 rs16830494 COL6A6 G A 2.8614 missense_variant 
4 164547367 rs9990679 36951 G C 3.0541 intron_variant 
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CHR POS SNP HGNC ANC_ALLELE DER_ALLELE FineMAV_HIM_H CONSEQUENCE 
6 10070806 rs370734563 OFCC1 - A 4.3426 intron_variant,non_coding_transcript_variant 
6 10587038 rs539351 GCNT2 G C 2.5057 missense_variant 
6 31140909 rs79527728 POU5F1 T G 3.6341 upstream_gene_variant 
6 31502767 rs3131628 SNORD117 T C 2.8806 downstream_gene_variant 
6 31506624 - SNORD117 C T 2.6672 upstream_gene_variant 
6 32609212 rs1142326 HLA-DQA1 . T 3.3247 missense_variant 
6 32628022 rs1140347 HLA-DQB1 . G 2.6002 synonymous_variant 
6 33053609 rs11551421 HLA-DPB1 G A 5.6718 missense_variant 
6 33068772 rs79470430 HLA-DPA2 G A 2.9873 upstream_gene_variant 
6 33071744 rs61074882 COL11A2P1 C T 3.7319 non_coding_transcript_exon_variant 
6 33071839 rs61705355 COL11A2P1 C A 4.8989 intron_variant,non_coding_transcript_variant 
6 45709477 rs57630563 - G T 2.4582 regulatory_region_variant 
6 134385155 rs78562617 - C G 2.8132 regulatory_region_variant 
6 143168431 rs79504391 HIVEP2 T C 2.595 intron_variant 
7 9257189 rs1285418 - G A 2.5189 intergenic_variant 
9 89165089 - - T G 3.6425 regulatory_region_variant 
9 129383900 rs10760442 LMX1B G A 2.9083 intron_variant 
10 115086017 rs79267391 - G A 3.2478 regulatory_region_variant 
10 115096759 rs12573692 - G A 2.6265 intergenic_variant 
10 124936990 rs78590159 - G A 2.5057 intergenic_variant 
11 96757271 rs17129673 - A G 2.7382 intergenic_variant 
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CHR POS SNP HGNC ANC_ALLELE DER_ALLELE FineMAV_HIM_H CONSEQUENCE 
12 57626018 rs11557166 SHMT2 C T 2.5305 synonymous_variant 
12 110350819 rs773936923 TCHP A G 2.4872 missense_variant 
14 37154111 rs201299512 SLC25A21 A C 2.8607 stop_gained 
15 37809660 rs113706235 - C T 2.7775 intergenic_variant 
15 90023558 rs17807723 RHCG G A 3.2258 missense_variant 
17 5960915 rs12944495 WSCD1 A G 2.8401 upstream_gene_variant 
18 58221665 - AC010928.1 C A 2.5594 upstream_gene_variant 
18 72573324 rs17055773 ZNF407 A G 2.5544 intron_variant 
18 72578312 rs7227571 ZNF407 C T 2.5691 intron_variant 
19 56030150 - SSC5D - C 2.5428 stop_gained 
22 24468386 rs17854874 CABIN1 G A 2.5506 missense_variant 
22 44608457 rs139203 PARVG A C 2.4746 downstream_gene_variant 
Y 4733000 - - . A 2.4336 intergenic_variant 
Y 6932163 rs373532788 TBL1Y . A 2.9657 missense_variant 
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High versus low altitude Himalayans 
Low altitude 
CHR POS SNP HGNC ANC_ALLELE DER_ALLELE FineMAV_TIB_L CONSEQUENCE 
1 1423286 rs571285142 ATAD3B . C 2.2791 stop_gained 
1 8418541 rs200525338 RERE C T 2.5369 missense_variant 
1 15770022 COSM897576 CTRC . C 2.3754 3_prime_UTR_variant 
1 23418153 rs10799790 LUZP1 T C 2.2911 missense_variant 
1 40773150 rs12077871 COL9A2 . G 2.1929 downstream_gene_variant 
1 1.52E+08 rs150014958 TCHHL1 . G 2.1533 stop_gained 
1 1.88E+08 rs16827680 - A G 3.163 intergenic_variant 
1 2.04E+08 rs11584773 - T C 2.4775 intergenic_variant 
1 2.04E+08 rs11586883 - T G 2.5548 intergenic_variant 
2 18697640 rs16985174 - C G 2.3117 regulatory_region_variant 
2 33701632 rs17594260 RASGRP3 C T 3.3745 intron_variant 
2 46747867 rs2346416 ATP6V1E2 A G 2.3372 upstream_gene_variant 
2 47039991 rs935376 LINC01118 G A 2.9429 upstream_gene_variant 
2 90259979 rs201899294 IGKV1D-8 . C 2.2158 stop_gained 
2 97860471 rs150846613 ANKRD36 . T 2.2178 missense_variant 
2 1.62E+08 rs55762147 - T C 2.2391 intergenic_variant 
2 1.79E+08 rs4894028 TTN C T 3.1114 missense_variant 
2 1.79E+08 rs62621236 TTN A G 2.7474 missense_variant 
2 1.79E+08 rs747122 TTN C T 2.435 missense_variant 
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CHR POS SNP HGNC ANC_ALLELE DER_ALLELE FineMAV_TIB_L CONSEQUENCE 
2 1.79E+08 rs11897366 TTN A C 2.1655 synonymous_variant 
2 1.79E+08 rs10164753 TTN C T 2.903 missense_variant 
2 1.79E+08 rs10497517 TTN A G 2.5016 synonymous_variant 
2 1.79E+08 rs16866425 TTN T C 2.1862 synonymous_variant 
2 1.8E+08 rs4893852 TTN A G 2.6875 intron_variant 
2 1.8E+08 rs13398235 TTN G A 2.6125 intron_variant 
2 1.8E+08 rs11888217 TTN C T 2.2375 intron_variant 
2 1.8E+08 rs4893853 TTN T C 2.17 missense_variant 
2 1.8E+08 rs4894048 TTN C T 2.3025 missense_variant 
2 2.13E+08 rs13390226 ERBB4 G A 3.399 intron_variant 
3 37562369 rs142719179 ITGA9 C T 2.2588 intron_variant 
3 1.14E+08 rs1025399 GRAMD1C A G 2.2304 intron_variant 
3 1.61E+08 rs223125 B3GALNT1 C T 2.1773 missense_variant 
4 1563853 rs111807331 - T C 2.1587 intergenic_variant 
4 1564086 rs113334316 - C T 2.1587 intergenic_variant 
4 9386295 rs35948112 RP11-
1396O13.13 
. A 3.65 stop_gained 
4 48514580 rs550020018 FRYL C T 2.2902 missense_variant 
4 1.57E+08 rs2705453 - G A 2.2468 intergenic_variant 
5 1.09E+08 rs13181131 PJA2 T C 2.4641 intron_variant 
5 1.77E+08 rs148853192 DOK3 G A 3.6507 upstream_gene_variant 
6 10070806 rs370734563 OFCC1 - G 4.1136 intron_variant,non_coding_transcript_variant 
  
 
 
2
6
9
 
CHR POS SNP HGNC ANC_ALLELE DER_ALLELE FineMAV_TIB_L CONSEQUENCE 
6 25273653 rs77918027 RP3-
522P13.2 
T C 2.1578 splice_donor_variant,non_coding_transcript_variant 
6 32184835 rs151131761 NOTCH4 C T 2.2516 missense_variant 
6 32573713 rs9270974 - . C 2.2307 intergenic_variant 
6 32578040 rs9271174 - . C 2.2664 regulatory_region_variant 
6 32628022 rs1140347 HLA-DQB1 . A 2.8671 synonymous_variant 
6 1.62E+08 rs9355339 AGPAT4 T C 2.3496 intron_variant 
8 39912400 rs2929103 - G T 2.4331 regulatory_region_variant 
8 90507811 - - C T 4.2429 intergenic_variant 
8 1.11E+08 rs78254607 SYBU C A 2.3738 intron_variant 
8 1.22E+08 rs76075043 - C T 2.4696 intergenic_variant 
9 17922765 rs13294429 - T C 2.2668 intergenic_variant 
9 25530564 rs2183901 - T C 2.5563 intergenic_variant 
9 25538211 rs557419369 - T A 2.9447 intergenic_variant 
9 27062721 rs3429 IFT74 C T 2.8875 missense_variant 
9 34306410 rs17350674 KIF24 C A 2.7489 missense_variant 
9 97321410 rs541509845 FBP2 . C 2.2158 missense_variant 
10 25777562 rs1547685 GPR158 A G 2.2212 intron_variant 
10 34582735 rs11009717 PARD3 T A 3.4654 intron_variant 
10 34599236 rs11009725 PARD3 A C 2.8055 downstream_gene_variant 
10 34604895 rs11009730 PARD3 T G 2.948 intron_variant 
10 34626113 rs10508802 PARD3 A G 2.5882 intron_variant 
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CHR POS SNP HGNC ANC_ALLELE DER_ALLELE FineMAV_TIB_L CONSEQUENCE 
10 77874502 rs182098476 C10orf11 C T 2.3887 intron_variant 
10 78784075 rs7922133 KCNMA1 C T 2.3913 intron_variant 
11 20101744 rs1867115 NAV2 A C 3.0006 synonymous_variant 
11 38827333 rs78267989 - T A 2.5183 intergenic_variant 
11 61643375 rs371188401 FADS3 . C 2.1828 missense_variant 
11 1.26E+08 rs115533243 CDON T C 2.6109 missense_variant 
12 20720679 rs12369747 PDE3A C T 2.6788 intron_variant 
12 49304447 rs58829932 CCDC65 T C 2.3363 intron_variant 
12 49333799 rs2228417 ARF3 G A 2.8613 synonymous_variant 
12 54491224 rs12819039 Y_RNA A G 2.5423 downstream_gene_variant 
12 1.1E+08 rs34725387 MYO1H C T 2.243 missense_variant 
12 1.16E+08 rs11614480 - T C 3.3112 intergenic_variant 
12 1.16E+08 rs11615848 - G T 2.4407 intergenic_variant 
12 1.21E+08 rs206968 RP1-
166H1.2 
G C 2.6672 downstream_gene_variant 
13 73675865 rs914799 FABP5P1 A T 2.5125 upstream_gene_variant 
13 73681090 rs2483174 - G T 2.3963 intergenic_variant 
14 37154111 rs201299512 SLC25A21 A C 2.889 stop_gained 
14 98920402 rs11622215 - A G 2.215 intergenic_variant 
15 53782668 rs12916434 - T A 2.1604 intergenic_variant 
15 53811633 rs12902770 WDR72 T C 2.7249 intron_variant 
15 68628163 rs2306022 ITGA11 C T 2.2775 missense_variant 
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CHR POS SNP HGNC ANC_ALLELE DER_ALLELE FineMAV_TIB_L CONSEQUENCE 
16 6675913 rs11648207 RBFOX1 C T 2.1976 intron_variant 
16 31099000 rs201075024 PRSS53 C T 2.7295 missense_variant 
16 75532994 rs385847 CHST6 C T 2.3838 upstream_gene_variant 
16 75532995 rs116974915 CHST6 C A 2.2713 upstream_gene_variant 
17 1340129 rs145983279 CRK C T 2.3596 missense_variant 
17 56387461 rs372749390 BZRAP1 C T 2.1514 missense_variant 
17 76010121 rs76402227 TNRC6C C T 2.3887 intron_variant 
18 23395887 rs117034580 RN7SL97P C T 2.2664 downstream_gene_variant 
18 54697922 rs2848967 WDR7 A G 2.55 3_prime_UTR_variant 
18 66178930 rs17804596 - C A 2.7036 intergenic_variant 
19 10685705 rs375010828 AP1M2 - C 2.247 missense_variant,splice_region_variant 
19 43233421 rs202207386 PSG3 N C 2.2158 stop_gained 
19 52380625 rs149543099 ZNF577 . G 2.247 stop_gained 
19 56030150 - SSC5D - C 2.568 stop_gained 
X 82751254 rs12860283 - C T 2.3331 intergenic_variant 
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APPENDIX D 
 
Experimental protocols used in this study 
- Hypoxic protocol 
- RT-qPCR protocol 
- SYBR Green qPCR Protocol 
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Hypoxic protocol 
Before starting: 
 Prepare conditioned medium: 
o Culture cells in appropriate size flask (T75, T150) under normal culture 
media (21%O2, 37⁰C, 5% CO2). 
o Collect the medium from cultured cells (handle the flask carefully to avoid 
taking too many cells with the medium) and transfer it to a Falcon tube. 
o Centrifuge the medium from cultured cells at 1500 rpm for 4 minutes to 
remove any cell debris, etc. 
o Collect supernatant from the medium of cultured cells (leave ~1 of medium 
in the Falcon tube with the pellet). 
o Mix the same volume (1:1) of the medium from cultured cells with fresh 
medium (RMPI 1640 [Thermo Fisher cat num: 11875093] + 15/20% FBS 
[Thermo Fisher cat num: 10082139 ] + PenStrep [cat num: 10378016 ). 
o Filter the conditioned medium using a 0.2µm filter [Whatman-SIGMA cat 
num: 10462200] in a new Falcon tube. 
o The conditioned medium can be stored in the fridge. Use it within few days 
(3-4 days).  
 
 Automatic count of cell lines for the experiment using trypan blue or AOPI 
(Cellometer 2000). Check cell viability is above 90%. 
Experimental set up: 
 Two conditions: hypoxia (1% O2, 37⁰C, 5% CO2) and normoxia (21%O2, 37⁰C, 5% 
CO2). 
 Time points: 4h, 16h, 24h, 48h, 72h (time points can vary). 
 Replicates: 2 per sample in each condition.  
 Samples labelling: from 1 to total number of samples, replicates indicated as “A” and 
“B”. Maximise randomisation. 
 
Experimental procedure: 
Day 1 
 Label six-well plates according to experimental set up, indicating the time point, 
sample and replicate (important to be able to process hypoxic samples quickly and 
reduce exposure to normoxia). 
 Prepare six-well plates with conditioned medium: fill each well of the six-well plate 
with 3ml of conditioned medium. Total amount of medium: six wells per plate x 
number of six well plates in the experiment (Note: consider all samples, different 
time points and replicates). 
 Place plates with conditioned medium for hypoxic conditions in the hypoxic 
incubator (1% O2, 37⁰C, 5% CO2) and leave overnight to degasify. 
 Number of cells for each cell line: ~1.5x106 cells/ml.  
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 Take the right amount of total cells for each sample (Note: consider all samples, 
different time points and replicates) and place them in a new T25 flask with some 
fresh medium (this is a critical step if cells are not growing well) and leave them 
overnight to adjust. 
Day 2 
 Centrifuge gently (500 rpm, 4 minutes) cells in T25 flasks from Day 1. 
 Note: Total volume for each well: 3 ml of conditioned medium (prepared in Day 1) + 
0.7ml of cells for 72h time point, 1 ml of cells for 24h and 48h time points and 1.5 ml 
for 4h time point (the small volume of cells is important to reduce re-gasification of 
the hypoxic medium). 
 Re-suspend pellet of each cell lines in the right amount of conditioned medium for 
all samples.  
 Take the six-well plates in the normoxic incubator. Seed plates with 1.5 ml of cells 
for 4h time point and with 1ml of cells for 24h and 48h plates. 
 Take the six-well plates in the hypoxic incubator one at the time. Seed plates with 
1.5 ml of cells for 4h time point, with 1ml of cells for 24h and 48h plates and with 
0.7ml for 72h time point.  
 Once all plates are seeded, wait 1h to allow the hypoxic medium to degasify 
completely again and start counting the time points. 
Day3, Day4, Day5 
 When each time point is reached: 
o Label 15ml Falcon tubes with sample name, time point and replicate. 
o Start processing hypoxic samples. 
o Take plates from incubator and transfer quickly samples to the 
Falcon tubes. 
o Centrifuge cells at 500 rcf (~2000 rpm) for 2/3 minutes. 
o Remove supernatant and re-suspend cells in QIAGEN Buffer RLT 
[QIAGEN cat num: 79216]: pipette well up and down and vortex each 
tube to be sure cells are completely lysed. Work on ice. 
o Freeze samples at -80⁰C.  
o RNA extraction: look RNeasy Mini kit protocol [QIAGEN cat num: 
74104].  
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RT-qPCR protocol 
 
 
RNA extraction 
 
Performed with the Qiagen RNeasy mini RNA extraction kit with DNase treatment. 
RNeasy mini kit: 74104 
DNase set: 79254 
 
Use ~1-2x106 cells per 350 µL buffer RLT. 
 
Reverse Transcriptase Protocol 
 
Aim: To convert total RNA into cDNA for use in quantitative PCR 
 
Nanodrop of total RNA 
 
Measure the total RNA on the nanodrop machine to get the concentration and also to 
determine the purity of the RNA isolated. 
 
The 260/280 ratio estimates the amount of protein contamination (measured at 280nm) 
compared to the nucleotide (measured at 260nm) concentration.  A good RNA extraction 
should have a value of above 1.8. 
 
The 260/230 ratio gives the amount of other impurities (measured at 230nm), such as 
ethanol or salt.   A clean extraction should have a value of above 1.8. 
 
Low values for the 260/280 or 260/230 ratio may cause a slight loss in efficiency  
 
Procedure for reverse transcribing 500ng RNA into cDNA for use 
with quantitative PCR 
To convert the total RNA into cDNA, the protocol uses random primers (a mix of different 
hexamers); these will bind to different parts of the RNA and prime the conversion of the 
single stranded RNA into complementary DNA (cDNA) which can then be used for 
quantitative PCR. 
Reagents  
RNA  
Random Primer  Promega C1181 
dNTP   Life Tech 10 mM 
RNASE OUT  Invitrogen 10777-019 
Superscript II  Invitrogen  18064071 
Step 1 - Denaturation of RNA and Primer 
 
Thaw RNA samples on ice to avoid degradation.  After thawing of all reagents, mix the tubes 
by vortexing briefly and then spin down in a micro centrifuge.   
  
Per reaction 
RNA   500ng made up to a total volume of 11.875uL with nuclease free 
water 
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Random Primer 0.5uL 
dNTP   1uL 
 
1. Add the appropriate amount of nuclease free water, random primer and dNTP 
(primer and dNTP can be added together as a mix) to each tube.  
2. Add 500ng of RNA to each tube and spin down to make sure everything is at the 
bottom. 
3. Incubate at 65⁰C in a heat block for 5min, then snap cool on ice.  This step is to 
denature any secondary structure in the RNA and also to denature the random 
primer; the snap cooling ensures that the structure does not reform.  
4. Spin tubes down and place in a rack at room temperature. 
 
Step 2 - Reverse Transcription of RNA 
 
Per reaction – make as a master mix for appropriate number of samples. 
5x 1st strand buffer 4uL 
0.1M DTT  2uL 
RNase out  0.5uL 
Superscript II  0.125uL 
 
1. Add 6.625uL of the master mix to the side of each tube and then spin down. The final 
reaction volume is 20uL. 
 
2. Incubate in heat block/PCR machine.  
25⁰C  x   10min – primer annealing step 
42⁰C  x   50min – extension step  
70⁰C  x   15min – inactivation of enzyme. 
 
Dilute the cDNA to a final volume of 500uL with nuclease free water prior to use for qPCR. 
 
Use 5 µL of diluted cDNA per 20 µL qPCR reaction. 
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SYBR Green qPCR Protocol 
 
Based on using ABI StepOne Plus and KAPA SYBR Fast 2x (KK4604) 
Plates: MicroAmp Fast optical 96-well plates (4346906) and some MicroAmp optical 
adhesive film (4311971). 
 
20 µL reaction 
10 µL 2x KAPA SYBR Fast ABI 
0.8 µL 10 µM primer mix 
4.2 µL nuclease-free water 
5 µL dilutes cDNA 
 
ABI StepOne Plus cycling 
 
95 °C – 3minutes 
95 °C – 20 seconds 
61 °C – 20 seconds x40 
72 °C – 20 seconds 
+melt curve to check for single products (you may want to sequence these amplicons to check 
for specificity). 
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